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 Proper tissue function is maintained by continuous cell renewal of somatic stem cells that 
reside within many tissues. In addition to tissue homeostasis, somatic stem cells are also 
responsible for tissue regeneration after injury and growth during development or high nutrient 
availability. Although these processes occur in many tissues, some basic questions are still left 
unanswered. I investigated fundamental questions, including 1) how somatic stem cells function 
in response to nutrients under renewal versus growth conditions, 2) how overnutrition (i.e. 
obesity) modulates the nutrient-induced alterations in stem cell proliferation, and 3) whether 
there are sex differences in the proliferation and differentiation of stem cells under normal and 
disease states (i.e. obesity). I used intestinal epithelial stem cells (IESCs) as a model system due 
to their rapid proliferation ability and the availability for experimental measurement and 
manipulation. I found that 1) under high nutrient availability, IESCs increase proliferation by 
switching from using oxidative phosphorylation to glycolysis, that glycolysis is at least partially 
necessary for nutrient-induced proliferation to occur and that the protein kinase B/hypoxia 
inducible factor 1 subunit alpha (AKT/HIF1A) pathway is differentially involved in proliferation 
under low versus high nutrient availability, 2) it is the factors related to obesity and not the high 
fat diet that is driving an increase in proliferation in diet-induced obese mice compared with lean 
mice, 3) although obesity induces similar lasting effects in IESCs in males and females, the stem 
cells in females show an increase in proliferation compared with those from males whenever 
there is a change in their nutrient environment and that it takes them longer to adapt to a new 
nutrient environment, and 4) Phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT), and 
not the classical mitogenic mitogen activated protein kinase (MAPK) pathway, is necessary for 
obesity-induced IESC proliferation in obese humans. Taken together, these results indicate that 
nutrient availability enhances IESC proliferation by modulating energy metabolism, and diet-
induced obesity, independent of the diet type, impacts IESCs and epithelial tissue without sex 
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CHAPTER 1: LITERATURE REVIEW 
 
1.1 Somatic stem cells 
What are somatic stem cells? 
 Somatic stem cells are undifferentiated cells located in many tissues that are responsible 
for producing new cells to maintain tissue homeostasis. These stem cells will proliferate in order 
to renew spent cells, regenerate the tissue after injury, and grow the tissue during development or 
high nutrient availability. Somatic stem cells have two common properties: 1) the capacity to 
self-renew to generate more stem cells, and 2) the ability to differentiate into progenitor cells 
which then give rise to all of the mature cell types of the tissue (Mihaylova et al., 2014). In order 
to identify somatic stem cells, the two common properties of stem cells (i.e. self-renewal, 
multipotency) are determined using different methods, such as lineage-tracing and 
transplantation assays (Rycaj and Tang, 2015). Using these methods, somatic stem cells have 
been found in many organs and tissues, including the brain, bone marrow, blood vessels, skin, 
skeletal muscle, heart, liver, stomach, intestine, teeth, ovary, and testes (Clevers, 2015). 
Although there have been great advances in the stem cell biology field, there are still many basic 
questions about somatic stem cells that remain to be answered, including: 1) how do somatic 
stem cells normally respond to nutrient availability, 2) how do somatic stem cells function under 
different conditions - renewal, regeneration or growth, 3) what happens to these cells under 
various disease conditions, and 4) do somatic stem cells exhibit sex differences.  
Why is it important to answer these basic questions about somatic stem cells? 
 Defining key molecules controlling the proliferation of somatic stem cells and 
repair/growth of the tissue could translate into therapeutic strategies to stop aberrant proliferation 
or develop tissues for transplantation. The ability to “program” the stem cells prior to 
transplantation to proliferate at a given rate, mode and differentiate into the desired cell types 
would also be of great benefit. Moreover, therapies targeting the somatic stem cells may be 
superior to those that target the differentiated cell types in altering tissue function because stem 






1.2 Intestinal epithelial stem cells (IESCs)  
Why are IESCs a good model system? 
 Intestinal epithelial stem cells (IESCs) have been widely used to investigate properties of 
stem cell proliferation. They rapidly proliferate and are able to renew the epithelial tissue every 
few days allowing for experimental measurement and manipulation in short periods of time 
(Clevers, 2013). Assessing the impact of different conditions on the proliferation of IESCs, and 
not most other tissue-specific stem cells, is possible because multiple proteins have been 
identified as IESC biomarkers, including leucine rich repeat containing G protein-coupled 
receptor 5 (LGR5), olfactomedin 4 (OLFM4), achaete-scute family basic helix-loop-helix 
transcription factor 2 (ASCL2), Musashi ribonucleic acid binding protein 1 (MSI1), and secreted 
protein acidic and cysteine rich related modular calcium binding 2 (SMOC2) (Barker, 2014). 
Using antibodies against these biomarkers allows for histological examination of the stem cells, 
and using antibodies against extracellular membrane bound biomarkers (e.g. LGR5) may allow 
for isolation using antibody-based fluorescence-activated cell sorting (FACS). A transgenic 
reporter mouse expressing fluorescent proteins downstream of the promotors driving IESC 
biomarker expression have also been developed and are commercially available [LGR5-green 
fluorescent protein (LGR5-GFP) mice]. These LGR5-GFP mice respond similarly to C57BL/6J 
mice on a variety of indices measured (e.g. food intake, body weight) and IESCs isolated from 
LGR5-GFP mice respond similarly to those isolated from C57BL/6J mice. Moreover, LGR5 is 
the stem cell marker of epithelial tissues in the stomach, small intestine, colon, mammary gland, 
hair follicle, kidney and ovary (Schindler et al., 2018), indicating that properties of LGR5 stem 
cell proliferation in the intestine may also apply to other tissues. In addition, IESCs are 
responsible for increasing the growth of the intestinal epithelial tissue in response to obesity by 
increasing the rate of proliferation (Beyaz et al., 2016; Mah et al., 2014). Other tissues of the 
body (e.g. adipose tissue, muscle, liver) also grow in size as a result of obesity (Dungan et al., 
2016; Qureshi and Abrams, 2007). This indicates that the properties of stem cell-induced tissue 
growth in intestinal epithelium may apply to these other tissues. 
IESCs and the IESC niche 
 Intestinal epithelial stem cells (IESCs) are localized near the base of the intestinal crypts 
and are responsible for the maintenance, growth and regeneration of the intestinal epithelium 
through continuous cell renewal (Barker et al., 2010; Leblond and Stevens, 1948). Intestinal 
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epithelial stem cells (IESCs) give rise to progenitor cells which, in turn, differentiate into mature 
intestinal epithelial cell types [e.g. enterocytes, Paneth cells, enteroendocrine cells, goblet cells, 
microfold (M) cells, cup cells, tuft cells] as they migrate along the crypt-villus axis. Enterocytes 
comprise the vast majority of the epithelial cells and are responsible for nutrient absorption 
(Gerbe et al., 2012). Paneth cells are located in the crypts, and secrete antimicrobial peptides and 
growth factors which support the neighboring IESCs (Clevers, 2013). Enteroendocrine cells 
secrete satiety hormones (Clevers, 2013). Goblet cells are scattered throughout the epithelium, 
and secret mucus that protects the epithelium from the luminal contents (Clevers, 2013). 
Microfold (M) cells are located in the region of the epithelium covering the gut-associated 
lymphoid follicles, and deliver intestinal microbial antigens to the underlying immune cells 
(Gerbe et al., 2012). Cup cells are located in the villi and are characterized by shorter microvilli 
and weaker brush border alkaline phosphatase activity than those of enterocytes, but their 
functions are unknown (Gerbe et al., 2012). Tuft cells are located in the villi and initiate immune 
responses (Gerbe and Jay, 2016). In the process of differentiation, all of these mature cell types, 
except the Paneth cells, continue to move up toward the tip of the villus in the small intestine or 
the surface of epithelium in the colon, where mature cells then undergo apoptosis. The apoptotic 
cells are then extruded into the lumen and replaced by new differentiated cells. 
 The stem cell niche consists of multiple components and cell types in the epithelium, 
lamina propria, musclularis mucosae and submucosa (Figure 1.1). These include 1) the 
extracellular matrix, 2) Paneth cells in the epithelium, 3) mesenchymal cells of lamina propria, 4) 
smooth muscle cells of musclularis mucosae, 5) immune cells, and 6) endothelial and neural 
cells/nerve endings in lamina propria and submucosa (Peck et al., 2017). A brief explanation of 
how each of these factors contributes to the maintenance of the stem cell niche and/or IESC 
proliferation is included below. 
1.) The extracellular matrix includes collagen fibers, fibronectin filaments, integrins, laminins, 
and glycosaminoglycan, forming the physical niche (Meran et al., 2017). These components can 
induce biomechanical changes in the IESCs to alter proliferation (Meran et al., 2017). 
2.) Paneth cells, the differentiated epithelial cell type surrounding the IESCs, secrete a variety of 
ligands for IESC-expressed receptors that regulate proliferation, including growth factors [i.e. 
epidermal growth factor (Poulsen et al., 1986; Sato et al., 2011), transforming growth factor α 
(Sato et al., 2011)], and mitogenic factors [i.e. wingless-type mouse mammary tumor virus 
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integration site family member 3 (WNT3) (Gregorieff et al., 2005; Sato et al., 2011), WNT11 
(Sato et al., 2011), Delta-like ligand 4 (Sato et al., 2011)].  
3.) Mesenchymal cells of the lamina propria consist of stromal cells (myofibroblasts, fibroblasts), 
pericytes of the capillaries, bone marrow-derived stromal stem cells, and smooth muscle cells 
associated with lymph vessels (Powell et al., 2011). The mesenchymal cells of the lamina propria 
secrete noncanonical WNTs [(WNT2B, 4, 5A, 5B; (Gregorieff et al., 2005)], WNT antagonists 
[secreted frizzled related protein 1 (SFRP1), dickkopf WNT signaling pathway inhibitor 3 
(DKK3); (Gregorieff et al., 2005)] and insulin like growth factor 1 [(IGF1); (Winesett et al., 
1995)] to regulate IESC proliferation. The myofibroblasts secret Bone morphogenetic protein 
(BMP)-inhibitory molecules, including gremlin 1, gremlin 2, and chordin-like 1 (Kosinski et al., 
2007), enhancing proliferation but inhibiting differentiation of IESCs. 
4.) Smooth muscle cells of musclularis mucosae secret Bmp-inhibitory molecules, including 
gremlin 1, gremlin 2, and chordin-like 1 (Kosinski et al., 2007), enhancing proliferation but 
inhibiting differentiation of IESCs. 
5.) Immune cells in lamina propria and submucosa contribute to the protection of the epithelium 
by releasing factors that promote tissue repair (Sailaja et al., 2016). Innate lymphoid cells secret 
interleukin 22 (IL22), increasing IESC numbers, decreasing apoptosis, and enhancing epithelial 
integrity during inflammatory intestinal damage (Hanash et al., 2012). In contrast to the direct 
effect on IESCs, immune cells may also indirectly affect IESCs by regulating other cells within 
the stem cell niche. Regulatory T cells play important roles in maintain the homeostasis of 
lamina propria, a contributor of the IESC niche (Korn et al., 2014). Immune cell-derived 
cytokines, IL1A and IL1B, drive changes in inflammatory responses and extracellular matrix 
metabolism in myofibroblasts of lamina propria (Okuno et al., 2002). These data indicate that 
immune cells may regulate IESCs by driving changes in lamina propria homeostasis or function. 
6.) Endothelial and neural cells/nerve endings in lamina propria and submucosa contribute to the 
growth and regeneration of the epithelium by regulating the proliferation of IESCs or progenitor 
cells (Bjerknes and Cheng, 2001; Davis et al., 2018; Paris et al., 2001). Inhibition of endothelial 
apoptosis by pharmacological administration of fibroblast growth factor 2 (FGF2) prevented 
radiation-induced damage and death of IESCs (Paris et al., 2001). Glucagon like peptide 2 
(GLP2) binds to receptors on enteric neurons and activates enteric neurons, which may then 
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causes an indirect effect to increase crypt cell proliferation through enteric neuron released 
neurotransmitters/neuropeptides (Bjerknes and Cheng, 2001; Drucker et al., 1996).  
Signaling pathways that regulate IESCs 
 The proliferation and differentiation of IESCs are tightly controlled by various signaling 
pathways, including WNT, Notch, epidermal growth factor (EGF), and BMP pathways (Beumer 
and Clevers, 2016; Clevers, 2013). These signaling pathways are regulated by ligands secreted 
by the epithelial cells (e.g. Paneth cells) and mesenchymal cells underlying the epithelial cells in 
the crypts or villi (Powell et al., 2011). Although receptors for growth factors have been 
localized to the basal (facing the lamina propria) surface of the IESCs to induce intracellular 
signaling of the pathways noted above, it is not clear whether other ligands induce signaling 
through the basal or apical surface (facing the intestinal luman) (Winesett et al., 1995). 
 The WNT ligand, WNT3, is secreted by Paneth cells (Farin et al., 2012), while the WNT 
ligands,WNT2B, WNT4, WNT5A, are secreted in mesenchymal cells (Aoki et al., 2016). The 
WNT receptors (e.g. frizzled family receptor 7) are expressed in IESCs (Flanagan et al., 2015). 
As shown in Figure 1.2, when WNT ligands bind to the frizzled-low density lipoprotein receptor 
related protein 5/6 (frizzled-LRP5/6) receptor complex, the cytoplasmic adenomatosis polyposis 
coli/Axin/glycogen synthase kinase 3 beta (APC/Axin/GSK3B) destruction complex is inhibited, 
resulting in the accumulation of β-catenin in the cytoplasm. β-catenin then translocates into the 
nucleus to act as a transcriptional coactivator of transcription factors (TCFs), which eventually 
induces transcription of WNT target genes (e.g. cyclinD1, c-myc) and leads to increased 
proliferation (Clevers and Nusse, 2012). Conversely, inactivation of TCFs lead to a loss of 
IESCs (van Es et al., 2012). Overexpression of dickkopf WNT signaling pathway inhibitor 1 
(DKK1), a secreted WNT signaling inhibitor, leads to the loss of crypts and decreased 
proliferation (Kuhnert et al., 2004; Pinto et al., 2003). Increased accumulation of β-catenin by 
mutations in APC, a negative WNT signaling regulator, promotes the formation of IESC-derived 
intestinal tumors (Snippert et al., 2014; Vermeulen et al., 2013). Taken together, WNT signaling 
induces the proliferation of IESCs. 
 Notch ligands are secreted by adjacent niche cells. Delta-like 1 and 4 (DLL1 and DLL4)] 
are secreted by Paneth cells (Sato et al., 2011), and Jagged2 is secreted by other niche cells 
underneath the IESCs (Sander and Powell, 2004). Notch receptors (e.g. Notch1, Notch2) are 
expressed in IESCs (Carulli et al., 2015). As shown in Figure 1.3, the ligands bind to the 
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extracellular domain of the Notch receptors (Notch1-4). Upon binding, the intracellular domain 
is released by proteolytic cleavage and translocates into the nucleus and associates with the C 
promoter-binding factor 1/ Suppressor of Hairless/longevity assurance gene homolog 1 
[CBF1/Su(H)/LAG1 (CSL)] transcriptional complex. This will induce the transcription of target 
genes [e.g. hairy and enhancer of split-1 (HES1)] to drive the differentiation into absorptive cell 
lineage (Kopan, 2012). Notch signaling induces the differentiation into the absorptive cell 
lineage (i.e. enterocytes), but not the secretory cell lineage (i.e. Paneth cells, goblet cells, 
enteroendocrine cells). Inhibition of Notch signaling leads to the conversion of IESCs into 
secretory lineage (i.e. Paneth cells, goblet cells) (VanDussen et al., 2012). Notch signaling 
activates the transcription of target gene HES1, a transcription factor, which, in turn, represses 
the transcription of atonal basic helix-loop-helix transcription factor 1 (ATOH1) and neurogenin 
3 (NEUROG3) (Beumer and Clevers, 2016). Deletion of the Notch signaling effector HES1 
causes increased secretory cell formation (Ueo et al., 2012). Loss of ATOH1 causes depletion of 
secretory cell lineage (Paneth cells, goblet cells, enteroendocrine cells) (Yang et al., 2001). 
NEUROG3 mutation leads to depletion of enteroendocrine cells (Jenny et al., 2002). Taken 
together, these data indicate that the Notch-HES1 pathway enhances the differentiation into 
absorptive cell lineage (i.e. enterocytes), and inhibits the differentiation into the secretory cell 
lineage by repressing the expression of ATOH1 and NEUROG3. 
 Epidermal growth factor (EGF) is secreted by Paneth cells, and EGF receptor is 
expressed in IESCs (Suzuki et al., 2010). As shown in Figure 1.4, when EGF binds to the 
extracellular ligand-binding domain of EGF receptor, a type of tyrosine kinase receptor, the 
receptors form homo- or hetero-dimers, activate the intracellular tyrosine kinase domain, and 
trigger downstream signaling pathways [phosphatidylinositol 3-kinase/protein kinase B 
(PI3K/AKT), mitogen-activated protein kinase (MAPK), phospholipase C gamma/protein kinase 
C (PLCG/PRKC) pathways)] to increase cell proliferation and survival (Wieduwilt and Moasser, 
2008). The negative regulator of EGF signaling, leucine rich repeats and immunoglobulin like 
domains 1 (LRIG1), decreases IESC proliferation and number (Wong et al., 2012). This 
indicates that EGF signaling induces IESC proliferation.  
 Antagonists to BMP, gremlin 1, gremlin 2, and chordin-like 1, are secreted by 
mesenchymal cells surrounding the crypt cells (Kosinski et al., 2007), and BMPs are secreted by 
mesenchymal cells within lamina propria in the villi (Powell et al., 2011). The BMP receptors 
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are expressed in both crypt cells (including IESCs) and villus cells (Beumer and Clevers, 2016). 
As shown in Figure 1.5, when BMPs bind to the type I or type II serine/threonine kinase 
receptors, the type II receptor phosphorylates the type I receptor which, in turn, phosphorylates 
homologues of the Drosophila protein, mothers against decapentaplegic (Mad) and the 
Caenorhabditis elegans protein small (Sma) 1, 5, 8 (SMAD1, 5, 8). Phosphorylated SMADs 
associate with SMAD4 to form a complex, translocating into the nucleus. The complex 
associates with coactivators to induce expression of differentiation genes and associates with 
corepressors to inhibit the expression of proliferation genes (Wang et al., 2014). Bone 
morphogenetic proteins (BMPs) limit IESC proliferation through SMAD1, 4-mediated 
repression of the transcription of stem cell signature genes (Qi et al., 2017). Moreover, the BMP 
inhibitor, noggin, is a key growth factor added in the IESC in vitro culture medium that increases 
proliferation. Omission of noggin from the culture medium causes the IESC/progenitor cells to 
undergo differentiation (Sato et al., 2009). Conditional loss of BMP receptor type 1A also 
enhances IESC proliferation (He et al., 2004). Taken together, these data indicate that BMP 
signaling inhibits IESC proliferation, but enhances differentiation, which results in enhanced 
proliferation and inhibited differentiation in the crypts, but promoted differentiation in the villi. 
1.3 Nutrient-induced changes in intestinal epithelium and IESCs 
Nutrient-induced changes in intestinal epithelium 
 Nutrient availability induces growth of the intestinal epithelium through increases in stem 
cell proliferation. Since it was originally postulated that increased luminal nutrient content drives 
the increase in epithelial size (Mayer et al., 1954), a variety of studies have verified that any 
situation where there is an increase in the amount of nutrients in the intestine, there is a change in 
the epithelial size as indicated by an increase in stem cell proliferation, the number of stem cells, 
total epithelial cell number, villi height or crypt depth [methods include: intestinal transposition 
(Altmann and Leblond, 1970), diet-induced obesity (Beyaz et al., 2016; Mah et al., 2014), 
lactation (Cripps and Williams, 1975), cold exposure (Kaushik and Kaur, 2005)]. In contrast, the 
exclusion of luminal nutrients does the opposite [methods include: fasts (Ross and Mayhew, 
1985), surgical bypass (Gleeson et al., 1972; Robinson et al., 1980), hibernation (Carey, 1990; 
Carey and Cooke, 1991)]. In addition, data support the role of luminal nutrients, and not just the 
systemic nutrients, in driving growth of the tissue because parenteral nutrition leads to a decrease 
in epithelial size and atrophy of the villi (Buchman et al., 1995). Though, it is unlikely that 
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luminal nutrients directly interact with the apical surface of the crypt cells because goblet cells in 
the crypts secret mucus to form a diffusion barrier to protect the crypt cells (Birchenough et al., 
2016). It is likely that luminal nutrients absorbed from enterocytes enter into the local blood 
vessels and circulation to affect crypt cells through the basal surface receptors or transporters 
(Figure 1.1). Glucose, amino acids and small/medium chain fatty acids would likely be able to 
move along a concentration gradient through passive or active diffusion between the local blood 
vessels and interstitial space around the crypts. In contract, long-chain fatty acids are packaged 
into chylomicrons, travel in the lymph vessels, and finally enter systemic circulation. Circulating 
chylomicrons may be transported by the superior mesenteric artery and its branches, and 
hydrolyzed by lipoprotein lipase (LPL) located on the luminal surface of vascular endothelial 
cells, releasing the free long-chain fatty acids so that they may contact the basal surface 
transporters or receptors of the crypts. 
Direct versus indirect nutrient-induced mechanisms 
 Macronutrients are used to produce energy for stem cells, and are also used as the 
constituents of the biomass for normal cell function or biomass to make new cells. Sensing the 
levels of macronutrients is important for stem cells to shuttle the nutrients to the proper energy 
versus biomass production pathway and may involve 1) a direct interaction of the nutrients with 
membrane transporters or receptors, 2) an indirect mechanism by detecting circulating surrogate 
molecules (e.g. insulin, IGF1) whose levels correctly reflect nutrient abundance, or 3) an indirect 
mechanism by detecting local surrogate molecules (e.g. growth factors, local IGF1) secreted by 
niche cells. Facilitative transporters have been recognized for glucose, amino acids and fatty 
acids that move the macronutrients along a concentration gradient and, thus, transport is 
dependent upon extracellular nutrient levels. It is not known if nutrients directly play a role in the 
proliferation of IESCs, but this direct mechanism has been found in other proliferative cell types.  
Glucose, amino acid, fatty acid receptors and/or transporters 
 Glucose transporters (GLUTs) are responsible for the glucose uptake in mammalian cells. 
Glucose has been found to be absorbed into proliferative epithelial cells through GLUT2, leading 
to the phosphorylation and inactivation of GSK3B, the accumulation of β-catenin in the nucleus, 
and the expression of target gene cyclin D1 (Mao et al., 2013). Activation of WNT/β-catenin 
pathway is then able to enhance cell proliferation (Mao et al., 2013; Reya and Clevers, 2005). 
Glucose is transported into cells by solute carrier family 5 members (SLC5As; secondary active 
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transport) and facilitative glucose transporters [GLUTs; facilitated diffusion; (Harada and 
Inagaki, 2012)]. SLC5A1 is highly expressed at the apical membrane in the intestinal epithelial 
cells of the small intestine (Harada and Inagaki, 2012). GLUT1 through GLUT4 are the primary 
players in cell membrane-mediated glucose responses in mammalian cells. GLUT2 is a low 
affinity transporter (Km > 15 mM) and transports glucose only when glucose levels are high 
(Efeyan et al., 2015). In contrast, GLUT1 and GLUT3 have high affinities for glucose (Km is as 
low as 1 mM of glucose) and is thought to be responsible for the low level of glucose uptake 
required to sustain respiration under homeostatic conditions (Efeyan et al., 2015). Moreover, 
GLUT4 is responsible for insulin-stimulated glucose uptake, which is highly expressed in insulin 
target tissues [e.g. skeletal muscle, adipose tissue; (Stephens and Pilch, 1995)]. Glucose 
transporter 4 (GLUT4) is activated by insulin via translocation from GLUT4-containing vesicles 
to the plasma membrane (Stephens and Pilch, 1995). Thus, GLUT1-3 may be expressed by 
IESCs for basal glucose uptake, and GLUT4 may be expressed by IESCs for insulin-stimulated 
glucose uptake. 
 Moreover, amino acids, including glutamine (Moore et al., 2015) and methionine (Saito 
et al., 2017), enhance IESC proliferation. Glutamine activates mechanistic target of rapamycin 
kinase (MTOR) signaling, a pathway involved in the regulation of cell cycle and protein 
synthesis (Moore et al., 2015). Amino acids can act through excitatory receptors which are 
primarily expressed on the membranes of neuronal cells (Matthews and Anderson, 2002), or be 
transported into cells through transporters. Amino acid transporters actively transport from 
extracellular fluid to the cells, and are classified into different systems due to different substrate 
specificity and transport mechanism (Hyde et al., 2003). These systems are divided into three 
types: neutral amino acid transporters (e.g. system A, ASC, L, T), cationic amino acid 
transporters (e.g. system B0,+, y+), and anionic amino acid transporters (e.g. system X−AG, x
-
c) 
(Hyde et al., 2003). The intracellular amino acids could be used for protein synthesis, synthesis 
of other non-protein compounds, and energy source.  
 Short-chain fatty acids (SCFAs) and medium-chain fatty acids (MCFAs) are transported 
into cells by simple diffusion as free fatty acids, independent of fatty acid transporters or 
translocase (Schonfeld and Wojtczak, 2016). In contrast, long-chain fatty acids (LCFAs) bound 
to plasma albumin, require solute carrier family 27 member 1 (SLC27A1) or fatty acid 
translocase cluster of differentiation 36 (CD36) along or together with plasma membrane-
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associated fatty acid-binding protein (FABPpm) for the uptake by cells (Schwenk et al., 2010). In 
addition, fatty acids bind and activate fatty acid receptors, a family of G protein-coupled 
receptors (GRPs) to initiate intracellular cell signaling, regulating energy metabolism (Nakamura 
et al., 2014). GPR41 and GPR43 are activated by SCFAs, GPR84 is activated by MCFAs, and 
GPR40 and GPR120 are activated by LCFAs (Nakamura et al., 2014). In addition, in vitro 
administration of long-chain fatty acids (e.g. palmitic acid, oleic acid) to crypts and proliferative 
epithelial cell lines enhances proliferation by activating peroxisome proliferator activated 
receptor delta (PPARD) and WNT/β-catenin pathways (Beyaz et al., 2016; Mao et al., 2013). 
Palmitic acid actives WNT/β-catenin signaling, including the phosphorylation and inactivation of 
GSK3B, the accumulation of β-catenin, and the expression of cyclin D1, which, in turn, 
enhances proliferation (Mao et al., 2013). Administration of PPARD agonist, GW501516, to 
organoids induces an increas in IESC number and organoid formation (Beyaz et al., 2016). In 
contrast to the promoting effect of fatty acids on IESC proliferation, multiple studies show that 
omega-3 polyunsaturated fatty acid inhibits the number of tumor-initiating IESCs during the 
initiation and progression processes of colon cancer by enhancing tumor protein p53 signaling to 
induce apoptosis (Kim et al., 2016) and inhibiting WNT/β-catenin signaling to decrease 
proliferation (Kim et al., 2016; Vasudevan et al., 2014). Taken together, these data indicate that 
fatty acids may promote the proliferation of IESCs, but there may be a differential effect of the 
type of fatty acids. 
Metabolism of nutrients in proliferating cells 
 Proliferating cells utilize nutrients to produce adenosine triphosphate (ATP) for 
bioenergetic activity and generate intermediates needed for the biosynthesis of nucleotides, lipids 
and amino acids to duplicate all components during cell proliferation (Vander Heiden et al., 
2011). As shown in Figure 1.6, nonproliferating cells have a basal rate of glycolysis, converting 
glucose to pyruvate in the cytoplasm. Pyruvate is then transported into the mitochondria to be 
oxidized to generate acetyl coenzyme A (acetyl-CoA). Fatty acids are also oxidized to generate 
acetyl-CoA. Glucose- and fatty acid-derived acetyl-CoA is then oxidized through tricarboxylic 
acid (TCA) cycle to generate reduced nicotinamide adenine dinucleotide (NADH) and reduced 
flavin adenine dinucleotide (FADH2), which is then oxidized in the electron transport chain to 
generate H+ protons that transit via the ATP synthase to produce ATP. Moreover, amino acids 
are oxidized in the TCA cycle by converting to pyruvate and TCA cycle intermediates, including 
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acetyl-CoA, oxaloacetate, α-ketoglutarate, succinyl-CoA and fumarate. In contrast, proliferating 
cells have greatly increased rate of glycolysis, converting glucose to pyruvate. Most of the 
pyruvate is converted to lactate in the cytoplasm, regenerating NAD+ to allow high rates of 
glycolysis to persist. The lactate is then secreted from the cells. The remaining pyruvate is 
oxidized to generate acetyl-CoA, generating TCA cycle intermediate citrate to induce the 
synthesis of fatty acids and cholesterol used for lipid membranes required for cell proliferation. 
Fatty acids are also oxidized to generate acetyl-CoA, generating citrate to induce the synthesis of 
fatty acids and cholesterol. The metabolism of amino acids, particularly glutamine, is largely 
increased, converting glutamine to TCA cycle intermediates, citrate and oxaloacetate. The 
glutamine-derived citrate drives fatty acid synthesis, and glutamine-derived oxaloacetate 
resupplies the decreased levels of oxaloacetate to sustain the TCA cycle, generating TCA cycle 
intermediates for synthesis of biomass needed for cell proliferation (Currie et al., 2013; 
DeBerardinis et al., 2008; Fritz and Fajas, 2010). 
 A master regulator of metabolism in proliferating cells is the phosphatidylinositol 3-
kinase/protein kinase B/mechanistic target of rapamycin kinase (PI3K/AKT/MTOR) and 
hypoxia inducible factor 1 subunit alpha (HIF1A) signaling pathways (DeBerardinis et al., 2008). 
Growth factors (e.g. insulin, IGF1) activate PI3K/AKT/MTOR to enhance cellular biosynthesis 
by 1) increasing the expression of nutrient transporters to increase the uptake of nutrients [e.g. 
glucose, amino acids; (Edinger and Thompson, 2002)], 2) regulating gene expression and 
enzyme activity to increase glycolysis (Elstrom et al., 2004), 3) increasing the expression of 
lipogenic genes to enhance lipid synthesis (Bauer et al., 2005; Chang et al., 2005), and 4) 
increasing protein synthesis via MTOR-dependent manner (Gingras et al., 2001). Moreover, 
hypoxia-inducible factor 1α (HIF1A) is a transcription factor that induces the transcription of 
target genes (e.g. glucose transporter, glycolytic enzymes) via the HIF-1 transcription factor 
complex (Semenza et al., 1994). The alterations of these target genes lead to changes in 
glycolysis (Semenza et al., 1994). Growth factors promote HIF1A synthesis and accumulation by 
activating PI3K/AKT/MTOR pathway (Jiang et al., 2001). Thus, these same pathways may be 
involved in linking metabolism with proliferation by shuttling nutrients to generate intermediates 





Protein-kinase pathways involved in indirect nutrient sensing 
 In contrast to a direct sensing mechanism, an indirect nutrient sensing mechanism by 
detecting surrogate molecules may underlie a nutrient-induced increase in IESC proliferation. 
The surrogate molecules may consist of two types: circulating hormones (e.g. insulin, IGF1) and 
local hormones or growth factors secreted by niche cells. It is well known that in response to 
high nutrient availability, high levels of circulating insulin and IGF1 are released from the 
pancreas and liver, respectively (Rafalski and Brunet, 2011), and high levels of local intestinal 
IGF1 are released from the pericryptal mesenchymal cells (Winesett et al., 1995). Insulin and 
IGF1 bind to their respective receptors on the cell membrane, leading to the activation of 
downstream PI3K/AKT and mitogen activated protein kinase (MAPK) pathways (DeBerardinis 
et al., 2008). Activation of these pathways is then able to enhance cell survival and proliferation 
by regulating gene expression for necessary molecules and enzyme activity (DeBerardinis et al., 
2008). Insulin and IGF1 receptors are expressed in IESCs and have been shown to modulate 
nutrient-induced expansion and growth of IESCs (Mah et al., 2014). An indirect mechanism of 
nutrient-induced IESC proliferation has been found. The nutrients that are absorbed across the 
epithelial enterocytes induce the release of IGF1 from mesenchymal cells that underlie the IESCs. 
The local release of IGF1 then stimulates the proliferation of IESCs or progenitor cells through 
insulin/IGF1 receptor signaling, including the classical metabolic PI3K-dependent pathway and 
the canonical proliferation MAPK-dependent pathway (Ben Lulu et al., 2012; Lu et al., 2017; 
Mah et al., 2014; Van Landeghem et al., 2015). On the other hand, an indirect mechanism of 
nutrient sensing would necessitate that other niche cells would provide these signals, though, it is 
still unclear how the niche cells sense nutrients. Paneth cells, the differentiated cell type 
surrounding the IESCs, secrete a variety of factors that could fulfill this role, including growth 
factors [i.e. epidermal growth factor (Poulsen et al., 1986; Sato et al., 2011), transforming growth 
factor α (Sato et al., 2011)] and mitogenic factors [i.e. WNT3 (Gregorieff et al., 2005; Sato et al., 
2011), WNT11 (Sato et al., 2011), Delta-like ligand 4 (Sato et al., 2011)]. Thus, nutrient sensing 
and nutrient-induced proliferation may involve a combination of direct, intrinsic indirect and 
extrinsic indirect mechanisms to guide IESC proliferation. These nutrient-induced alterations in 
canonical WNT/β-catenin and insulin/IGF1 receptor signaling would contribute to the diet-




Nutrient-induced IESC differentiation 
 The size and cellular make-up of the differentiated cells appear to reflect a composition 
of cells that would be best suited for the digestion of a diet that is maintained across time and can 
be altered when the diet is changed. The high adaptability of the epithelium to change cellular 
make-up is likely due to a coordinated effort of the presence and nature of the distinct food 
components (e.g. proteins, lipids, carbohydrates) in the lumen of the intestinal tract mixed with 
signals from the basal surface of the tissue (e.g. hormonal, neural). 
 The available nutrients may guide the differentiation process to generate the best 
composition of epithelial cells to digest the diet of an individual. After IESCs give rise to 
progenitor cells, the progenitor cells continue to differentiate into mature epithelial cells as they 
migrate along the crypt-villus axis. The signals from the lumen of the intestine and/or the basal 
surface of the tissue likely direct the progenitor cells at the crypt-villus axis to differentiate into 
the functional cells needed. Although the progenitor cells in crypts undergo multiple 
proliferation processes before beginning to differentiate, a process which is regulated through 
canonical WNT/β-catenin signaling (Pinto et al., 2003), a role for Notch signaling in directing 
epithelial lineage allocation has been outlined (Jensen et al., 2000; Yang et al., 2001). HES1 and 
ATOH1, two downstream transcription factors from Notch signaling, work in opposition to each 
other to drive the differentiation into absorptive enterocytes or secretory cells, respectively 
(Jensen et al., 2000; Yang et al., 2001). Downstream of ATOH1, neurogenin 3 directs the 
differentiation into enteroendocrine cells (Jenny et al., 2002). In addition to Notch signaling, 
BMP signaling drives the differentiation into secretory cells (Auclair et al., 2007). It still has yet 
to be elucidated, though, how the molecular mechanisms control epithelial cell differentiation 
and how dietary signals may mediate changes in these processes. 
1.4 The effect of overnutrition/obesity on intestinal epithelium and IESCs 
There is a connection between overnutrition/obesity and dysfunction of the intestinal epithelium  
 Chronic overnutrition leads to obesity, a condition that negatively impacts the form and 
function of many organs, including the growth of specific tissues and the changes in cellular 
metabolism. These alterations contribute to the persistence of hyperphagia and weight gain, and 
the incidence of associated diseases, such as metabolic syndrome, type 2 diabetes, cardiovascular 
disease and cancer. The intestine is one organ that is significantly affected by obesity. In 
response to obesity, the intestinal epithelium shows increased tissue size and nutrient absorption, 
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but decreased satiety hormone release and immune barrier function (Dailey, 2014). These 
changes subsequently contribute to increasing incidence of secondary diseases, including 
irritable bowel syndrome, inflammatory bowel disease, dyspepsia and cancer (Dailey, 2014). 
Thus, identifying the mechanisms by which obesity alters the morphology and function of the 
intestinal epithelium will allow for the development of therapeutic strategies to attenuate or 
reverse the negative effects of obesity and may be a model by which to understand the impact of 
obesity on other tissues. 
Obesity influences the proliferation of IESCs 
 The impact of obesity to induce lasting consequences on somatic stem cell proliferation 
and/or differentiation has been previously found [e.g. IESCs (Beyaz et al., 2016; Mah et al., 
2014), bone marrow-derived mesenchymal stem cells (Wu et al., 2013), hematopoietic stem cells 
(Lee et al., 2017), adipose-derived stem cells (Baptista et al., 2015; Wu et al., 2013)], such that 
isolated stem cells from obese compared with lean mice grow or function differently in vitro, and 
“obese” stem cells retain their obese properties even after weight loss in humans and non-human 
animals. In particular, high-fat diet-induced obesity increases IESC number and proliferation, 
total epithelial cell number, crypt depth or villus height in vivo (Baldassano et al., 2013; Beyaz et 
al., 2016; Mah et al., 2014; Mao et al., 2013), and drives lasting effects on IESCs, such that 
isolated IESCs from obese versus lean mice grow at different rates in vitro (Beyaz et al., 2016; 
Mah et al., 2014). High-fat diet-induced obesity increases peroxisome proliferator activated 
receptor delta (PPARD) and WNT/β-catenin signaling, and the expression of Notch ligands Jag1 
and Jag2 in IESCs (Beyaz et al., 2016), indicating that obesity may induce IESC proliferation by 
regulating PPARD, WNT/β-catenin and Notch signaling pathways. Moreover, the retention of an 
obese phenotype in the growth of IESCs derived from obese animals in vitro, and in future 
generations of new cells, indicates that stable/heritable modifications have occurred that 
influence gene regulation and expression. Epigenetic changes potentially underlie the obesity-
induced alterations in IESC proliferation mechanisms across generations of new cells. Obesity 
influences the transcription profile of stem and non-stem cells (Mihaylova et al., 2014). Many of 
these changes can be linked to DNA methylation of transcriptional regulatory elements (Li et al., 




Obesity impacts the proliferation and growth of the epithelial tissue through modulating 
insulin/IGF1 receptor signaling  
 Obesity increases systemic levels of insulin/IGF1 and is associated with insulin receptor 
resistance in cells of many organs or tissues. Despite extensive research on the roles for insulin 
and IGF1 in coordinating systemic growth and development with nutrient homeostasis in normal 
and obese conditions, little is known about their roles in controlling somatic stem cells. Mah et al. 
(Mah et al., 2014) postulate that high fat diet-induced obesity drives an increase in circulating 
insulin levels and the absorption of the digested high fat diet drives the local release of IGF1 
from mesenchymal cells that underlie the IESCs. Together with the high local and circulating 
levels of fatty acids and glucose that occur in obesity, changes in insulin/IGF1 receptor signaling 
could occur and lead to the growth of the tissue (Mah et al., 2014). These factors promote 
obesity-induced insulin/IGF1 receptor resistance in non-stem cells of other tissues and drive an 
acquired receptor signaling dependence on elevated insulin and IGF1 levels. The three highly 
homologous tyrosine kinase receptors by which insulin and IGF1 mediate their biological effects, 
insulin receptor isoform A (INSRA), insulin receptor isoform B (INSRB) and insulin like growth 
factor 1 receptor (IGF1R), are expressed in IESCs (Mah et al., 2014). Both insulin and IGF1 are 
able to bind to each receptor, albeit at different affinities, and INSR and IGF1R can also form 
heterodimers that modulate the selectivity and affinity for insulin and IGF1 in activating 
downstream signaling molecules (Boucher et al., 2014).  
 As shown in Figure 1.7, after ligand binding, the conformational change and 
autophosphorylation of the receptors results in the recruitment and phosphorylation of receptor 
substrates, insulin receptor substrate (IRS) and Rous sarcoma oncogene homology 2 domain-
containing transforming protein C1 (SHC) proteins, which activates PI3K-dependent pathway 
and MAPK-dependent pathway, respectively (Boucher et al., 2014). IRS proteins recruit and 
activate PI3K, leading to the generation of second messenger phosphatidylinositol-3,4,5-
triphosphate (PIP3) by phosphorylating phosphatidylinositol-4,5-bisphosphate (PIP2), which is a 
phospholipid component of cell membranes and a substrate for PI3K. PIP3 recruits and activates 
AKT that subsequently mediates proliferation, survival and metabolism. AKT phosphorylates 
cell cycle inhibitors, cyclin dependent kinase inhibitor 1A (CDKN1A), cyclin dependent kinase 
inhibitor 1B (CDKN1B), leading to cytoplasmic localization and inhibition of their growth-
suppressing activities, which, in turn, enhance cell proliferation (Motti et al., 2004; Zhou et al., 
16 
 
2001). Moreover, AKT phosphorylates mouse double minute 2 (MDM2), B cell 
leukemia/lymphoma 2 associated X (BAX), B cell leukemia/lymphoma 2 associated agonist of 
cell death (BAD) and caspase-9, inhibiting apoptosis and promoting survival (Cardone et al., 
1998; Cheng et al., 2010; Datta et al., 1997; Yamaguchi and Wang, 2001). In addition, AKT 
phosphorylates and activates MTORC1 complex, inhibiting eukaryotic translation initiation 
factor 4E binding protein 1 (EIF4EBP1), activates ribosomal protein S6 kinases (S6Ks) S6K1 
and S6K2, hypoxia-inducible factor 1α (HIF1α) and sterol regulatory element binding 
transcription factors (SREBF1 and SREBF2), which, eventually regulate multiple genes 
controlling glycolysis, pentose phosphate pathway, de novo lipid synthesis, and protein synthesis, 
providing the biomass for cell proliferation (Duvel et al., 2010). In addition to AKT/MTORC1-
meditated regulation of metabolism, AKT also phosphorylates and inhibits Forkhead box O 
(FOXO) transcription factors, controlling the transcription of lipogenic and gluconeogenic genes 
(Boucher et al., 2014). On the other hand, activated receptors recruits and phosphorylates SHC, 
activating RAS to form RAS-GTP which stimulates Ser/Thr kinase RAF. RAF then activates 
mitogen-activated protein kinase kinase (MAP2K), leading to the activation of MAPKs, 
MAPK1/3, which, in turn, directly control cell proliferation and gene transcription (Boucher et 
al., 2014). 
 It is traditionally thought that there is a balance between the PI3K-dependent signaling 
pathway (regulating nutrient flow for cell survival), and the MAPK-dependent signaling pathway 
(regulating cell proliferation) (Boucher et al., 2014). The balance between these two pathways 
determines the cellular response to insulin and IGF1. Indeed, insulin resistance in other tissues is 
accompanied by a reduction in signaling of one pathway and an intact or heightened signaling in 
the other (e.g. endothelial cells, adipocytes) (Carlson et al., 2003; Muniyappa and Sowers, 2013). 
Alternatively, INSR and IGF1R resistance may occur due to abnormal downstream PI3K or 
MAPK signaling. Inactivation of a number of downstream signaling molecules [e.g. AKT, 
mechanistic target of rapamycin kinase C2 (MTORC2), pyruvate dehydrogenase kinase 1 
(PDK1)] is sufficient for induction of insulin resistance and mimics in vivo dysregulation in 
many tissues (Boucher et al., 2014). The action of these molecules in insulin-induced somatic 
stem cell proliferation has not been identified. In addition, it is not clear how systemic 
insulin/IGF1 may interact with local IGF1 to mediate changes in IESC proliferation, 
differentiation and tissue growth. Thus, obesity may impact the proliferation and growth of the 
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epithelial tissue through modulating insulin/IGF1 receptor signaling, but the associated 
mechanisms remain undiscovered. 
1.5 Sex differences in somatic stem cells 
 Somatic stem cells in many tissues are regulated in a sex-specific manner. In mammals, 
sex-specific regulation of stem cells has been found in hematopoietic (Nakada et al., 2014; Notta 
et al., 2010), neural (Pawluski et al., 2009), and muscle (Deasy et al., 2007) stem cells. In these 
cell types, stem cells in females exhibit increased stem cell number, proliferation or regeneration 
potential and/or increased organ size compared with males during reproduction or tissue 
transplantation. The promoted estrogen levels and estrogen receptor 1 (ESR1) signaling induced 
greater hematopoietic stem cell proliferation in females than that in males (Nakada et al., 2014). 
The increased levels of circulating estrogen and progesterone contributes to the greater 
neurogenesis in females than males (Pawluski et al., 2009). In contrast to be directly regulated by 
steroid hormones, sex differences in muscle stem cells may arise from innate sex-related 
differences in response to cell stress (e.g. hypoxia, oxidative stress), such that in response to cell 
stress, stem cells in females maintain an undifferentiated state, whereas, stem cells in males 
undergo increased differentiation, leading to greater regeneration potential in females than males 
(Deasy et al., 2007). In Drosophila, IESCs in females exhibit greater proliferation, regenerative 
capacity and organ size than in males, arising from genetic sexual identity of IESCs (Hudry et al., 
2016). In Drosophila, two core components of the sex determination pathway, Sex lethal (Sxl) 
and transformer (TRA) are expressed in IESCs in females, leading to greater IESC proliferation 
in tissue growth and regeneration in response to injury (Hudry et al., 2016). Because early sex 
specification is different between Drosophila and mammals (Hudry et al., 2016), unique tissue 
and species-specific stem cell properties are demonstrated and may not equate to similar sex-












Figure 1.1: Schematic representation of the intestinal epithelial cell types and intestinal 
epithelial stem cell niche 
Intestinal epithelial stem cells (IESCs) give rise to progenitor cells which, in turn, differentiate 
into mature intestinal epithelial cell types [e.g. enterocytes, Paneth cells, enteroendocrine cells, 
goblet cells, microfold (M) cells, cup cells, tuft cells] as they migrate along the crypt-villus axis. 
The stem cell niche consists of multiple components and cell types in the epithelium, lamina 
propria, musclularis mucosae and submucosa. These include 1) the extracellular matrix, 2) 
Paneth cells in the epithelium, 3) mesenchymal cells of lamina propria, 4) smooth muscle cells of 
musclularis mucosae, 5) immune cells, and 6) endothelial and neural cells/nerve endings in 





Figure 1.2: Wingless-type mouse mammary tumor virus integration site (WNT) signaling 
When WNT ligands bind to the frizzled-low density lipoprotein receptor related protein 5/6 
(frizzled-LRP5/6) receptor complex, the cytoplasmic adenomatosis polyposis coli/Axin/glycogen 
synthase kinase 3 beta (APC/Axin/GSK3B) destruction complex is inhibited, resulting in the 
accumulation of β-catenin in the cytoplasm. β-catenin then translocates into the nucleus to act as 
a transcriptional coactivator of transcription factors (TCFs), which eventually induces 











Figure 1.3: Notch signaling 
Notch ligands are secreted by adjacent signaling cells. Notch receptors (e.g. Notch1, Notch2) are 
expressed in receiving cells. The ligands bind to the extracellular domain of the Notch receptors 
(Notch1-4). Upon binding, the Notch intracellular domain (NICD) is released by proteolytic 
cleavage and translocates into the nucleus and associates with the C promoter-binding factor 1/ 
Suppressor of Hairless/longevity assurance gene homolog 1 [CBF1/Su(H)/LAG1 (CSL)] 














Figure 1.4: Epidermal growth factor (EGF) signaling 
When EGF binds to the extracellular ligand-binding domain of EGF receptor, a type of tyrosine 
kinase receptor, the receptors form homo- or hetero-dimers, activate the intracellular tyrosine 
kinase domain, and trigger downstream signaling pathways [phosphatidylinositol 3-
kinase/protein kinase B (PI3K/AKT), mitogen-activated protein kinase (MAPK), phospholipase 












Figure 1.5: Bone morphogenetic protein (BMP) signaling 
When BMPs bind to the type I or type II serine/threonine kinase receptors, the type II receptor 
phosphorylates the type I receptor which, in turn, phosphorylates homologues of the Drosophila 
protein, mothers against decapentaplegic (Mad) and the Caenorhabditis elegans protein small 
(Sma) 1, 5, 8 (SMAD1, 5, 8). Phosphorylated SMADs associate with SMAD4 to form a complex, 












Figure 1.6: Metabolism of nonproliferating cells and proliferating cells 
Nonproliferating cells have basal rate of glycolysis, converting glucose to pyruvate in the 
cytoplasm. Pyruvate is then transported into the mitochondria to be oxidized to generate acetyl 
coenzyme A (acetyl-CoA). Acetyl-CoA is then oxidized through tricarboxylic acid (TCA) cycle 
to produce adenosine triphosphate (ATP). Moreover, amino acids are oxidized in the TCA cycle 
to produce ATP. In contrast, proliferating cells have greatly increased rate of glycolysis, 
converting glucose to pyruvate. Most of the pyruvate is converted to lactate in the cytoplasm. 
The lactate is then secreted from the cells. Glycolysis metabolites are used to produce biomass. 
The metabolism of amino acids, particularly glutamine, is largely increased, converting 













Figure 1.7: Insulin and Insulin like growth factor 1 (IGF1) receptor signaling 
When insulin and IGF1 bind to insulin receptor isoform A (INSRA), insulin receptor isoform B 
(INSRB) and insulin like growth factor 1 receptor (IGF1R), the conformational change and 
autophosphorylation of the receptors results in the recruitment and phosphorylation of receptor 
substrates, insulin receptor substrate (IRS) and Rous sarcoma oncogene homology 2 domain-
containing transforming protein C1 (SHC) proteins, which activates PI3K-dependent pathway 
and MAPK-dependent pathway, respectively (105). IRS proteins recruit and activate PI3K, 
leading to the generation of second messenger phosphatidylinositol-3,4,5-triphosphate (PIP3) by 
phosphorylating phosphatidylinositol-4,5-bisphosphate (PIP2) which is a phospholipid 
component of cell membranes and a substrate for PI3K. PIP3 recruits and activates AKT that 
subsequently mediates proliferation, survival and metabolism. On the other hand, activated 
receptors recruits and phosphorylates SHC, activating RAS to form RAS-GTP which stimulates 
Ser/Thr kinase RAF. RAF then activates mitogen-activated protein kinase kinase (MAP2K), 
leading to the activation of MAPKs, MAPK1/3, which, in turn, directly control cell proliferation 
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CHAPTER 2: GLUCOSE STIMULATES INTESTINAL EPITHELIAL CRYPT 
PROLIFERATION BY MODULATING CELLULAR ENERGY METABOLISM 
 
 This chapter was published in the Journal of Cellular Physiology. The citation for this 
article is as follows: Zhou W, Ramachandran D, Mansouri A, Dailey MJ. Glucose stimulates 




 The intestinal epithelium plays an essential role in nutrient absorption, hormone release 
and barrier function. Maintenance of the epithelium is driven by continuous cell renewal by stem 
cells located in the intestinal crypts. The amount and type of diet influence this process and result 
in changes in the size and cellular make-up of the tissue. The mechanism underlying the nutrient-
driven changes in proliferation is not known, but may involve a shift in intracellular metabolism 
that allows for more nutrients to be used to manufacture new cells. We hypothesized that nutrient 
availability drives changes in cellular energy metabolism of small intestinal epithelial crypts that 
could contribute to increases in crypt proliferation. We utilized primary small intestinal epithelial 
crypts from C57BL/6J mice to study 1) the effect of glucose on crypt proliferation, and 2) the 
effect of glucose on crypt metabolism using an extracellular flux analyzer for real-time metabolic 
measurements. We found that glucose increased both crypt proliferation and glycolysis, and the 
glycolytic pathway inhibitor 2-Deoxy-D-glucose (2-DG) attenuated glucose-induced crypt 
proliferation. Glucose did not enhance glucose oxidation, but did increase the maximum 
mitochondrial respiratory capacity, which may contribute to glucose-induced increases in 
proliferation. Glucose activated protein kinase B/hypoxia inducible factor 1 subunit alpha 
(AKT/HIF1A) signaling pathway, which might be at least in part responsible for glucose-
induced glycolysis and cell proliferation. These results indicate that high glucose availability 
induces an increase in crypt proliferation by inducing an increase in glycolysis with no change in 
glucose oxidation. 
2.2 Introduction  
 The intestinal epithelium plays an essential role in nutrient absorption, hormone release 
and immune barrier function. The entire epithelium is continuously renewed every 4-5 days, 
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which is driven by stem cells located at the base of the intestinal crypts (Barker et al., 2010). 
Intestinal epithelial stem cells (IESCs) give rise to progenitors that differentiate into mature 
intestinal epithelial cell types as they migrate along the crypt-villus axis. The amount and type of 
diet consumed influence this process and result in changes in the size and cellular make-up of the 
tissue (Dailey, 2014). Any situation with an increase in the luminal nutrient content has been 
shown to be accompanied by an increase in epithelial size as indicated by an increase in IESC 
number and proliferation, total epithelial cell number, villi length or crypt depth [methods 
include: intestinal transposition (Altmann and Leblond, 1970), diet-induced obesity (Beyaz et al., 
2016; Mah et al., 2014), lactation (Cripps and Williams, 1975) or cold exposure (Kaushik and 
Kaur, 2005)]. Whereas, the exclusion of luminal nutrients does the opposite [methods include: 
fasts (Ross and Mayhew, 1985), surgical bypass (Gleeson et al., 1972; Robinson et al., 1980), 
hibernation (Carey, 1990; Carey and Cooke, 1991)]. It is not clear, though, how nutrient 
availability dictates an increase in IESC proliferation and tissue size. 
 Alterations in energy metabolism of proliferating cells must occur in order to not only 
utilize more nutrients to produce adenosine triphosphate (ATP), but also to produce the biomass 
needed for cell proliferation. The metabolism of proliferating cells, including normal and cancer 
cells, is not the same as that of differentiated cells. Whereas differentiated cells rely on oxidative 
phosphorylation to produce ATP, actively proliferating cells rely on glycolysis to produce the 
biomass needed to manufacture new cells (Vander Heiden et al., 2009). It is unclear if this same 
type of change in metabolism is the mechanism underlying the nutrient-induced changes in IESC 
proliferation, where more nutrients induce greater glycolysis and less oxidative phosphorylation. 
In addition, IESCs are unique cells in that they are continuously dividing to regenerate cells 
normally lost due to apoptosis under homeostatic conditions and are also responsible for growing 
the tissue under high nutrient availability. It is not clear how IESCs mediate these two scenarios, 
but it necessitates that disparate mechanisms be utilized under conditions where tissue size is 
maintained versus those that lead to tissue growth. Thus, we tested if the metabolic profile of 
intestinal epithelial crypts is altered by nutrient availability and whether this leads to increases in 
proliferation. We utilized primary small intestinal epithelial crypts from C57BL/6J mice to study 
1) the effect of glucose on crypt proliferation, 2) the effect of glucose on crypt metabolism using 
a Seahorse XFe96 Extracellular Flux Analyzer for real-time metabolic measurements, and 3) 
whether hypoxia inducible factor 1 subunit alpha (HIF1A), a known regulator of both glycolysis 
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and proliferation plays a role in these glucose-induced effects (Semenza, 2003). We first 
measured the expression of different glucose transporter (GLUT) isoforms, GLUT1-GLUT4, and 
then crypt proliferation in response to glucose and metabolic modulators. Glycolysis was 
determined by measuring the extracellular acidification rate (ECAR), and glucose oxidation and 
mitochondrial respiration were determined by measuring the oxygen consumption rate (OCR) in 
response to glucose and metabolic modulators. Signaling pathways related to HIF1A-induced 
glycolysis and cell proliferation in response to glucose were also analyzed. 
2.3 Materials and Methods 
Animals 
 Male C57BL/6J mice at 10- to 12-weeks-old were used for quantitative real-time 
polymerase chain reaction (qPCR), and cell proliferation measurements. These mice were bred at 
the Division of Animal Resources animal facility at the University of Illinois at Urbana-
Champaign and were maintained with ad libitum access to tap water and laboratory chow 
(Tecklad 22/5, Tecklad Diets, Madison, WI) on a 12:12 light:dark cycle in a climate-controlled 
room (22 ± 1 °C and 60% relative humidity). All procedures were approved by the Institutional 
Animal Care and Use Committee at the University of Illinois at Urbana-Champaign. Male 
C57BL/6J mice were also used for metabolic measurements, but these mice were bred at the 
ETH Schwerzenbach laboratory animal facility and were maintained with ab libitum access to 
tap water and laboratory chow (3436, Kliba, Kaiseraugst, Switzerland). All procedures were 
approved by the Cantonal Veterinary Office of Zurich. 
Crypt isolation 
 Intestinal crypts were isolated as previously described (Sato and Clevers, 2013). Briefly, 
C57BL/6J mice were sacrificed by decapitation. The entire small intestine was harvested, opened 
longitudinally and washed with cold 1x PBS to remove luminal contents. The villi were scraped 
off with a coverslip. The tissue was cut into 2-4 mm pieces with scissors and washed 5-10 times 
with cold 1x PBS until the supernatant was almost clear. Tissue fragments were incubated with 2 
mM EDTA (Fisher Scientific, Pittsburgh, PA) and gently rocked at 4 °C for 30 min. After 
removal of EDTA, tissue fragments were washed with 1x PBS 3 times. The supernatant was then 
collected and passed through a 70-um cell strainer (Corning, Corning, NY) and centrifuged at 
300 g at 4 °C for 5 min. The cell pellet was resuspended with glucose-free basal crypt culture 
medium [SILAC™ Advanced DMEM/F-12 Flex Medium (Gibco, Grand Island, NY) containing 
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147.5 mg/L L-arginine (Sigma-Aldrich, St. Louis, MO), 91.25 mg/L L-Lysine (Sigma-Aldrich, 
St. Louis, MO), 2 mM GlutaMax (Gibco, Grand Island, NY), 10 mM HEPES (Gibco, Grand 
Island, NY) and 100 U/mL Penicillin-Streptomycin (Gibco, Grand Island, NY)] and centrifuged 
at 200 g for 2 min to remove single cells. The isolated crypts remaining were used for qPCR, 
glucose uptake, cell proliferation, metabolic assays or Western blots. 
Quantitative real-time PCR 
 To determine the gene expression of GLUTs in crypt cells, total RNA was extracted from 
isolated crypts using RNeasy Plus Mini Kit (Qiagen, Hilden, Germany). To determine the effect 
of glucose on HIF1A gene expression, isolated crypts embedded in Matrigel (Corning, Corning, 
NY) at 1,000 crypts/50 μL were incubated either in crypt culture medium without glucose 
[glucose-free basal crypt culture medium containing 50 ng/mL EGF (Gibco, Grand Island, NY), 
100 ng/mL Noggin (PeproTech, Rocky Hill, NJ), 500 ng/mL R-Spondin-1 (PeproTech, Rocky 
Hill, NJ), 1x N2 (Gibco, Grand Island, NY), 1x B27 (Gibco, Grand Island, NY) and 1 mM N-
Acetyl-L-cysteine (Sigma-Aldrich, St. Louis, MO)] or with low (5.5 mM) or high (17.5 mM) 
concentrations of glucose for 30 min with 5% CO2 at 37 °C. These concentrations were chosen 
based on hepatic portal vein or systemic glucose levels between and after meals in mice (Ayala 
et al., 2010; Han et al., 2008). Total RNA was extracted from crypts embedded in Matrigel using 
RNeasy Plus Universal Mini Kit (Qiagen, Hilden, Germany). RNA was reverse transcribed into 
cDNA using iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Quantitative real-time PCR 
was performed with TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, CA) 
and TaqMan probes (Applied Biosystems, Foster City, CA) using Applied Biosystems 7900HT 
Real-Time PCR System. Negative reverse-transcribed samples were generated and all reactions 
were carried out in triplicate. The following TaqMan probes were used: GLUT1: 
Mm00441480_m1, GLUT2: Mm00446229_m1, GLUT3: Mm00441483_m1, GLUT4: 
Mm00436615_m1, HIF1A: Mm00468869_m1, glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH): Mm99999915_g1. To determine relative expression values, the 2-ΔΔCt method was 
used, where triplicate Ct values for each sample were averaged and subtracted from those 
derived from GAPDH.   
Glucose uptake measurement 
 Freshly isolated crypts were embedded in Matrigel at 200 crypts/10 μL, seeded on 96-
well plate, and incubated in crypt culture medium. To determine glucose uptake of crypts in 
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response to varying levels of glucose, isolated crypts were incubated either in crypt culture 
medium without glucose or with low (5.5 mM) or high (17.5 mM) concentrations of glucose for 
30 min with 5% CO2 at 37 °C. Then the culture medium was removed, cells were washed with 
1x PBS, and 100 μL of 1 mM 2-DG (Promega Corporation, Madison, WI) diluted in 1x PBS was 
added. After an additional 30 min incubation at room temperature, glucose uptake was measured 
using Glucose Uptake-GloTM Assay (Promega Corporation, Madison, WI) according to the 
manufacturer’s instructions. 
Cell proliferation measurements 
 For determination of the crypt proliferation in response to glucose, isolated crypts were 
incubated either in crypt culture medium without glucose or with low (5.5 mM) or high (17.5 
mM) concentrations of glucose (Sigma-Aldrich, St. Louis, MO). Crypts were incubated with 5% 
CO2 at 37 °C for 2 h, 4 h, 6 h, 24 h or 48 h. Crypt proliferation was then measured using Cell 
Proliferation Reagent WST-1 (Roche Diagnostics, Indianapolis IN) according to the 
manufacturer’s instructions. For determination of the crypt proliferation in response to glycolytic 
pathway inhibitor 2-Deoxy-D-glucose (2-DG) (Sigma-Aldrich, St. Louis, MO) or oxidative 
phosphorylation uncoupler carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) 
(Sigma-Aldrich, St. Louis, MO), 100 mM 2-DG or 500 nM FCCP was added to crypt culture 
medium [IntestiCult™ Organoid Growth Medium (Stemcell Technologies, Vancouver, Canada) 
containing 100 U/mL Penicillin-Streptomycin]. Crypts were incubated with 5% CO2 at 37 °C for 
30 min. Crypt proliferation was then measured using CyQuant NF Cell Proliferation Assay Kit 
(Molecular Probes, Eugene, OR) according to the manufacturer’s instruction. 
Metabolic measurements 
 Extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) were 
measured using a Seahorse XFe96 Extracellular Flux Analyzer (Seahorse Bioscience, North 
Billerica, MA) as previously described (Fan et al., 2015). Briefly, 1 hr prior to the XF assay, 20 
μL XF assay medium was added to each well of Matrigel-precoated XF96 plate. Freshly isolated 
crypts were then seeded at 600 crypts/well in 20 μL XF assay medium. The plate was incubated 
at 37 °C in a non-CO2 incubator for 45 min. An additional 160 μL XF assay medium was then 
added and the plate was incubated at 37 °C in a non-CO2 incubator for an additional 10 min to 
equilibrate the crypt cells and media before being transferred into a Seahorse XFe96 
Extracellular Flux Analyzer. Three baseline metabolic measurements were taken. After the 
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addition of each compound, 3 or 5 response measurements were taken. All compounds were 
added to the injection ports with a 3 min mix prior to the metabolic measurements. For the 
measurement of glycolysis and glucose oxidation, the base XF assay medium (Seahorse 
Bioscience, North Billerica, MA) was supplemented with 2 mM Glutamax, 1 mM sodium 
pyruvate (Gibco, Grand Island, NY), and 100 U/mL Penicillin-Streptomycin (Fan et al., 2015). 
Glycolysis was determined by measuring ECAR in response to glucose (0 mM, 5.5 mM and 17.5 
mM) and the glycolytic pathway inhibitor 2-DG (100 mM) (Clara et al., 2016). Glucose 
oxidation was determined by measuring OCR in response to glucose (0, 5.5 and 17.5 mM) and 
the glucose oxidation pathway inhibitor UK5099 (15 μM, Sigma-Aldrich, St. Louis, MO) (Clara 
et al., 2016). For glucose-induced mitochondrial respiration measurement, the base XF assay 
medium was supplemented with 17.5 mM glucose, 2 mM Glutamax, 1 mM sodium pyruvate, 
and 100 U/mL Penicillin-Streptomycin (Fan et al., 2015). Mitochondrial respiration was 
determined by measuring OCR in response to modulators of mitochondrial respiration [i.e. ATP 
synthase inhibitor oligomycin (4 μg/mL, Sigma-Aldrich, St. Louis, MO), mitochondrial 
uncoupler carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP; 500 nM), complex I 
inhibitor rotenone (5 μM, Sigma-Aldrich, St. Louis, MO), complex III inhibitor antimycin A (5 
μg/mL, Sigma-Aldrich, St. Louis, MO)] (Clara et al., 2016; Clara et al., 2017). 
Western blots 
 To determine the effect of glucose on protein levels of glucose transporters (GLUTs), 
phosphorylated AKT (pAKT) and AKT, isolated crypts embedded in Matrigel were incubated 
either in crypt culture medium without glucose or with low (5.5 mM) or high (17.5 mM) 
concentrations of glucose for 30 min with 5% CO2 at 37 °C. Then crypts were recovered from 
Matrigel using Corning Cell Recovery Solution (Corning, Corning, NY) according to the 
manufacturer’s instructions. Total protein was extracted using M-PER mammalian protein 
extraction reagent (Thermo Scientific, Waltham, MA) with PhosSTOP phosphatase inhibitor 
cocktail tablet (Roche Diagnostics, Indianapolis, IN) and cOmplete protease inhibitor cocktail 
tablet  (Roche Diagnostics, Indianapolis, IN). A total of 20 μg of protein were separated using a 
Bolt 4-12% Bis-Tris plus gel (Invitrogen, Waltham MA) at 200 volts for 32 mins. The gel was 
transferred onto a Immun-Blot PVDF membrane (Bio-Rad, Hercules, CA) at 100 volts for 1 hr 
and then blocked in 5% Bovine Serum Albumin (Sigma-Aldrich, St. Louis, MO) diluted in 1X 
TBS with 0.1% Tween 20 (Sigma-Aldrich, St. Louis, MO) for 1 hr at room temperature with 
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gentle shaking. The membrane was then incubated in rabbit primary antibodies against GLUT1 
(1:1,000; Abcam, Cambridge, UK), GLUT2 (1:500; Abcam, Cambridge, UK), pAKT (Ser473) 
(1:500; Cell Signaling Technologies, Beverly, MA), AKT (1:1,000; Cell Signaling Technologies, 
Beverly, MA), and GAPDH (1:1,000; Cell Signaling Technologies, Beverly, MA) diluted in 
blocking buffer described above, overnight at 4 °C with gentle shaking. The membrane was 
rinsed in 1X TBS with 0.1% Tween 20 and incubated with anti-rabbit IgG, HRP-linked antibody 
(1:2,000, Cell Signaling Technologies, Beverly, MA) at room temperature for 1 hr with gentle 
shaking. Protein was detected using SuperSignal™ West Pico chemiluminescent substrate 
(Invitrogen, Carlsbad, CA) according to manufacturer’s instructions and imaged with an 
ImageQuant LAS 410 Luminescent image analyzer (GE Healthcare, Chicago, IL). Relative 
protein expression was estimated using band intensity quantified by imageJ software, and 
normalized to that of GAPDH. 
Data analysis 
 Data are expressed as Mean ± SEM. For qPCR, Western blots, glucose uptake and crypt 
proliferation, differences between groups were analyzed using a one-way ANOVA at each time 
point followed by a Tukey-Kramer post-hoc test, where appropriate. For determination of the 
crypt proliferation in response to metabolic modulators (i.e., 2-DG and FCCP), differences 
between groups were determined using a Student’s t test. For metabolic measurements, 
differences between groups were analyzed using a two-way RM ANOVA (interaction of 
treatment and time) followed by Tukey-Kramer post-hoc test. p<0.05 was considered statistically 
significant. 
2.4 Results 
Glucose transporters (GLUTs) were expressed in intestinal epithelial crypts  
 Glucose transporter 1 (GLUT1), GLUT2, GLUT3 and GLUT4 were expressed in 
intestinal epithelial crypts. The expression of GLUT2 was higher than that of GLUT1, GLUT3 
and GLUT4 (Table 1; p<0.05).  
Glucose induced an increase in glucose uptake 
 Glucose increased glucose uptake in a concentration-dependent manner. In particular, 
glucose uptake was increased in the 17.5 mM glucose condition compared with the 5.5 and 0 





Glucose induced an increase in crypt proliferation 
 Crypt proliferation was increased in the 5.5 and 17.5 mM glucose conditions compared 
with the 0 mM at 2 h, 4 h, 6 h, 24 h and 48 h after glucose application (Figure 2.2; p<0.05).  
Glucose induced an increase in glycolysis that contributes to the increase in crypt proliferation 
 Glucose increased ECAR in a concentration-dependent manner. In particular, ECAR was 
increased in the 17.5 mM glucose condition compared with the 5.5 and 0 mM, and in the 5.5 mM 
glucose condition compared with 0 mM, at each time point measured (i.e., 7, 13, 20, 26 and 33 
min (Figure 2.3B; p<0.05). The glycolytic pathway inhibitor, 2-DG, reduced either glucose-
induced OCR or ECAR compared with the vehicle control at each time point measured (Figure 
2.3C and 2.3D; p<0.05) and reduced glucose-induced crypt proliferation (Figure 2.3G; p<0.05). 
However, neither glucose nor the mitochondrial pyruvate carrier inhibitor, UK-5099, affected 
OCR at any time point (Figure 2.3A and 2.3E).  
Glucose induced an increase in the maximum mitochondrial respiration capacity of crypts, 
which contributes to the increase in crypt proliferation 
 Glucose increased FCCP-stimulated OCR in the 5.5 and 17.5 mM glucose conditions 
compared with the 0 mM at the 26 min time point (Figure 2.4A; p<0.05). Moreover, FCCP 
increased glucose-induced crypt proliferation (Figure 2.4B; p<0.05). 
Glucose induced an increase in HIF1A gene expression 
 Hypoxia inducible factor 1 subunit alpha (HIF1A) gene expression was increased in the 
5.5 mM glucose condition compared with the 0 mM after 30 min glucose application (Figure 2.5; 
p<0.05). 
Glucose induced an increase in protein levels of GLUT1, GLUT2, pAKT and AKT 
 Glucose transporter 1 (GLUT1) protein level was increased in the 5.5 mM glucose 
condition compared with the 0 and 17.5 mM, and in the 17.5 mM glucose condition compared 
with 0 mM (Figure 2.6B; p<0.05). Protein levels of GLUT2, Phospho-protein kinase B (pAKT) 
and AKT were increased in the 5.5 mM glucose condition compared with the 0 mM after 30 min 
glucose application (Figure 2.6C-E; p<0.05). 
2.5 Discussion 
 The aim of these experiments was to investigate the energy metabolism and cell 
proliferation in crypt cells under nutrient-driven growth conditions and the mechanisms linked to 
44 
 
nutrient-induced changes. The major findings were: 1) glucose induced an increase in glucose 
uptake of crypts in a concentration-dependent manner, 2) glucose induced an increase in crypt 
proliferation in a concentration-independent manner, 3) glucose increased glycolysis in a 
concentration-dependent manner, 4) inhibition of glycolysis blocked the glucose-induced 
increase in crypt proliferation, 5) glucose increased the maximum mitochondrial respiration 
capacity in a concentration-independent manner, 6) uncoupling ATP synthesis from the electron 
transport chain increased crypt proliferation, and 7) low, but not high glucose, activated the 
AKT/HIF1A signaling pathway, a pathway influences proliferation and glycolysis. 
 We used an in vitro isolated crypt model to try to capture the separate mechanisms that 
may drive regenerative proliferation under low nutrient conditions and those responsible for high 
nutrient-induced growth of the tissue. Although we found glucose concentration-dependent 
effects on early crypt metabolism, we found similar increases in proliferation under both the low 
and high glucose levels. It is no surprise that the concentration-dependent changes in metabolism 
are not solely driving changes in proliferation and must also be contributing the energy 
utilization of the non-proliferating cells within the crypt. This is apparent when we block key 
steps in metabolism, like glycolysis or the mitochondrial pyruvate carrier, and find only an 
attenuation and not a complete block of proliferation. It may also be the case that we did not 
appropriately recapitulate in vivo glucose levels in our in vitro preparation by failing to use a low 
enough glucose level to find a change in both metabolism and proliferation. Systemic levels of 
glucose in C57BL/6J mice, the strain utilized in the present study, vary greatly, but generally fall 
to ~5 mM during acute fasts and rise as high as ~20 mM after meals (Berglund et al., 2008; Han 
et al., 2008; Klueh et al., 2006; Savontaus et al., 2008). These systemic values, though, may not 
be the same within the crypt microenvironment. The IESCs within the crypt are likely affected 
by the concentration of nutrients in the venules that would include ingested nutrients, systemic 
levels of nutrients supplied to the crypts by the superior mesenteric artery and cells underlying 
the crypt epithelium within the lamina propria. Thus, we do not know if the exact levels of 
glucose utilized reflect the in vivo crypt environment. We can only conclude that the crypt cells 
are able to respond to the levels of glucose chosen in this study by altering metabolism in a 
concentration-dependent manner, but alter proliferation in a concentration-independent manner.  
 The nutrient source for the crypt has not been defined, but data support the role of 
luminal nutrients, and not systemic nutrients, in driving growth of the tissue. Parenteral nutrition 
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leads to a decrease in epithelial size and atrophy of the villi. Thus, an interaction of the luminal 
nutrients with the epithelial tissue appears necessary. That said, we do not believe that it is the 
direct luminal contact of the nutrients with the apical surface of the crypt cells that is driving 
proliferation. It has been postulated that nutrients absorbed from enterocytes enter into the local 
vasculature and affect crypt cells through basal surface receptors or transporters (Winesett et al., 
1995). This idea of proliferation being driven by basal surface receptors is supported by organoid 
in vitro research where factors supplied to the media affect the basal surface of the cells and are 
not injected into the lumen of the organoids to affect the apical surface. Much of the organoid in 
vitro data mimics that found in in vivo conditions, thus, further supporting a role for basal 
surface receptors. Glucose, amino acids and small/medium chain fatty acids would likely be able 
to move along a concentration gradient through passive or active diffusion between the blood 
vessels and interstitial space around the crypt. The only absorbed nutrient that is not likely to 
have a direct effect is long-chain fatty acids as they are packaged into chylomicrons and travel in 
the lymph vessels with no free passage into the crypt niche. Unfortunately, there is no current 
technology to measure crypt nutrient levels to determine the nutrient niche environment of the 
crypt in vivo.  
 Sensing the level of macronutrients is important for the cell to shuttle the nutrients to the 
proper pathway and may involve the direct interaction of the nutrient with membrane 
transporters or receptors, or an indirect mechanism by detecting a surrogate molecule whose 
levels correctly reflect nutrient abundance. Glucose transporter 1 (GLUT1) through GLUT4 are 
the primary players in cell membrane-mediated glucose responses in mammalian cells and we 
found that GLUT1 and GLUT2 were highly expressed in intestinal crypt cells that include the 
IESCs. GLUT1 has a high affinity for glucose (Km is as low as 1 mM of glucose) and is thought 
to be responsible for the low level of glucose uptake required to sustain respiration under 
homeostatic conditions (Efeyan et al., 2015). In contrast, GLUT2 is a low affinity transporter 
(Km > 15 mM) and transports glucose only when glucose levels are high (Efeyan et al., 2015). 
Given that we found a similar increase in crypt proliferation under both low and high glucose 
levels, it is likely glucose sensing is not driving changes in the proliferative patterns between 
regeneration versus those responsible for growth of the tissue. As stated above, it may also be 
that our low glucose condition may not mimic a low enough level that would normally be seen in 
the crypt niche in vivo under regeneration conditions. In contrast to a direct sensing mechanism, 
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an indirect nutrient sensing mechanism may underlie a nutrient-induced increase in proliferation 
and growth of the tissue. It is well known that in response to high nutrient availability, high 
levels of circulating insulin and insulin like growth factor 1 (IGF1) are released from the 
pancreas and liver respectively (Rafalski and Brunet, 2011), and high levels of local intestinal 
IGF1 are released from the pericryptal mesenchyme (Winesett et al., 1995). IGF1 and insulin 
bind to their respective receptors on the cell membrane, leading to the activation of 
PI3K/AKT/MTOR pathway (DeBerardinis et al., 2008). Activation of this pathway is then able 
to increase the expression of nutrient transporters and direct glycolysis by regulating gene 
expression for necessary metabolic molecules and enzyme activity (DeBerardinis et al., 2008). 
IGF1 and insulin receptors are expressed in IESCs and have been shown to modulate nutrient-
induced expansion of the crypt cells (Mah et al., 2014). In our in vitro preparation, though, crypt 
epithelial tissue is in isolation with no input from circulating factors or surrounding cells. An 
indirect mechanism of nutrient sensing would necessitate that other crypt cells would provide 
these signals. Paneth cells, the differentiated cell type surrounding the IESCs, secrete a variety of 
factors that could fulfill this role, including growth factors [i.e. epidermal growth factor (Poulsen 
et al., 1986; Sato et al., 2011b), transforming growth factor α (Sato et al., 2011b)] and mitogenic 
factors [i.e. wingless-type mouse mammary tumor virus integration site family member 3 
(WNT3) (Gregorieff et al., 2005; Sato et al., 2011b), WNT11 (Sato et al., 2011b), Delta-like 
ligand 4 (Sato et al., 2011b)]. Thus, nutrient sensing and nutrient-induced proliferation may 
involve a combination of direct, intrinsic indirect and extrinsic indirect mechanisms to guide 
crypt proliferation when tissue size is held constant or when there is nutrient-induced tissue 
growth.   
 Proliferating cells utilize nutrients to produce ATP for bioenergetic activity and generate 
intermediates needed for the biosynthesis of nucleotides, lipids and amino acids to duplicate all 
components during cell proliferation (Vander Heiden et al., 2011). In order to understand how 
proliferating crypt cells shuttle nutrients to meet these requirements, we concentrated our 
measurements on glycolysis and glucose oxidation given the previous role identified for these 
pathways in proliferating cells. We also tested the effect of metabolic inhibitors on glucose-
induced cellular respiration. During respiration, the oxidation of reduced nicotinamide adenine 
dinucleotide (NADH) and reduced flavin adenine dinucleotide (FADH2), generated by the 
tricarboxylic acid (TCA) cycle, in the respiratory chain generates H+ protons that transit via the 
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ATP synthase to produce ATP. The oxidative phosphorylation uncoupler, carbonyl cyanide 4-
(trifluoromethoxy) phenylhydrazone (FCCP), dissipates the proton gradient so that protons 
cannot be used to produce ATP. As a result, electron flow through the electron transport chain 
(ETC) and FADH2 are maximally used to generate enough protons to maintain the membrane 
potential. Therefore, the FCCP-stimulated oxygen consumption rate (OCR) (i.e., maximum 
respiration capacity) can be used as a measure of the cells’ ability to consume any metabolic 
substrate present, not just glucose (Liesa and Shirihai, 2013; Nicholls et al., 2010; Pike Winer 
and Wu, 2014). We found that glucose increased the maximum respiration capacity and, as with 
the effect of glucose on crypt proliferation, this increase was independent of the glucose 
concentration. Furthermore, we found that mitochondrial uncoupler FCCP increased glucose-
induced crypt proliferation, indicating that glucose-induced crypt proliferation can be modulated 
by glucose-stimulated increases in the maximum respiration capacity. Therefore, it appears that 
glucose may induce greater glycolysis and increase the maximum respiratory capacity in order to 
maintain ATP levels while still producing the substrates needed to manufacture new cells. 
 Hypoxia inducible factor 1 subunit alpha (HIF1A) is a key transcription factor that 
directly induces the expression of genes involved in glycolysis and cell proliferation (Semenza, 
2003). Nutrients, growth factors and cytokines stimulate HIF1A synthesis through 
phosphatidylinositol 3-kinase/protein kinase B/mechanistic target of rapamycin kinase 
(PI3K/AKT/MTOR) and RAF/mitogen activated protein kinase kinase/mitogen-activated protein 
kinase 1 (RAF/MAP2K/ MAPK1) signaling pathways (Masoud and Li, 2015; Semenza, 2003). 
We found that low, but not high, glucose levels activated AKT and increased the expression of 
HIF1A, a pathway that can lead to increases in both glycolysis and cell proliferation (Figure 2.7) 
(Belaiba et al., 2007; Pore et al., 2006). This differential effect of low and high glucose on 
HIF1A has previously been found and is driven by a low glucose-induced activation, but a high 
glucose-induced degradation of HIF1A protein levels (Botusan et al., 2008; Catrina et al., 2004; 
Dehne et al., 2010; Gao et al., 2007). It may be that there is a feedback circuit to keep HIF1A-
induced glycolysis or cell proliferation in check to ensure abnormal cell function does not occur. 
In non-tumor cells, HIF1A expression is elevated at glucose concentrations below 5.5 mM but is 
reduced at high glucose concentrations (Botusan et al., 2008; Catrina et al., 2004; Dehne et al., 
2010; Gao et al., 2007). In tumor cells, high glucose concentrations continue to increase HIF1A 
expression (Lu et al., 2005; Lu et al., 2002; Vordermark et al., 2005). We may have captured this 
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feedback circuit in our measurements of glucose-induced HIF1A expression and proliferation 
given that there is varied HIF1A expression even though proliferation is equal under the low and 
high glucose conditions. 
 Understanding how nutrients alter proliferation and the size of intestinal tissue is still in 
its infancy and there is no clear role for the effect of varying the nutrient content, mass or feeding 
schedules. A short-term increase or decrease (i.e. fast) in luminal nutrients appears to induce a 
growth or retraction, respectively, in tissue size with a concomitant change in proliferation. A 
unique situation is found when the long-term nutritional status of an animal is varied. Both 
overnutrition (i.e. high-fat feeding) and under nutrition (i.e. caloric restriction) result in an 
increase in stem cell number and proliferation, but only overnutrition results in an increase in the 
tissue size. Caloric restriction results in a decreased epithelial size. This long-term nutritional 
status may be driven not just by the immediate level of nutrients in the crypt niche, but also by 
other factors associated with long-term over- or undernutrition that modulate how the crypt cells 
respond to the available nutrients. 
 Nutrient-induced proliferation of stem cells involves more than just a switch from 
oxidative phosphorylation to glycolysis. Metabolic flux is altered at multiple levels in order to 
ensure the necessary biomass and ATP are produced. In addition, these metabolic changes 
appear to be what drives proliferation, but how glycolytic molecules induce non-metabolic 
functions is not known. Identifying how these processes interact with the cell cycle pathways 














2.6 Figures and Table 
 
Figure 2.1: Glucose induces an increase in glucose uptake  
Isolated crypts were treated with glucose (0, 5.5, 17.5 mM) for 30 min. Data are expressed as 















Figure 2.2: Glucose stimulates crypt proliferation 
Isolated crypts were treated with glucose (0, 5.5, 17.5 mM) across time (2, 4, 6, 24, 48 h). Data 
are expressed as Mean ± SEM (n=5). Means with different letters indicate significant differences 























Figure 2.3: Glucose induces an increase in glycolysis, and inhibition of glycolysis reduces 
glucose-induced crypt proliferation (continued) 
Data are expressed as Mean ± SEM. (A) Changes (%) in oxygen consumption rate (OCR) of 
isolated crypts after injection of glucose (0, 5.5, or 17.5 mM). n=6. * indicates significant 
interaction of treatment and time. (B) Changes (%) in extracellular acidification rate (ECAR) of 
isolated crypts after injection of glucose (0, 5.5, or 17.5 mM). n=6. * indicates significant 
interaction of treatment and time, *p < 0.05. (C) Changes (%) in OCR of isolated crypts after 
injection of 2-Deoxy-D-glucose (2-DG) (100 mM). n=8. * indicates significant interaction of 
treatment and time, *p < 0.05. (D) Changes (%) in ECAR of isolated crypts after injection of 2-
DG (100 mM). n=8. * indicates significant interaction of treatment and time, *p < 0.05. (E) 
Changes (%) in OCR of isolated crypts after injection of UK-5099 (15 μM). n=7. (F) Changes 
(%) in ECAR of isolated crypts after injection of UK-5099 (15 μM). n=7. (G) Isolated crypts 
were treated with 2-DG (100 mM) for 30 min. n=6. Means with different letters indicate 

















Figure 2.4: Glucose increases the maximum mitochondrial respiration capacity of crypts, 
and FCCP stimulates glucose-induced crypt proliferation 
Data are expressed as Mean ± SEM. (A) Changes (%) in OCR of isolated crypts after 
consecutive injection of oligomycin (Oligo) (4 μg/mL) at 0 min, carbonyl cyanide 4-
(trifluoromethoxy) phenylhydrazone (FCCP) (500 nM) at 26 min, rotenone (5 μM) + antimycin 
A (5 μg/mL) (Rot/Anti) at 46 min. n=7. * indicates significant effect of treatment (0 mM glucose 
and 5 mM glucose, 0 mM glucose and 17.5 mM glucose) on the first measurement after injection 
of FCCP, *p < 0.05. (B) Isolated crypts were treated with FCCP (500 nM) for 30 min. n=7. 













Figure 2.5: Low glucose induces an increase in hypoxia inducible factor 1 subunit alpha 
(HIF1A) gene expression 
Glucose induces an increase in glucose uptake. Isolated crypts were treated with glucose (0, 5.5, 
17.5 mM) for 30 min. Data are expressed as Mean ± SEM (n=3). Means with different letters 














Figure 2.6: Low glucose induces an increase in protein levels of glucose transporter 1 
(GLUT1), GLUT2, Phospho-protein kinase B (pAKT) and AKT 
Isolated crypts were treated with glucose (0, 5.5, 17.5 mM) for 30 min. Data are expressed as 







Figure 2.7: Proposed mechanism of glucose-induced glycolysis and cell proliferation 
Low glucose concentration activates AKT/HIF1A pathway, which, in turn, results in increases in 
glycolysis and cell proliferation. A feedback circuit that lowers HIF1A levels under high glucose, 


















Gene name Relative mRNA expression  
GLUT1 55.01 ± 19.03 a 
GLUT2 1153.26 ± 471.91 b 
GLUT3 1.00 ± 0.38 a 
GLUT4 1.93 ± 0.55 a 
Table 2.1: Glucose transporters (GLUTs) are expressed in intestinal epithelial crypts 
Data are expressed as Mean ± SEM of fold change in GLUT gene expression (n=3). Means with 
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CHAPTER 3: OBESITY, INDEPENDENT OF DIET, DRIVES LASTING EFFECTS ON 
INTESTINAL EPITHELIAL STEM CELL PROLIFERATION IN MICE 
 
 This chapter was published in Experimental Biology and Medicine. The citation for this 
article is as follows: Zhou W, Davis EA, Dailey MJ. Obesity, independent of diet, drives lasting 




 The intestinal epithelium plays an essential role in nutrient absorption, hormone release 
and barrier function. Maintenance of the epithelium is driven by continuous cell renewal by 
intestinal epithelial stem cells (IESCs) located in the intestinal crypts. Obesity affects this 
process and results in changes in the size and function of the tissue. Because both the amount of 
food intake and the composition of the diet are contributing factors to developing and 
maintaining obesity, it is necessary to tease apart the separate contributions of obesity versus the 
type/amount of diet in driving the epithelial changes. C57BL/6J mice were fed a 60% high-fat 
diet (HFD) versus a 10% low-fat diet (LFD) for 3 months. A pair fed (PF) group was included 
(mice were fed with HFD, but in equal kcal as that eaten by the LFD fed mice to keep them lean). 
We investigated the differences in 1) crypt-villus morphology in vivo, 2) the number and 
function of differentiated epithelial cell types in vivo, and 3) lasting effects on IESC proliferation 
and growth in vitro. We found that HFD-induced obesity, independent of the HFD, increased 
crypt depth, villus height, the number of IESCs and goblet cells in vivo, and enhanced the size of 
the enterospheres developed from isolated IESCs in vitro. In addition, there is an interaction of 
obesity, type of diet, and availability of the diet (PF versus ad libitum) on protein and mRNA 
expression of alkaline phosphatase (an enzyme of enterocytes). These results indicate that HFD-
induced obesity, independent of the HFD, induces lasting effects on IESC proliferation, and 
drives the differentiation into goblet cells, but an interaction of obesity and diet drive alterations 
in the function of the enterocytes. 
3.2 Introduction 
 The intestinal epithelium plays an essential role in nutrient absorption, satiety hormone 
release and immune barrier function. Maintenance of the epithelium is driven by continuous cell 
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renewal by intestinal epithelial stem cells (IESCs) located in the intestinal crypts (Barker et al., 
2010). IESCs give rise to progenitor cells, and then progenitor cells differentiate into mature 
intestinal epithelial cell types (e.g. enterocytes, enteroendocrine cells, goblet cells and Paneth 
cells) as they migrate along the crypt-villus axis. Obesity affects this process and results in 
changes in the size and cellular make-up of the tissue (Dailey, 2014). In particular, obesity 
increases IESC number and proliferation, total epithelial cell number, villus height or crypt depth 
in vivo (Baldassano et al., 2013; Beyaz et al., 2016; Mah et al., 2014; Mao et al., 2013). 
Moreover, diet-induced obesity causes lasting effects in IESCs, such that isolated IESCs from 
obese compared to lean mice grow at different rates in vitro (Beyaz et al., 2016; Mah et al., 
2014). These findings indicate that obesity may alter the proliferation, growth and function of the 
intestinal epithelial tissue through the modulation of somatic stem cells. 
 Previous studies investigating the effect of obesity on the proliferation of IESCs used a 
diet-induced obese mouse model that is limited to comparing a high-fat diet (HFD)-fed versus 
chow-fed mice (Beyaz et al., 2016; Mah et al., 2014). Although chow is a low-fat diet (LFD) that 
will result in a lean phenotype when consumed ad libitum in rodents, chow-fed mice do not eat 
the same kilocalorie (kcal) amount as the HFD-fed mice (Cani et al., 2008; Guo et al., 2009; Hill 
and Peters, 1998; Li et al., 2016; Sclafani, 1989). In addition, the ingredients and composition of 
these diets vary greatly (e.g. sugar, fiber and protein). Both the amount of food intake and the 
composition of the diet are factors that may lead to alterations in intestinal epithelial growth and 
function independent of the body weight differences between groups. In order to control for 
these factors, we chose to use a LFD that has the same ingredients as the HFD with only the 
amount of fat or carbohydrate varied, and included a pair fed (PF) group that was fed the HFD, 
but in equal kilocalories as that eaten by the LFD group. Using this model allows us to tease 
apart the separate contributions of obesity versus the type/amount of diet in altering proliferation, 
growth and function of the intestinal epithelial tissue. Mice were equally divided into 3 groups 
and fed 1) a 60% HFD ad libitum, 2) a 10% LFD fed ad libitum or 3) a HFD PF group. After 3 
months on the respective diets, mice were euthanized and the crypt depth, villi height, the 
number of different intestinal epithelial cell types and the expression of enzymes or secretory 
proteins of different intestinal epithelial cell types were measured in vivo, whereas the lasting 





3.3 Materials and Methods 
Animals 
 Male C57BL/6J mice at 10-weeks-old were obtained from the Jackson Laboratory (Bar 
Harbor, ME; N=24). Mice were individually housed in modified shoebox cages with a raised 
woven wire platform and lined with brown kraft paper for collection and measurement of food 
spillage. Mice were acclimated to the housing for 1 week with ad libitum access to tap water and 
laboratory chow (Tecklad 22/5, Tecklad Diets, Madison, WI) on a 12:12 light:dark cycle in a 
climate-controlled room (22 ± 1 °C and 60% relative humidity). All procedures were approved 
by the Institutional Animal Care and Use Committee at the University of Illinois at Urbana-
Champaign. 
 Following the 1 week acclimation, mice were fed a HFD or a LFD for 3 months. The 
HFD and control groups were as follows: 1) 60% HFD ad libitum fed (Research Diets D12492), 
2) 10% LFD ad libitum fed (Research Diets D12450J), and 3) 60% HFD PF group (fed a HFD, 
but in equal kcal as that eaten by the LFD fed animals to keep them lean), n=8 per group. It is not 
possible to include a LFD that eats the same kcal amount as the HFD ad libitum group without 
using a transgenic mouse or lesioning the hypothalamus to induce hyperphagia of the LFD. Mice 
were weighed weekly and food intake was measured daily. Mice in HFD PF group were given an 
equal kcal of the food eaten by the LFD fed mice a day later than other groups.   
 After 3 months, mice were killed by decapitation under isoflurane anesthesia (Henry 
Schein Animal Health, Dublin, OH). A subset of the mice (n=5 per group) were used for 
histology or quantitative real-time polymerase chain reaction (qPCR). A power analysis 
(G*Power 3.1.9.2) based on previously published data investigating the lasting effect of diet-
induced obesity on IESC growth in vitro and epithelial changes in vivo show that to achieve a 
power = 0.8 and a type I error of 0.05, an n=3 per group for in vitro experiments and an n=5 per 
group for in vivo analysis are needed (Beyaz et al., 2016; Mah et al., 2014). The intestine was 
exposed, and tissue was collected from the duodenum, jejunum, ileum and colon as previously 
described (Blackmore et al., 2017). Briefly, to ensure that we are collecting similar segments of 
the intestine for analysis between animals, we measured from the pyloric sphincter, discarded the 
first 1 cm and then collected two 5 mm samples to be processed for histology or qPCR. We then 
measured from the cecum, discarded the first 1 cm and then collected two 5 mm segments of the 
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ileum or colon. From the remaining jejunal segment, we measured from the middle and collected 
two 5 mm segments to be processed similarly to the duodenal and ileal segments. For histology, 
each of the 5 mm intestinal segments were fixed in 10% neutral buffered formalin for 24 h at RT 
and then stored in 70% ETOH at RT prior to paraffin embedding. For qPCR, each of the 5 mm 
intestinal segments were stored in RNAlater stabilization solution (Invitrogen, Carlsbad, CA) at -
80 °C prior to RNA extraction. Another subset of mice (n=3 per group) were used for isolation 
and culture of IESCs. For these mice, the entire small intestine was harvested for immediate 
IESC isolation. 
Intestinal epithelial stem cell (IESC) isolation 
 Intestinal epithelial stem cells (IESCs) were isolated as previously described (Sato and 
Clevers, 2013; Wang et al., 2013). Briefly, the entire small intestine was harvested, opened 
longitudinally and washed with cold 1x PBS to remove luminal contents. The villi were scraped 
off with a coverslip. The tissue was cut into 2-4 mm pieces with scissors and washed 5-10 times 
with cold 1x PBS until the supernatant was almost clear. Tissue fragments were incubated with 2 
mM EDTA (Fisher Scientific, Pittsburgh, PA) and gently rocked at 4 °C for 30 min. After 
removal of EDTA, tissue fragments were washed with 1x PBS 3 times. The supernatant was then 
collected and passed through a 70-μm cell strainer (Corning, Corning, NY) and centrifuged at 
300 g at 4 °C for 5 min. The cell pellet was resuspended with single cell dissociation medium 
(Advanced DMEM/F12 [Gibco, Grand Island, NY], 2 mM GlutaMax [Gibco, Grand Island, NY], 
10 mM HEPES [Gibco, Grand Island, NY], 100 U/mL Penicillin-Streptomycin [Gibco, Grand 
Island, NY], 1x N2 [Gibco, Grand Island, NY], 1x B27 [Gibco, Grand Island, NY], 10 μM Y-
27632 [Sigma-Aldrich, St. Louis, MO]) at 37 °C for 45 min. During incubation the cell 
suspension was pipetted every 10 min. Dissociated cells were passed through a 40-μm cell 
strainer (pluriSelect, Leipzig, Germany), followed by a 20-μm cell strainer (pluriSelect, Leipzig, 
Germany) and centrifuged at 300 g at 4 °C for 5 min. The pellet was then resuspended with 
staining medium (Advanced DMEM/F12, 2 mM GlutaMax, 10 mM HEPES, 100 U/mL 
Penicillin-Streptomycin, 10 μM Y-27632, 0.5 mM N-Acetyl-L-cysteine [Sigma-Aldrich, St. 
Louis, MO]), and stained with antibodies including CD45-FITC (1:100; eBioscience, San Diego, 
CA), CD44-PE/Cy5 (1.5:100; BioLegend, San Diego, CA), CD24-eFluor 450 (1.25:100; 
eBioscience, San Diego, CA), CD166-PE (1.5:100; R&D Systens, Minneapolis, MN) and 
GRP78 (0.5:100; Sigma-Aldrich, St. Louis, MO) at 4 °C for 30 min followed by secondary 
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antibody, goat anti-rabbit IgG, F(ab’)2-APC (1:100; Santa Cruz Biotechnology, Dallas, TX), 
straining for another 30 min at 4 °C, and IESCs were isolated as CD45-
CD44+CD24lowCD166medium/lowGPR78low/- by fluorescence-activated cell sorting (FACS) with a 
BD FACS ARIA II sorter into staining medium for following culture. Dead cells were excluded 
from the FACS with the viability dye propidium iodide (Invitrogen, Carlsbad, CA).  
Cell culture 
 Isolated IESCs were cultured as previously described (Wang et al., 2013; Yin et al., 
2014). Briefly, freshly isolated IESCs from each animal were embedded in Matrigel (Corning, 
Corning, NY) including 1 μM Jagged-1 peptide (Ana Spec, Fremont, CA) at 500 IESCs/10 μL, 
seeded on 96-well plate (replicates of 3 wells per animal) and incubated in IESC culture medium 
(Advanced DMEM/F12 containing 2 mM GlutaMax, 10 mM HEPES, 100 U/mL Penicillin-
Streptomycin, 1x N2, 1x B27, 1 mM N-Acetyl-L-cysteine, 50 ng/mL EGF [Gibco, Grand Island, 
NY], 100 ng/mL Noggin [PeproTech, Rocky Hill, NJ], 500 ng/mL R-Spondin-1 [PeproTech, 
Rocky Hill, NJ], 3μM CHIR99021 [Sigma-Aldrich, St. Louis, MO] and 1 mM valproic acid 
[Sigma-Aldrich, St. Louis, MO]). Two inhibitors of differentiation (CHIR99021 and valproic 
acid) were used to maintain IESCs in a self-renewing and undifferentiated state (Yin et al., 2014), 
which allow for us to assess the lasting effect of obesity or the type/amount of diet on IESC 
proliferation without the interference of mixed cell types in previously described IESC culture 
conditions. Medium was changed every other day. Representative images were captured from 
day 2 to day 12 post plating using an Axio Vert.A1 inverted microscope (Zeiss, Oberkochen, 
Germany) fitted with an Axiocam 503 mono camera (Zeiss, Oberkochen, Germany). 
Enterosphere size was quantified through analysis of captured images at 10x magnification using 
ImageJ software (NIH, Bethesda, MD). 
Histology 
 Formalin fixed tissue sections were embedded using paraffin and cut on a microtome at 5 
μm thickness and mounted onto charged glass microscope slides. For crypt-villus morphology, 
tissue sections were deparaffinized in xylenes followed by a series of graded ethanol, then rinsed 
in deionized water. Intestinal sections were counterstained in hematoxylin (Fisher HealthCare, 
Houston, TX) and dehydrated in a series of graded ethanol followed by xylenes. Slides were 
mounted with Permount mounting media (Fisher Scientific, Pittsburgh, PA) and stored at RT. 
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 For immunohistochemical processing for Olfactomedin-4 (Olmf4; an IESC marker) and 
Chromogranin A (an enteroendocrine cell marker), after deparaffinizing slides as described 
above, antigen retrieval was performed by immersing the slides in the sodium citrate buffer (10 
mM sodium citrate hydrochloride [Fisher Scientific, Pittsburgh, PA] and 0.05% Tween 20 
[Sigma- Aldrich, St. Louis, MO] diluted in distilled water, pH 6.0) for 20 min in a water bath at 
95°C, then allowed to cool while still immersed in the sodium citrate buffer solution for 30 min 
at RT. Slides were rinsed between each step in 1x  PBS. Slides were incubated in blocking 
solution (3% Normal Donkey Serum [Jackson ImmunoResearch, West Grove, PA] and 0.3% 
Triton X-100 [Sigma-Aldrich, St. Louis, MO] diluted in 1x PBS) for 1 h at RT. Sections were 
incubated overnight at 4 °C in the following primary antibodies diluted in the blocking solution: 
Olmf4 (1:400; Cell Signaling Technology, Danvers, MA), Chromogranin A (1:1,000; Abcam, 
Cambridge, United Kingdom). Sections were incubated in a donkey anti-rabbit biotin-conjugated 
IgG (H&L) secondary antibody (1:500, Jackson ImmunoResearch, West Grove, PA) diluted in 
1x  PBS for 1 h at RT. Sections were then incubated in an avidin-biotin complex (Vector 
Laboratories, Burlingame, CA) for 30 min at RT. A diaminobenzidine-hydrogen peroxidase 
reaction was performed using a substrate kit (Vector Laboratories, Burlingame, CA).  Slides 
were dehydrated and mounted as described above.  
 For Periodic Acid Schiff staining of mucins (a goblet cell marker) and Paneth cell 
granules (a Paneth cell marker), after deparaffinizing slides as described above, slides were 
immersed in 0.5% Periodic Acid (Newcomer Supply, Middleton, WI) for 10 min at RT and 
washed in distilled water. Sides were then immersed in Schiff reagent (Newcomer Supply, 
Middleton, WI) for 30 min at RT, and rinsed in 0.55% potassium metabisulfite (Fisher Scientific, 
Pittsburgh, PA) for 30 sec and followed by washing in warm running tap water for 10 min. 
Slides were counterstained in hematoxylin, dehydrated and mounted as described above.  
 For staining of alkaline phosphatase (an enterocyte marker), after deparaffinizing slides 
as described above, slides were immersed in alkaline phosphatase substrate working solution 
(Vector Laboratories, Burlingame, CA) for 25 min. Slides were then washed in 100 mM Tris 
hydrochloride (PH 8.2; Fisher Scientific, Pittsburgh, PA) for 5 min and followed by washing in 
running distilled water for 5 min. Slides were dehydrated and mounted as described above.  
 Intestinal tissues sections were visualized using a NanoZoomer Digital Pathology (NDP) 
System (Hamamatsu, Hamamatsu City, Japan) using a 40× objective and NDP Scan software. 
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Crypt depth and villus height of 3 intestinal cross sections (4 crypts or villi per section) from 
each segment of the intestine (duodenum, jejunum, ileum and colon) per mouse were measured 
using NDP View 2 software. The number of Olmf4-postive IESCs, Chromogranin A-positive 
enteroendocrine cells, Periodic Acid Schiff-positive goblet cells and Periodic Acid Schiff-
positive Paneth cells of 3 intestinal cross sections (3 crypts or villi per section) from the jejunum 
per mouse were measured using NDP View 2 software. The expression of alkaline phosphatase 
was determined by measuring relative intensity of alkaline phosphatase staining of 3 intestinal 
cross sections (3 villi per section) from the jejunum per mouse were measured using ImageJ 
software. 
Quantitative real-time polymerase chain reaction (qPCR) 
 In order to investigate whether obesity or the type/amount of diet alters the function of 
differentiated intestinal epithelial cell types, we measured the expression of alkaline phosphatase 
(an enzyme of enterocyte regulating lipid absorption and barrier function) (Lalles, 2010), 
lysozyme (an antimicrobial protein secreted by Paneth cells) (Bel et al., 2017), chromogranin A 
(a protein secreted by enteroendocrine cells, which facilitates the release of different peptide 
hormones through controlling dense-core secretory granule biogenesis) (Engelstoft et al., 2008; 
Kim et al., 2001), and mucin 2 (the major secretory mucin secreted by goblet cells) (Kim and Ho, 
2010). Total RNA was extracted from tissue using RNeasy Plus Mini Kit (Qiagen, Hilden, 
Germany). RNA was reverse transcribed into cDNA using QuantiTect Reverse Transcription Kit 
(Qiagen, Hilden, Germany). qPCR was performed with TaqMan Universal PCR Master Mix 
(Applied Biosystems, Foster City, CA) and TaqMan probes (Applied Biosystems, Foster City, 
CA) using Applied Biosystems QuantStudioTM 7 Flex Real-Time PCR System. Negative reverse-
transcribed samples were generated and all reactions were carried out in triplicate. The following 
TaqMan probes were used: Alpi: Mm01285814_g1, Lyz1: Mm00657323_m1, Chga: 
Mm00514341_m1, Muc2: Mm01276696_m1, and glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH): Mm99999915_g1. To determine relative expression values, the 2-ΔΔCt method was 
used, where triplicate Ct values for each sample were averaged and subtracted from those 
derived from GAPDH. 
Data analysis 
 Data are expressed as Mean ± SEM. For measurement of body weight and daily food 
intake, differences between groups were analyzed using a two-way RM ANOVA. Differences 
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between groups for average daily food intake were analyzed using a Student’s t test. For 
measurements of crypt depth, villus height, number of different intestinal cell types, the relative 
intensity of alkaline phosphatase staining and qPCR, differences between groups for each 
segment were analyzed using a one-way ANOVA. For measurement of enterosphere size, 
differences between groups at each time points were analyzed using a one-way ANOVA. 
Fisher’s LSD post-hoc tests were used where appropriate. p<0.05 was considered statistically 
significant. 
3.4 Results 
Body weight and food intake 
 Body weight and food intake were increased in the HFD fed mice compared with the 
LFD and HFD PF groups (Figure 3.1A, B&C; p<0.05).  
Intestinal crypt and villus morphometry 
 Crypt depth and villus height in the duodenum and jejunum were increased in the HFD 
fed mice compared with the LFD and HFD PF groups (Figure 3.2B&C; p<0.05), but no 
differences were found in the ileum and colon (Figure 3.2B&C). 
Number of intestinal epithelial cell types 
 The number of Olmf4-positive IESCs and Periodic Acid Schiff-positive goblet cells in 
the jejunum was increased in the HFD fed mice compared with the LFD and HFD PF groups 
(Figure 3.3B&H; p<0.05). There were no differences in the number of Periodic Acid Schiff-
positive Paneth cells and Chromogranin A-positive enteroendocrine cells in the jejunum between 
the HFD, HFD PF or LFD groups (Figure 3.3D&F).  
Expression of intestinal enzymes or secretory proteins 
 The protein levels of alkaline phosphatase (a marker for enterocytes) was highest in the 
HFD PF group in the jejunum (Figure 3.3J; p<0.05). Specifically, alkaline phosphatase levels in 
the HFD PF group were increased compared with the HFD and LFD groups (Figure 3.3J; 
p<0.05). Alkaline phosphatase levels were also increased in the HFD compared with the LFD 
group (Figure 3.3J; p<0.05). Gene expression of alkaline phosphatase was highest in the HFD PF 
group, with significant increases in the duodenum and jejunum (Figure 3.4D; p<0.05). 
Specifically, alkaline phosphatase expression in the HFD PF group was increased in the 
duodenum compared with the HFD group and in the jejunum compared with the HFD and LFD 
groups (Figure 3.4D; p<0.05). Alkaline phosphatase expression was also increased in the HFD 
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compared with the LFD group, but only in the jejunum (Figure 3.4D; p<0.05). There were no 
differences in the gene expression of lysozyme (a marker for Paneth cells), chromogranin A (a 
marker for enteroendocrine cells) and mucin 2 (a marker for goblet cells) between the HFD, 
HFD PF or LFD groups (Figure 3.4A, B&C). 
IESC proliferation in culture 
 The size of the enterospheres that developed from IESCs isolated from HFD fed mice 
was increased compared with those from HFD PF group and LFD group on day 11 and 12 post 
plating (Figure 3.5B; p<0.05). There were no differences in the number of enterospheres 
developed from IESCs isolated from any group (data not shown). 
3.5 Discussion 
 The aim of these experiments was to investigate whether obesity or the type/amount of 
diet differentially alters the proliferation, growth and function of the intestinal epithelial tissue. 
The major findings were: 1) HFD-induced obesity, independent of the HFD, increased crypt 
depth and villus height in the duodenum and jejunum of intestine in vivo, 2) HFD-induced 
obesity, independent of the HFD, induced increases in the number of IESCs and goblet cells in 
the jejunum in vivo, 3) HFD-induced obesity, independent of the HFD, enhanced IESC 
proliferation and growth in vitro, and 4) there was an interaction of obesity, the type of diet 
(HFD), and availability of the diet (PF versus ad libitum) on the function of enterocytes in the 
duodenum and jejunum of intestine in vivo. 
 Consistent with previous findings (Baldassano et al., 2013; Mah et al., 2014; Mao et al., 
2013; Wolnerhanssen et al., 2017), our results showed that HFD-induced obesity leads to a 
growth of the epithelium as measured by increases in crypt depth and villus height, and this 
increase in epithelial mass is reflected by an increase in the number of IESCs and goblet cells. 
We showed for the first time that this effect was not driven by the HFD alone and occurs even 
when a LFD of a similar composition is used as a control condition (as opposed to a chow-fed 
group). Because the intestinal epithelial cells are the first point of contact with ingested food and 
prepare the body for the nutrients that are entering the system, it makes sense that their cellular 
make-up would be comprised of cells that would be best suited for the digestion of a diet that is 
maintained across time. The high adaptability of the epithelium to change its cellular make-up is 
likely due to a coordinated effort of the presence and nature of the distinct food components (e.g. 
proteins, lipids, carbohydrates) in the lumen of the intestinal tract mixed with signals from the 
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basal surface of the tissue (e.g. hormonal, neural). These signals likely direct the IESCs to 
proliferate and direct the progenitor cells at the crypt-villus axis to differentiate into the 
functional cells needed. Moreover, this obesity-induced tissue growth is pronounced in the 
proximal, but not the distal intestine. Although we find differences in the HFD-induced obesity 
effect between the proximal and distal axis, there is data to support the idea that the IESCs are 
not intrinsically different between the intestinal segments and, instead, proliferation and 
differentiation along the proximal to distal axis is driven by the local niche environment at each 
segment. Intestinal transposition studies where duodenal, jejunal or ileal segments are transposed 
with each other show that the proliferation, total number of epithelial cells and villus height are 
determined by the environment and not an intrinsic property of the crypts that contain the IESCs 
at each segment (Altmann and Leblond, 1970). For example, the short villi normally seen in ileal 
segments quickly grow long when transplanted into the duodenum or vice versa (Altmann and 
Leblond, 1970). The function of transposed or transplanted segments can also be regained 
(Altmann and Leblond, 1970). In addition, we find that isolated crypts from the duodenum, 
jejunum, ileum, or colon grown under the same conditions in vitro will produce all of the same 
types of daughter cells even though they do not produce these in vivo (unpublished observations). 
For example, enteroendocrine cell types typically vary along the proximal to distal axis of the 
intestinal tract with I cells in the proximal and L cells in the distal intestine. We find that both 
cell types are produced in the same enterospheres in vitro, regardless from where the crypts were 
isolated along the intestinal axis (unpublished observations). Thus, it is likely that the 
environment along the intestinal axis (proximal to distal intestine) drives the differences in 
response to HFD-induced obesity and not intrinsic differences between the IESCs from each 
intestinal segment. There is likely a coordinated effort of the presence and nature of the distinct 
food components and enzymes in the lumen of each segment of the intestinal tract mixed with 
signals from the basal surface of the tissue. 
 We found that there is an interaction of obesity, the type of diet, and availability of the 
diet (PF versus ad libitum) on protein and mRNA expression of alkaline phosphatase, but not the 
expression of markers for other differentiated cell types. Moreover, this effect is pronounced in 
the proximal, but not the distal segments of intestine. Alkaline phosphatase is a brush border 
protein that has a number of activities, including the hydrolysis of various substrates, and 
participates in a rate-limiting step regulating fat absorption (Lalles, 2010; Narisawa et al., 2003). 
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It is expressed exclusively in villus-associated enterocytes and can be released into the lumen or 
circulation (Goldberg et al., 2008). Although often used as a marker for the number of 
enterocytes, it is likely a better marker for the activity occurring in the enterocytes. Alkaline 
phosphatase is increased during fat absorption and is higher in animals maintained on a high fat 
diet (Lawrie and Yudkin, 1949). Just as we have found, though, there are dissimilar results 
between groups of animals due to the differences in the amount eaten or fatty acid composition 
of the HFD (de La Serre et al., 2010; Kaur et al., 1996; Lalles, 2010; Sefcikova et al., 2008; 
Wahnon et al., 1992). The role of alkaline phosphatase in HFD-driven effects is further 
complicated by data showing that alkaline phosphatase levels are positively correlated with 
obesity (Khan et al., 2015; Ognibene et al., 1997), but that high levels of alkaline phosphatase 
can protect against HFD-induced obesity and the development of type II diabetes (Kaliannan et 
al., 2013; Malo, 2015; Ognibene et al., 1997). The distinction for the role of alkaline phosphatase 
may depend on when the protein is measured in the progression of HFD ingestion, development 
of obesity and the diabetic condition given that HFD dose-dependent effects on gene expression 
have been found. It appears that the intestinal epithelium has the capacity to handle increasing 
levels of dietary fat until a threshold (20% fat), but then progressive adaptations in epithelial 
activity are more pronounced as dietary fat levels continue to increase above that threshold (from 
20% to 30% to 45% fat) (de Wit et al., 2011). We postulate that the HFD-driven increase in 
alkaline phosphatase in our HFD PF group is attenuated in our HFD group by circulating factors 
related to obesity. Conversely, there may have been an adaptation in the PF animals to the 
feeding regimen in order to enhance the absorption of food. These mice are fed in a single HFD 
meal that is normally eaten in its entirety within an hour, instead of being able to eat the food ad 
libitum as in the HFD group. Moreover, the differences seen along the intestinal axis are likely 
because alkaline phosphatase-regulated lipid absorption mainly takes place in the proximal and 
not the distal intestine (de Wit et al., 2011). Thus, the interaction of diet, obesity and the feeding 
regimen may alter the function of enterocytes in the proximal intestine and could potentiate the 
downstream effects of HFD-induced obesity. In addition, although we found that HFD-induced 
obesity increased goblet cell number, there were no differences in the expression of mucin 2, the 
major secretory mucin secreted by goblet cells, between groups. It is likely that obesity-induced 
increases in goblet cell number may contribute to the changes in the expression of other types of 
mucus proteins secreted by goblet cells, but not the expression of mucin 2. 
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 We have replicated the findings that HFD-induced obesity results in lasting effects on 
IESC growth in vitro (Beyaz et al., 2016; Mah et al., 2014). We show for the first time that this 
effect 1) occurs even when proliferation is investigated without concomitant differentiation and 2) 
was not driven by HFD alone and requires hyperphagia of the HFD and/or obesity. Although the 
delayed in vitro effect (significant differences between groups is not apparent until day 11) likely 
reflects the need for a threshold number of cells in the enterospheres to be present for statistical 
comparison, it is striking that the obesity-induced effect on IESC proliferation remains across 
multiple days of growth in vitro. Thus, there must be some intrinsic differences in how the 
“obese” versus “lean” stem cells adapt to a new environment. The retention of mechanisms of 
IESC proliferation after isolation and culture may be driven by in vivo high circulating levels of 
insulin and local release of insulin like growth factor 1 (IGF1), as indicated previously (Andres 
et al., 2015; Mah et al., 2014; Van Landeghem et al., 2015). The long-term changes in 
insulin/IGF1 receptor signaling in the IESCs may promote epigenetic modifications in the 
proliferation process, which might be retained in IESCs across generations of new cells in vitro, 
mechanisms that have yet to be studied. Regardless of the mechanism, it is not known whether 
this obesity-induced effect on IESC proliferation would also be maintained in vivo after weight 
loss or if animals were switched to a new diet. This might have far-reaching consequences for an 
individual as this may be a key factor in maintaining altered tissue growth and function 
associated with obesity. It is not clear, though, how the obesity-induced cellular adaptation may 


















Figure 3.1: Body weight (A), daily food intake (B) and average daily food intake (C) of mice 
fed with high-fat diet (HFD) or low-fat diet (LFD) for 3 months 
Data are expressed as Mean ± SEM (n=8). * indicates significant different between HFD and 
HFD PF groups and between HFD and LFD groups at that time point, p<0.05. # indicates 









Figure 3.2: Representative images of hematoxylin stained crypt-villus morphology in the 
jejunum (A), and quantification of crypt depth (B) and villus height (C) in intestinal 
segments (duodenum, jejunum, ileum and colon) collected from mice fed with HFD or LFD 
Scale bar, 100 μm. Data are expressed as Mean ± SEM (n=5). Means with different letters 















Figure 3.3 (continued) 
Representative images of the jejunal sections collected from mice fed with HFD or LFD stained 
with Olmf4 (IESC marker), Scale bar, 20 μm (A), Paneth cell granules (Paneth cell marker), 
Scale bar, 20 μm (C), Chromogranin A (enteroendocrine cell maker), Scale bar, 100 μm (E), 
mucins (goblet cell marker), Scale bar, 100 μm (G), and alkaline phosphatase (enterocyte 
marker), Scale bar, 100 μm (I). Quantification of the number of Olmf4-positive IESCs (B), 
Periodic Acid Schiff-positive Paneth cells (D), Chromogranin A-positive enteroendocrine cells 
(F), and Periodic Acid Schiff-positive goblet cells (H) in the jejunum. Quantification of relative 
intensity of alkaline phosphatase staining (J). Data are expressed as Mean ± SEM (n=5). Means 





















Figure 3.4: Gene expression of enzymes or secretory proteins of different intestinal 
epithelial cell types in intestinal segments (duodenum, jejunum, ileum and colon) collected 
from mice fed with HFD or LFD 
Gene expression of lysozyme (Paneth cells) (A), chromogranin A (enteroendocrine cells) (B), 
mucin 2 (goblet cells) (C), and alkaline phosphatase (enterocytes) (D). Data are expressed as 
Mean ± SEM of fold change relative to HFD PF group in the duodenum (n=5). Means with 










Figure 3.5: Representative images (A) and quantification of the size of enterospheres that 
developed from IESCs (B) isolated from mice fed with HFD or LFD 
Scale bar, 200 μm. Data are expressed as Mean ± SEM (n=3). Means with different letters 
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CHAPTER 4: SEX DIFFERENCES INFLUENCE INTESTINAL EPITHELIAL STEM 
CELL PROLIFERATION INDEPENDENT OF OBESITY 
 
 This chapter is in press in Physiological Reports. The citation for this article is as follows: 
Zhou W, Davis EA, Li K, Nowak RA, Dailey MJ. Sex differences influence intestinal epithelial 
stem cell proliferation independent of obesity. Physiol Rep. 2018 [in press; Physiol Rep, 6 (11), 
2018, e13746, https://doi.org/10.14814/phy2.13746]. 
 
4.1 Abstract 
 The intestinal epithelium is continuously regenerated by cell renewal of intestinal 
epithelial stem cells (IESCs) located in the intestinal crypts. Obesity affects this process and 
results in changes in the size and cellular make-up of the tissue, but it is unknown if there are sex 
differences in obesity-induced alterations in IESC proliferation and differentiation. We fed male 
and female mice a 60% high-fat diet (HFD) or a 10% low-fat diet (LFD) for 3 months and 
investigated the differences in 1) the expression of markers of different intestinal epithelial cell 
types in vivo, and 2) lasting effects on IESC growth in vitro. We found that the growth of IESCs 
in vitro were enhanced in females compared with males. HFD induced similar in vivo changes 
and in vitro early growth of IESCs in males and females. The IESCs isolated and grown in vitro 
from females, though, showed an enhanced growth that was independent of obesity. To 
determine whether this effect was driven by sex steroid hormones, we used primary intestinal 
crypts isolated from male and female mice and investigated the differences in 1) the expression 
of steroid hormone receptors, and 2) cell proliferation in response to steroid hormones. We found 
that estrogen receptor 1 was expressed in crypts from both sexes, but estrogen had no effect on 
proliferation in either sex. These results indicate that obesity similarly effects IESCs in males 
and females, but IESCs in females have greater proliferation ability than males, but this is not 
driven by a direct effect of sex steroid hormones on IESCs or other crypt cells that provide 
essential niche support for IESCs. 
4.2 Introduction 
 The intestinal epithelium plays important roles in nutrient absorption, satiety hormone 
release and immune barrier function. The epithelium is regenerated every few days in order to 
maintain the proper function of the tissue, a process that is driven by continuous cell renewal of 
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intestinal epithelial stem cells (IESCs) localized near the base of intestinal crypts (Barker et al., 
2010; Leblond and Stevens, 1948). IESCs give rise to progenitor cells which, in turn, 
differentiate into mature intestinal epithelial cell types (e.g. Paneth cells, enterocytes, 
enteroendocrine cells, goblet cells). Obesity influences this process and results in changes in the 
size and cellular make-up of the tissue (Dailey, 2014). In particular, high-fat diet-induced obesity 
increases IESC number and proliferation, total epithelial cell number, crypt depth or villus height 
in vivo (Baldassano et al., 2013; Beyaz et al., 2016; Mah et al., 2014; Mao et al., 2013) and 
drives lasting effects on IESCs, such that isolated IESCs from obese versus lean mice grow at 
different rates in vitro (Beyaz et al., 2016; Mah et al., 2014). These findings indicate that obesity 
may affect the growth and function of the intestinal epithelial tissue through modulating IESCs. 
However, most studies regarding the effect of obesity on IESCs and intestinal epithelial 
regeneration are skewed toward the use of male animals, without delineating the sex differences 
in obesity-induced alterations. 
 Stem cells in many tissues are regulated in a sex-specific manner. In mammals, sex-
specific regulation of stem cells has been found in hematopoietic (Nakada et al., 2014), neural 
(Pawluski et al., 2009), and muscle (Deasy et al., 2007) stem cells, such that stem cells in 
females exhibit increased stem cell number, proliferation or regeneration potential compared 
with males. In Drosophila, IESCs in females exhibit greater proliferation, regenerative capacity 
and organ size than in males (Hudry et al., 2016). That said, unique tissue and species-specific 
stem cell properties are demonstrated and may not equate to similar sex-induced changes in 
mammalian IESCs. Thus, we tested whether there were sex differences in the proliferation and 
differentiation of IESCs in mammals, and if obesity-driven changes in IESCs differed between 
males and females. In Experiment 1, we fed male and female mice a 60% high-fat diet (HFD) or 
a 10% low-fat diet (LFD) for 3 months to investigate sex differences in obesity-induced 
alterations in IESC proliferation and differentiation. We then measured changes in 1) crypt depth, 
villus height and the expression of markers of different intestinal epithelial cell types in vivo, 2) 
lasting effects on IESC growth in vitro, and 3) proliferation of organoids that developed from 
IESCs in response to nutrient (i.e. glucose) application in vitro. In Experiment 2, we tested 
whether sex differences in IESC proliferation may result from the differential expression of 
steroid hormone receptors or steroid hormone-induced proliferation because these mechanisms 
have been previously found to influence stem cell proliferation between the sexes (Nakada et al., 
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2014; Pawluski et al., 2009). We used primary small intestinal epithelial crypts, which include 
IESCs, progenitor cells and Paneth cells, isolated from male and female mice and investigated 
the differences in 1) the expression of estrogen receptor 1 (ESR1), estrogen receptor 2 (ESR2), 
progesterone receptor (PGR) and androgen receptor (AR), and 2) proliferation in response to 
steroid hormone application in vitro. 
4.3 Materials and Methods 
Experiment 1 
Animals 
 Male (n=24) and female (n=20) leucine rich repeat containing G protein-coupled receptor 
5-enhanced green fluorescent protein-internal ribosome entry site-cyclization recombinase-
estrogen receptor T2 (LGR5-EGFP-IRES-CreERT2) mice at 10- to 12-weeks-old were used. 
These mice were bred at the Division of Animal Resources facility at the University of Illinois at 
Urbana-Champaign from original breeding pairs obtained from the Jackson Laboratory (Bar 
Harbor, ME). Mice were individually housed in modified shoebox cages with a raised woven 
wire platform and lined with brown kraft paper for collection and measurement of food spillage. 
Mice were acclimated to the housing for 1 week with ad libitum access to tap water and 
laboratory chow (Teklad 22/5, Teklad Diets, Madison, WI) on a 12:12 light:dark cycle in a 
climate-controlled room (22 ± 1 °C and 60% relative humidity). All procedures were approved 
by the Institutional Animal Care and Use Committee at the University of Illinois at Urbana-
Champaign. 
 Following 1 week acclimation, mice were fed a HFD or LFD for 3 months. Male and 
female mice were divided into groups based on average body weight as follows: 1) 60% HFD 
fed (Research Diets D12492; n=13 males; n=11 females), and 2) 10% LFD fed (Research Diets 
D12450J; n=11 males; n=9 females). We have previously found that HFD-induced obesity, and 
not just the HFD, is necessary to induce changes in IESC proliferation compared with lean, LFD 
mice (Zhou et al., 2017). Thus, we did not include a HFD fed group that was weight-matched to 
the LFD group. Mice were weighed weekly and food intake was measured daily by weighing the 
food left in the hopper and subtracting the food spillage. 
 After 3 months, mice were killed by decapitation under isoflurane anesthesia (Henry 
Schein Animal Health, Dublin, OH). The mice were killed in the middle of the light cycle 
following a 6hr food deprivation. A subset of the mice (n=3 per group) were used for isolation 
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and culture of IESCs and another subset of mice (the rest of the mice in each group n=6-10) were 
used for histology or quantitative real-time polymerase chain reaction (qPCR). A power analysis 
(G*Power 3.1.9.2) based on previously published data investigating the lasting effect of diet-
induced obesity on IESC growth in vitro and epithelial changes in vivo show that to achieve a 
power = 0.8 and a type I error of 0.05, an n=3 per group for in vitro experiments and an n=5 per 
group for in vivo analysis are needed (Beyaz et al., 2016; Lee et al., 2017). The intestine was 
exposed and the entire small intestine was harvested for immediate IESC isolation. Another 
subset of mice (the rest of mice in each group n=6-10) were used for histology or qPCR. For 
these mice, we exposed the intestine and collected the mid-small intestinal tissue (i.e. jejunum) 
as previously described (Blackmore et al., 2017). Briefly, to ensure that we were collecting 
similar segments of the intestine for analysis between animals, we measured from the pyloric 
sphincter and ileocecal valve to isolate the middle of jejunum and collected two 5 mm segments 
to be processed for histology or qPCR. For histology, each of the 5 mm intestinal segments were 
fixed in 10% neutral buffered formalin for 24 h at room temperature (RT) and then stored in 70% 
ethanol at RT prior to paraffin embedding. For qPCR, each of the 5 mm intestinal segments were 
stored in RNAlater stabilization solution (Invitrogen, Carlsbad, CA) at -80 °C prior to RNA 
extraction. 
Isolation of small intestinal crypts 
 Small intestinal crypts were isolated as previously described (Zhou et al., 2018). Briefly, 
the entire small intestine was harvested, opened longitudinally and washed with cold 1x PBS to 
remove luminal contents. The villi were scraped off with a coverslip. The tissue was cut into 2-4 
mm pieces with scissors and washed 5-10 times with cold 1x PBS until the supernatant was 
almost clear. Tissue fragments were incubated with 2 mM EDTA (Fisher Scientific, Pittsburgh, 
PA) and gently rocked at 4 °C for 30 min. After removal of EDTA, tissue fragments were 
washed with 1x PBS 3 times. The supernatant was then collected and passed through a 70-μm 
cell strainer (Corning, Corning, NY) and centrifuged at 300 g at 4 °C for 5 min. The cell pellet 
was resuspended with basal culture medium (Advanced DMEM/F-12 Medium [Gibco, Grand 
Island, NY] containing 2 mM GlutaMax [Gibco, Grand Island, NY], 10 mM HEPES [Gibco, 
Grand Island, NY] and 100 U/mL Penicillin-Streptomycin [Gibco, Grand Island, NY]) and 
centrifuged at 200 g for 2 min to remove single cells. The isolated crypts remaining were used 
for immediate IESC isolation. 
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Intestinal epithelial stem cell (IESC) isolation and culture 
 Intestinal epithelial stem cells (IESCs) were isolated and cultured as previously described 
(Sato and Clevers, 2013; Wang et al., 2013). Briefly, freshly isolated crypts from LGR5-EGFP-
ires-CreERT2 mice were resuspended with single cell dissociation medium (basal culture 
medium containing 1x N2 [Gibco, Grand Island, NY], 1x B27 [Gibco, Grand Island, NY] and 10 
μM Y-27632 [Sigma-Aldrich, St. Louis, MO]) at 37 °C for 45 min. During incubation the cell 
suspension was pipetted every 10 min. Dissociated cells were passed through a 40-μm cell 
strainer (pluriSelect, Leipzig, Germany), followed by a 20-μm cell strainer (pluriSelect, Leipzig, 
Germany) and centrifuged at 300 g at 4 °C for 5 min. Single, live IESCs were sorted as GFPhigh 
by fluorescence-activated cell sorting (FACS) with a BD FACS ARIA II sorter into single cell 
dissociation medium. Dead cells were excluded from the FACS with the viability dye propidium 
iodide (Invitrogen, Carlsbad, CA). Freshly isolated IESCs from each animal were embedded in 
Matrigel (Corning, Corning, NY) including 1 μM Jagged-1 peptide (Ana Spec, Fremont, CA) at 
500 IESCs/10 μL, seeded on 96-well plates (replicates of 5 wells per animal) and incubated in 
IESC culture medium (basal culture medium containing 1x N2, 1x B27, 1 mM N-Acetyl-L-
cysteine, 50 ng/mL EGF [Gibco, Grand Island, NY], 100 ng/mL Noggin [PeproTech, Rocky Hill, 
NJ] and 500 ng/mL R-Spondin-1 [PeproTech, Rocky Hill, NJ]). Medium was changed every 
other day. Representative images were captured on day 3, 5, 7, 9, and 12 post plating using an 
Axio Vert.A1 inverted microscope (Zeiss, Oberkochen, Germany) fitted with an Axiocam 503 
mono camera (Zeiss, Oberkochen, Germany). By day 3, isolated IESCs have proliferated to 
produce more IESCs and progenitor crypt cells (i.e. transit amplifying cells). By day 5, we begin 
to see the differentiated daughter cells that make-up the villus epithelium (e.g. enterocytes and 
enteroendocrine cells). By day 7, budding from the spheroid begins and the organoid with its 
structural villi and crypts begins to be formed. Organoid size and number were quantified 
through analysis of captured images at 10x or 2.5x magnification, respectively. Organoid size 
was quantified using ImageJ software (NIH, Bethesda, MD). Organoid number was counted in 
each well. 
Cell proliferation measurement 
 We have previously found that nutrient availability enhances intestinal organoid/crypt 
cell proliferation in vitro (Zhou et al., 2018). Thus, to determine if obesity impacts the ability of 
cells to respond to changes in nutrient availability, and if these obesity-driven alterations differ 
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between males and females, we investigated the proliferation of organoids that developed from 
IESCs in response to glucose. Isolated IESCs were cultured for 12 days to form organoids 
(replicates of 5 wells per group per animal). Organoid cultures were changed to glucose-free 
IESC culture medium (SILAC™ Advanced DMEM/F-12 Flex Medium [Gibco, Grand Island, 
NY] containing 147.5 mg/L L-arginine [Sigma-Aldrich, St. Louis, MO], 91.25 mg/L L-Lysine 
[Sigma-Aldrich, St. Louis, MO], 2 mM GlutaMax, 10 mM HEPES, 100 U/mL Penicillin-
Streptomycin, 1x N2, 1x B27, 1 mM N-Acetyl-L-cysteine, 50 ng/mL EGF, 100 ng/mL Noggin 
and 500 ng/mL R-Spondin-1), and incubated for 4 h (Blackmore et al., 2017; Cognard et al., 
2013). Organoids were then incubated either in IESC culture medium without glucose or with 
low (5.5 mM) or high (17.5 mM) concentrations of glucose (Sigma-Aldrich, St. Louis, MO) with 
5% CO2 at 37 °C for 1 d. These concentrations were chosen based on hepatic portal vein or 
systemic glucose levels between and after meals in mice (Zhou et al., 2018). Cell proliferation 
was then measured using Cell Proliferation Reagent WST-1 (Roche Diagnostics, Indianapolis IN) 
according to the manufacturer’s instructions. 
Histology 
 Morphometric analyses were performed on formalin fixed, paraffin embedded, and 
hematoxylin stained cross sections. Briefly, Intestinal sections (5 mm) were fixed in 10% neutral 
buffered formalin for 24 h at RT and then stored in 70% ethanol at RT until later processing. In 
order to paraffin embed the tissue, sections were dehydrated in a series of graded ethanols, 
cleared in xylene and infiltrated with paraffin in a Tissue Tek VIP 1000 tissue processor (Miles, 
Elkhart, IN). Paraffin blocks of tissue were cut on a microtome at 5 μm thickness and mounted 
onto charged glass microscope slides. Tissue sections were then deparaffinized in xylenes, 
hydrated in a series of graded ethanols, and rinsed in deionized water. Sections were stained in 
hematoxylin (Fisher HealthCare, Houston, TX) followed by dehydration in a series of graded 
ethanols and cleared in xylene. Slides were coverslipped with Permount mounting media (Fisher 
Scientific, Fair Lawn, NJ). Intestinal tissue sections were visualized using a NanoZoomer Digital 
Pathology (NDP) System (Hamamatsu, Hamamatsu City, Japan) using a 40× objective and NDP 
Scan software. Nine crypts or villi from the jejunal sections per mouse were chosen based on 
intact morphology of the intestine (Argenzio et al., 1990; Heise et al., 1991; Jinga et al., 2017; 




Quantitative real-time polymerase chain reaction (qPCR) 
 To determine the expression of markers of different intestinal epithelial cell types in 
tissue, total RNA was extracted from tissue using RNeasy Plus Mini Kit (Qiagen, Hilden, 
Germany). RNA was reverse transcribed into cDNA using QuantiTect Reverse Transcription Kit 
(Qiagen, Hilden, Germany). qPCR was performed with TaqMan Universal PCR Master Mix 
(Applied Biosystems, Foster City, CA) and TaqMan probes (Applied Biosystems, Foster City, 
CA) using Applied Biosystems QuantStudioTM 7 Flex Real-Time PCR System. Negative 
reverse-transcribed samples were generated and all reactions were carried out in triplicate. The 
following TaqMan probes were used: alkaline phosphatase, intestinal: Mm01285814_g1, 
chromogranin A: Mm00514341_m1, LGR5: Mm00438890_m1, lysozyme 1: Mm00657323_m1, 
mucin 2: Mm01276696_m1 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH): 
Mm99999915_g1. To determine relative expression values, the 2-ΔΔCt method was used, where 




 Male (n=3) and female (n=3) C57BL/6J mice at 10-weeks-old were used. These mice 
were obtained from the Jackson Laboratory (Bar Harbor, ME), and were maintained with ad 
libitum access to tap water and laboratory chow (Teklad 22/5, Teklad Diets, Madison, WI) on a 
12:12 light:dark cycle in a climate-controlled room (22 ± 1 °C and 60% relative humidity). All 
procedures were approved by the Institutional Animal Care and Use Committee at the University 
of Illinois at Urbana-Champaign. Male and female mice were killed by decapitation under 
isoflurance anesthesia. Female mice were killed at the diestrus stage of the estrous cycle (when 
estradiol levels are low) to minimize the variability in hormone levels during the estrous cycle 
(Patel et al., 2017). For both male and female mice, the chest cavity was opened and blood was 
collected from the right ventricle of the heart for immediate serum separation, which was then 
stored at -20 °C prior to serum estradiol level measurement. The intestine was then exposed and 
the entire small intestine was harvested for immediate crypt isolation.  
Isolation of small intestinal crypts 
 Small intestinal crypts were isolated as described above. The isolated crypts were used 
for qPCR or cell proliferation measurement. Day 1 of isolated crypts includes the IESCs and 
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progenitor cells. By day 3 of crypt culture, organoids with villus and crypts were present. 
Quantitative real-time polymerase chain reaction (qPCR) 
 To determine the expression of steroid hormone receptors in isolated crypts, total RNA 
was extracted from isolated crypts using RNeasy Plus Mini Kit (Qiagen, Hilden, Germany). To 
determine the expression of ERα in response to 17β-estradiol in crypts, total RNA was extracted 
from crypts embedded in Matrigel using RNeasy Plus Universal Mini Kit (Qiagen, Hilden, 
Germany). Reverse transcription, qPCR and determination of relative expression values were 
performed as described above. The following TaqMan probes were used: ESR1: 
Mm00433149_m1, ESR2: Mm00599821_m1, AR: Mm00442688_m1, PGR: Mm00435628_m1 
and GAPDH: Mm99999915_g1. 
Cell proliferation measurement 
 For determination of the proliferation in response to 17β-estradiol, freshly isolated crypts 
from each animal were embedded in Matrigel at 200 crypts/10 μL, seeded on 96-well plate 
(replicates of 4 wells per group per animal), incubated in phenol red-free IESC culture medium 
(glucose-free IESC culture medium containing 17.5 mM glucose). Crypts were then incubated 
either in phenol red-free IESC culture medium with 0.1% ethanol (control) or with different 
concentrations of 17β-estradiol (1 or 10 nM) with 5% CO2 at 37 °C for 1 d or 3 d. These 
concentrations were chosen based on effective physiological doses found to elicit changes in 
intestinal epithelium and in the proliferation of estrogen receptor positive cell types (Brunner et 
al., 1989; Chow et al., 2004; Lippman et al., 1976; O'Mahony et al., 2007; Picotto et al., 1996; 
Strom et al., 2004). MCF-7 estrogen receptor positive cells (American Type Culture Collection, 
Rockville, MD) were used as the positive control. MCF-7 cells were seeded at 10,000 cells/well 
in 96-well plates (replicates of 4 wells per group), incubated in MCF-7 culture medium (phenol 
red-free MEM [Gibco, Grand Island, NY] containing 5% charcoal stripped fetal bovine serum 
[Gibco, Grand Island, NY], 0.1 mM non-essential amino acids [Gibco, Grand Island, NY], 2 mM 
GlutaMax, 1 mM sodium pyruvate, 10 μg /mL insulin and 100 U/mL Penicillin-Streptomycin), 
and cultured for 1 d. MCF-7 cells were then incubated either in MCF-7 culture medium with 
0.1% ethanol (control) or with different concentrations of 17β-estradiol (1 or 10 nM) with 5% 
CO2 at 37 °C for additional 1 or 3d (Brunner et al., 1989; Chow et al., 2004; Lippman et al., 
1976). 17β-estradiol or 0.1% ethanol was added to crypts or MCF-7 cells daily. Cell proliferation 
was then measured using Cell Proliferation Reagent WST-1. 
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Serum estradiol levels 
 Estradiol levels in collected sera were measured using Mouse/Rat Estradiol enzyme-
linked immunosorbent assay (ELISA) kit (Calbiotech, El Cajon, CA) according to the 
manufacturer’s instructions. 
Data analysis 
 Data are expressed as Mean ± SEM. For measurements of body weight and food intake, 
differences between groups were analyzed using a two-way RM ANOVA. For measurements of 
crypt depth, villus height, the expression of markers of different intestinal epithelial cell types, 
organoid size, organoid number, and ERα expression and cell proliferation in response to 17β-
estradiol, differences between groups at each time point were analyzed using a two-way 
ANOVA. For measurement of cell proliferation in response to glucose, differences between 
groups were analyzed using a three-way ANOVA. For measurement of MCF-7 cell proliferation 
in response to 17β-estradiol, differences between groups at each time point were analyzed using 
a one-way ANOVA. Fisher’s LSD post-hoc tests were used where appropriate. For measurement 
of the expression of steroid hormone receptors and serum estradiol levels, differences between 
groups were analyzed using a Student’s t test. p<0.05 was considered statistically significant. 
Assumptions of normality, homogeneity of variance, and independence were met for all 
significant data. 
4.4 Results 
Body weight and food intake 
 Body weight and food intake were increased in the HFD fed mice compared with the 
LFD group in male (Figure 4.1A&B; p<0.05) and female mice (Figure 4.1C&D; p<0.05). 
Intestinal crypt and villus morphometry 
 Crypt depth and villus height were greater in HFD fed mice than LFD group (Figure 4.2A, 
B&C; p<0.05), but there was no sex effect or interaction between diet and sex (Figure 4.2B; 2C). 
Expression of intestinal epithelial cell markers 
 The expression of alkaline phosphatase (enterocyte marker) and chromogranin A 
(enteroendocrine cell marker) were increased in HFD fed mice compared with LFD group 
(Figure 4.3A&B; p<0.05), but there was no sex effect or interaction between diet and sex (Figure 
4.3A&B). There was no diet effect, sex effect or interaction between diet and sex on the 
expression of lysozyme (Paneth cell marker) and mucin 2 (goblet cell marker) (Figure 4.3C&D). 
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The expression of LGR5 (IESC marker) was greater in females than males (Figure 4.3E; p<0.05), 
but there was no diet effect or interaction between diet and sex (Figure 4.3E). 
Intestinal epithelial stem cell (IESC) growth and proliferation in response to glucose in vitro 
 The size of the organoids that developed from IESCs isolated from HFD fed mice was 
greater than those isolated from the LFD group on day 3 post plating (Figure 4.4C; p<0.05). The 
size of the organoids that developed from isolated IESCs was greater in females than males on 
days 3, 5, 7 and 9 post plating (Figure 4.4C; p<0.05). There was no interaction between diet and 
sex on any day (Figure 4.4C). The number of organoids that developed from IESCs on day 12 
post plating was greater in females than males (Figure 4.4D; p<0.05), but there was no diet effect 
or interaction between diet and sex (Figure 4.4D). When these day 12 organoids were then 
exposed to varying levels of glucose, proliferation was greater in the 5.5 and 17.5 mM glucose 
conditions compared with the control group, was greater in HFD group than LFD group, and was 
greater in females than males (Figure 4.4E; p<0.05). There was an interaction between glucose 
and diet (Figure 4.4E; p<0.05), but there was no interaction between glucose and sex, between 
diet and sex, or between glucose, diet and sex on the proliferation (Figure 4.4E). 
Expression of steroid hormone receptors in isolated crypts and serum estradiol levels 
 Estrogen receptor 1 (ESR1) was expressed in isolated crypts from both male and female 
mice without sex differences (Figure 4.5A), but ESR2, androgen receptor (AR), and 
progesterone receptor (PGR) were not expressed in either sex (data not shown). There were no 
differences in the serum estradiol levels between male and female mice at sacrifice (Figure 4.5B).  
Cell proliferation in response to estrogen 
 Estrogen receptor 1 (ESR1) was expressed in crypts in both male and female mice after 1 
or 3 d 17β-estradiol application, but there was no 17β-estradiol effect, sex effect or interaction 
between 17β-estradiol and sex on the expression of ESR1 (Figure 4.6A). Cell proliferation was 
greater in 10 nM 17β-estradiol condition than 1 nM 17β-estradiol condition after 1 d application 
(Figure 4.6B; p<0.05), but 1 or 10 nM 17β-estradiol condition was not different from the control 
group (Figure 4.6B). There was no sex effect or interaction between 17β-estradiol and sex on 
crypt proliferation after 1 d 17β-estradiol application (Figure 4.6B). There was no 17β-estradiol 
effect, sex effect or interaction between 17β-estradiol and sex on crypt proliferation after 3 d 
17β-estradiol application (Figure 4.6B). 1 and 10 nM 17β-estradiol increased the proliferation of 




 The aim of these experiments was to investigate whether there are sex differences in the 
proliferation and differentiation of Intestinal epithelial stem cells (IESCs) in mammals, if 
obesity-driven changes in IESCs differ between males and females, and whether steroid 
hormones contribute to these sex differences. The major findings were: 1) High-fat diet (HFD) 
induced similar in vivo changes in females as has previously been found in males, 2) HFD 
enhanced the early growth of IESCs in vitro in females as has previously been found in males, 3) 
the growth of IESCs in vitro was enhanced in females compared with males, independent of 
HFD, 4) HFD and sex-induced changes in proliferation remained when challenged with a new 
nutrient (i.e. glucose) environment, 5) Estrogen receptor 1 (ESR1), but not ESR2, progesterone 
receptor (PGR) and androgen receptor (AR), was expressed in both male and female crypts, and 
6) estrogen had no effect on proliferation in either sex. 
 A myriad of differences in the morphology and function of the intestinal epithelium have 
been documented between obese and lean individuals, but whether these changes are similarly 
found in males and females has not explicitly been investigated previously. We have replicated 
findings that obese humans and non-human animal models have greater villus height and crypt 
depth and that this increase in epithelial mass is reflected by an increase in the number of 
enterocytes similarly in males and females (Kageyama et al., 2003; Mayer and Yannoni, 1956; 
Verdam et al., 2011). Because enterocytes comprise the vast majority of the epithelial cells, any 
change in their numbers would likely result in significant functional differences, which has 
previously been seen as an obesity-induced increase in absorptive capacity (Balint et al., 1980; 
Ferraris and Vinnakota, 1995; Mayer and Yannoni, 1956; Singh et al., 1972). In addition to the 
increase in enterocytes, we found that the increase in epithelial size may be driven by an increase 
in enteroendocrine cells. Whereas some studies find a similar obesity-induced increase in 
enteroendocrine cells (Aranias et al., 2015; Dusaulcy et al., 2016; Widmayer et al., 2015), others 
find no change (Beyaz et al., 2016; Mah et al., 2014) or decreases in their numbers (Richards et 
al., 2016; Wolnerhanssen et al., 2017). Obesity-induced changes in goblet and Paneth cell 
number between studies have also been found (Beyaz et al., 2016; Mah et al., 2014; Yang et al., 
2003). When comparing only the HFD-induced mouse studies (and not those that include obesity 
developed through the use of transgenic models or ventromedial hypothalamic lesions), 
differences between studies likely reflect the type of diet [60% HFD (Beyaz et al., 2016; 
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Dusaulcy et al., 2016; Richards et al., 2016; Widmayer et al., 2015) or 45% HFD (Mah et al., 
2014)], the comparator diet [low-fat (Dusaulcy et al., 2016) or chow (Beyaz et al., 2016; Mah et 
al., 2014; Richards et al., 2016; Widmayer et al., 2015)], or the length of time on the diet [4 
months (Dusaulcy et al., 2016; Richards et al., 2016), 6 months (Mah et al., 2014; Widmayer et 
al., 2015) or longer (Beyaz et al., 2016)]. Because the intestinal epithelial cells are the first point 
of contact with ingested food and prepare the body for the nutrients that are entering the system, 
it makes sense that their cellular make-up would be comprised of cells that would be best suited 
for the digestion of a diet that is maintained across time. The high adaptability of the epithelium 
to change its cellular make-up is likely due to a coordinated effort of the presence and nature of 
the distinct food components (e.g. proteins, lipids, carbohydrates) in the lumen of the intestinal 
tract mixed with signals from the basal surface of the tissue (e.g. hormonal, neural). These 
signals likely direct the progenitor cells at the crypt-villus axis to differentiate into the functional 
cells needed. A role for Notch signaling in directing epithelial lineage allocation has been 
outlined (Jensen et al., 2000; Yang et al., 2001). Atonal basic helix-loop-helix transcription 
factor 1 (ATOH1) and hairy and enhancer of split-1 (HES1) are two downstream transcription 
factors from Notch signaling that work in opposition to each other to drive the differentiation 
into secretory cells (i.e. enteroendocrine and goblet cells) or enterocytes, respectively (Jensen et 
al., 2000; Yang et al., 2001). Downstream of ATOH1, neurogenin 3 directs enteroendocrine 
differentiation from goblet cells (Jenny et al., 2002). Morbidly obese patients that have 
undergone gastric bypass surgery show changes in the transcription of these factors and resulting 
differentiated daughter cell composition 3 months after surgery that is similar to that of lean 
individuals, even though the post-gastric bypass patients are still obese (Wolnerhanssen et al., 
2017). This indicates that the combination of luminal dietary components and basal signals that 
may drive changes in these transcription factors and epithelial composition is independent of 
body weight - a finding that has previously been proposed (Altmann and Leblond, 1970; Dailey, 
2014; Steinbach et al., 1994). It still has yet to be elucidated, though, how the molecular 
mechanisms control epithelial cell differentiation and how dietary signals may mediate changes 
in these processes. 
 The impact of obesity to induce lasting consequences on stem cell proliferation and/or 
differentiation has been previously found [e.g. IESCs (Beyaz et al., 2016; Mah et al., 2014), bone 
marrow-derived mesenchymal stem cells (Wu et al., 2013), hematopoietic stem cells (Lee et al., 
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2017), and adipose-derived stem cells (Baptista et al., 2015; Wu et al., 2013)]. The conditions 
necessary for acquisition of the functional and molecular changes in stem cells appear to be 
progressive in nature. That is, the more extreme the obesity due to the length of time on a HFD 
or the transgenic obese model used appears to result in a more extreme phenotype in the stem 
cells, a phenotype that can persist after weight loss, after transplantation into a normal 
environment, or after isolation and in vitro culture of the stem cells (Baptista et al., 2015; Beyaz 
et al., 2016; Lee et al., 2017; Mah et al., 2014; Wu et al., 2013). These previous findings in other 
types of stem cells follow with what we found in IESCs. Although we have replicated the 
findings of Beyaz et al. (Beyaz et al., 2016) that a 60% HFD-induced obesity enhanced IESC 
growth in vitro compared with those isolated from lean mice, the length of time this effect lasted 
was different. We found that IESCs isolated from mice on a 60% HFD for 3 months retained in 
vitro differences in growth for only 3 days, whereas when mice were maintained on the diet for 
9-14 months, the in vitro differences remained for much longer (Beyaz et al., 2016). These data 
indicate that the length of time an animal is obese or maintained on a HFD may drive changes in 
the IESC niche to alter proliferation and growth of the tissue. Mah et al. (Andres et al., 2015; 
Mah et al., 2014; Van Landeghem et al., 2015) postulate that the lasting consequences of obesity 
on IESCs are driven by obesity-associated high circulating levels of insulin and local release of 
insulin like growth factor 1 (IGF1). The changes in insulin/IGF1 signaling in IESCs may then 
promote progressive epigenetic modifications in the proliferation process that are determined by 
the degree of metabolic disturbances associated with the obesity. The mice used in the present 
experiment and the other 60% HFD-induced obesity experiment (Beyaz et al., 2016), are a good 
model to mimic the human metabolic derangements observed in obesity. Hyperglycemia, 
hyperinsulinemia and insulin resistance can be seen as early as 4 weeks on a HFD, but can 
become progressively worse as the length of time on the HFD is maintained for longer durations 
(Inui, 2003; Sato et al., 2010; Wang and Liao, 2012). The aberrant insulin receptor signaling that 
occurs as a result of obesity, including protein kinase B (AKT) and mechanistic target of 
rapamycin kinase (MTOR) signaling, alters cell proliferation and growth and may mediate 
progressive changes in the epigenetic control of genes related to the cell cycle. This model of 





 We show for the first time that sex differences impact IESC proliferation (independent of 
HFD-induced obesity), which is shown as greater IESC growth in vitro. In particular, we found 
that there were no sex differences in the size of the crypt-villus in vivo, but when we isolated and 
cultured IESCs in vitro, a sex effect on IESC growth became apparent and lasted for multiple 
days. It is likely that in vivo, the IESCs were probably in a similar niche environment (e.g. high 
insulin, IGF1) for a long period of time. Therefore, the cells from males and females have 
similarly adapted, which lead to no sex differences in tissue size in vivo. When we moved the 
cells from in vivo to in vitro, they were being moved into a new environment. Because we plated 
equal numbers of cells from each group, there must be some intrinsic differences in how the 
male versus female cells respond to the new environment, which lead to the sex differences in 
vitro. This initial difference between male and female cells in how they proliferate in vitro 
disappeared so that there were no significant differences on day 12. When we took a subset of 
these "similar" acting cells on day 12 and transferred them to yet another new environment, the 
sex difference reappeared. We found that male and female cells differentially responded to a new 
glucose environment. This sex difference, though, may be driven by a difference in the number 
of organoids between the sexes on day 12, which is something that we could not control. We 
cannot explain why there are more organoids in females, but the size of the organoids is the same 
in females and males. Taken together, there must be some intrinsic differences in how the male 
versus female cells adapt to a new environment. 
 Although sex steroid hormones have been found to directly contribute to stem cell 
proliferation of select tissues (Nakada et al., 2014; Pawluski et al., 2009), we did not find that to 
be the case for IESCs. We found that the IESCs and other crypt cells lacked ESR2, PR and AR 
and only expressed ESR1 in both males and females. We also found no induction of proliferation 
with the application of estrogen even though the doses used induced proliferation in an estrogen 
sensitive cell line. This indicates that sex differences in IESCs do not result from short-term, 
direct effects of steroid hormones on IESCs or other crypt cells which provide essential niche 
support for IESCs. This estrogen-independent manner of action has been found in the 
regeneration of skeletal muscle stem cells (Deasy et al., 2007). Moreover, although sex steroids 
do not directly alter IESC proliferation, sex steroids may play an indirect role through 
modulating the stem cell niche as has been found in other stem cells (Calvi et al., 2003; Qiu et al., 
2014; Zhang et al., 2003). Stromal cells underlying the intestinal epithelium within the lamina 
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propria modulate the function of the IESCs (Kabiri et al., 2014; Tan and Barker, 2014) and 
express estrogen receptor (Press et al., 1986). Thus, circulating estrogen may indirectly regulate 
stem cell proliferation and differentiation thorough modulating stromal cells of lamina propria in 
the stem cell niche. 
 These results indicate that there is a differential IESC proliferative capacity in males 
versus females in response to changes in their nutrient environment, but this difference is 
independent of HFD-induced obesity and not driven by a direct effect of steroid hormones on 
IESCs or other crypt cells that provide essential niche support for IESCs. This finding is relevant 
to treatments used to remedy abnormal proliferation or function of the intestinal epithelium 
because the IESCs may differentially respond to acute changes in nutrient availability or 
pharmacological approaches aimed at altering proliferation and differentiation. A further 
understanding how the sex difference in cellular adaptation may affect tissue regeneration or 























Figure 4.1: Body weight and daily food intake of male (A&B) or female mice (C&D) fed 
with HFD or LFD for 3 months 











Figure 4.2: Representative image of hematoxylin stained crypt-villus morphology (A) and 
quantification of crypt depth (B) and villus height (C) in the jejunum collected from mice 
fed with HFD or LFD using diet and sex as two factors (two-way ANOVA) 









Figure 4.3: Gene expression of markers of different intestinal epithelial cell types in the villi 
and crypts of the jejunum collected from mice fed with HFD or LFD using diet and sex as 
two factors (two-way ANOVA) 
Gene expression of alkaline phosphatase (enterocytes) (A), chromogranin A (enteroendocrine 
cells) (B), lysozyme (Paneth cells) (C), mucin 2 (goblet cells) (D), and LGR5 (IESCs) (E). Data 








Figure 4.4: Representative images and quantification of the size and number of organoids 
that developed from intestinal epithelial stem cells (IESCs) isolated from male (A, C&D) or 
female (B, C&D) mice fed with HFD or LFD using diet and sex as two factors (two-way 
ANOVA) (continued) 
Data are expressed as Mean ± SEM (n=3). Scale bar, 200 μm. Cell proliferation of day 12 
organoids in response to glucose (E) using glucose, diet and sex as three factors (three-way 
























Figure 4.5: The expression of steroid hormone receptors in isolated intestinal crypts (A) 
and serum estradiol levels (B) 
Data are expressed as Mean ± SEM of fold change relative to the male group (n=3) for 
quantitative real-time polymerase chain reaction (qPCR), data are expressed as Mean ± SEM 



















Figure 4.6: Estrogen receptor 1 (ESR1) expression (A) and cell proliferation (B) in response 
to 17β-estradiol using 17β-estradiol and sex as two factors (two-way ANOVA; n=3), and the 
proliferation of MCF-7 cells (positive control) (one-way ANOVA; n=4) (C) 
Data are expressed as Mean ± SEM of fold changes. Means with different letters indicate 
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CHAPTER 5: INSULIN/IGF1 ENHANCES INTESTINAL EPITHELIAL CRYPT 
PROLIFERATION THROUGH PI3K/AKT, AND NOT MAPK1 SIGNALING IN OBESE 
HUMANS 
 
 This chapter is in press in Experimental Biology and Medicine. The citation for this 
article is as follows: Zhou W, Rowitz BM, Dailey MJ. Insulin/IGF1 enhances intestinal epithelial 
crypt proliferation through PI3K/AKT, and not MAPK1 signaling in obese humans. Exp Biol 




 The intestinal epithelium is continuously regenerated through proliferation and 
differentiation of stem cells located in the intestinal crypts. Obesity affects this process and 
results in greater stem cell proliferation and altered tissue growth and function. Obesity-induced 
high levels of insulin and insulin like growth factor 1 (IGF1) in the stem cell niche are found to 
impact proliferation in rodents indicating that insulin and IGF1 receptors may play a role in 
modulating intestinal epithelial stem cell (IESC) proliferation. To determine whether insulin or 
IGF1 can induce proliferation in human IESCs, and if two downstream insulin and IGF1 receptor 
signaling pathways, phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) and mitogen-
activated protein kinase 1 (MAPK1), are involved, we used primary small intestinal epithelial 
crypts isolated from obese humans and investigated 1) the effect of insulin or IGF1 on crypt 
proliferation, and 2) the effect of insulin and IGF1 signaling inhibitors on insulin or IGF1-
induced proliferation. We found that insulin and IGF1 enhanced the proliferation of crypt cells, 
including IESCs. Inhibition of the PI3K/AKT pathway attenuated insulin and IGF1-induced 
proliferation, but inhibition of the MAPK1 pathway had no effect. These results indicate that the 
classical metabolic PI3K pathway and not the canonical proliferation MAPK1 pathway is 
involved in the insulin/IGF1-induced increase in crypt proliferation in obese humans, which may 
contribute to abnormal tissue renewal and function. 
5.2 Introduction 
 The intestinal epithelium plays important roles in nutrient absorption, satiety hormone 
release and immune barrier function. In order to ensure proper tissue actions are maintained, the 
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cells are continuously regenerated through proliferation and differentiation of intestinal epithelial 
stem cells (IESCs) located in the intestinal crypts. Obesity affects this process and results in 
changes in tissue growth and function (Dailey, 2014). In particular, obesity increases IESC 
number and proliferation, total epithelial cell number, villus height or crypt depth in vivo, and 
causes lasting effects in IESCs, such that isolated IESCs from obese compared to lean mice grow 
at different rates in vitro (Beyaz et al., 2016; Mah et al., 2014).  These changes are associated 
with many negative adverse consequences in tissue function. The increase in proliferation leads 
to a greater chance of mutations and less DNA repair mechanisms which can lead to tumor 
growth and cancer (Bielas and Heddle, 2000; Comaills et al., 2016; Tomasetti and Vogelstein, 
2015), and may be the cause of the obesity-associated increase in the risk of intestinal cancers 
(Bjorge et al., 2005; Bardou et al., 2013). Aberrant proliferation of IESCs specifically, and not 
other intestinal epithelial cell types, also underlies both small intestinal (Yanai et al., 2017) and 
colon (Baker et al., 2014; Barker et al., 2009; Yanai et al., 2017) cancer. Moreover, greater 
proliferation leads to greater growth of the tissue, which is reflected as an increase in 
differentiated cell number and not just an increase in the number of stem or progenitor cells 
(Mah et al., 2014). In particular, the increase in tissue size is reflected by an obesity-induced 
increase in enterocyte number (Kageyama et al., 2003; Mayer and Yannoni, 1956; Verdam et al., 
2011). This increase in enterocyte number reflects the greater absorptive capacity of the 
epithelial tissue in obesity, a quality that is not desirable and could result in greater body weight 
gain (Balint et al., 1980; Ferraris and Vinnakota, 1995; Mayer and Yannoni, 1956; Singh et al., 
1972). Taken together, these findings indicate that obesity may alter the proliferation, growth and 
function of the intestinal epithelial tissue, and increase the risk of intestinal cancers through the 
modulation of IESCs. It is unclear, though, the mechanism underlying the obesity-induced 
alterations in IESCs. 
 Obesity induces high levels of circulating insulin and insulin like growth factor 1 (IGF1) 
released from the pancreas and liver, respectively, and high levels of local intestinal IGF1 
released from the mesenchymal cells that underlie the IESCs (Winesett et al., 1995). Insulin 
receptor isoforms A and B and IGF1 receptor are expressed in IESCs (Mah et al., 2014). 
Obesity-induced high levels of insulin and IGF1 in the stem cell niche are found to impact 
proliferation in rodents indicating that insulin and IGF1 receptors may play a role in modulating 
IESC proliferation (Mah et al., 2014; Van Landeghem et al., 2015). Moreover, insulin and IGF1 
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receptor resistance is a hallmark of obesity that can be driven by an imbalance between or 
abnormal signaling within two downstream pathways, phosphatidylinositol 3-kinase (PI3K) and 
mitogen-activated protein kinase 1 (MAPK1), in non-intestinal epithelial tissues (Boucher et al., 
2014; Carlson et al., 2003; Muniyappa and Sowers, 2013). It is unknown, though, if insulin or 
IGF1-induces IESC proliferation in humans, and if phosphatidylinositol 3-kinase/protein kinase 
B (PI3K/AKT) and MAPK1 pathways are involved in insulin or IGF1-induced proliferation in 
obesity. Thus, we used primary small intestinal epithelial crypts, which include IESCs and other 
crypt cells, isolated from obese humans, and investigated proliferation in response to insulin or 
IGF1, and insulin and IGF1 receptor signaling inhibitors (i.e. PI3K/AKT pathway inhibitor 
Wortmannin, MAPK1 pathway inhibitor PD98059). 
5.3 Materials and Methods 
Human tissue 
 Human intestinal mucosal tissue samples (1 x 1 inch) were obtained from tissue normally 
discarded from obese patients undergoing Roux-en-Y gastric bypass surgery. All procedures 
were approved by the institutional review board (IRB) at Carle Foundation Hospital and the 
University of Illinois at Urban-Champaign (IRB protocol #16068). Informed consent was 
obtained from the subjects and the privacy rights of the subjects were observed. 
Crypt isolation and culture 
 Intestinal crypts were isolated as previously described (Mahe et al., 2015; Sato et al., 
2011). Briefly, the villi were scraped off from the intestinal mucosal tissue with a curved forceps. 
The tissue was cut into 2-4 mm pieces with scissors and washed 5-10 times with cold 1x PBS 
until the supernatant was almost clear. Tissue fragments were incubated with 2 mM EDTA 
(Fisher Scientific, Pittsburgh, PA) chelation buffer (1x PBS containing 43.4 mM sucrose [Fisher 
Scientific] and 54.9 mM D-sorbitol [Fisher Scientific]) and gently rocked at 4 °C for 30 min. 
After removal of EDTA, tissue fragments were vigorously washed with cold chelation buffer for 
8 times. The supernatant was then collected and centrifuged at 200g at 4 °C for 5 min. Freshly 
isolated crypts were embedded in Matrigel (Corning, Corning, NY) at 200 crypts/10 μL, seeded 
on 96-well plates (replicates of 4 wells per group) and incubated in crypt culture medium 
(Advanced DMEM/F12 [Gibco, Grand Island, NY] containing 2 mM GlutaMax [Gibco], 10 mM 
HEPES [Gibco], 100 U/mL Penicillin-Streptomycin [Gibco], 1x N2 [Gibco], 1x B27 [Gibco], 1 
mM N-Acetyl-L-cysteine [Sigma-Aldrich, St. Louis, MO], 1% bovine serum albumin [Sigma-
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Aldrich], 10 mM nicotidamide [Sigma-Aldrich], 50 ng/mL EGF [Gibco], 100 ng/mL Noggin 
[PeproTech, Rocky Hill, NJ], 500 ng/mL R-Spondin-1 [PeproTech], 10 nM gastrin [Sigma-
Aldrich], 10 μM SB 202190 [Sigma-Aldrich], 500 nM A 83-01 [Sigma-Aldrich], and 100 ng/mL 
wingless-type mouse mammary tumor virus integration site 3A (WNT3A) [R&D, Minneapolis, 
MN]) overnight with 5% CO2 at 37 °C. 
Cell proliferation measurements 
 For determination of proliferation in response to insulin or IGF1, crypt cultures were 
changed to insulin and IGF1-free crypt culture medium (DMEM/F12 [Gibco] containing 2 mM 
GlutaMax, 10 mM HEPES, 100 U/mL Penicillin-Streptomycin, homemade N2 [DMEM/F12 
containing 100 μg/mL transferrin, Holo (Sigma-Aldrich), 6.3 ng/mL progesterone (Sigma-
Aldrich), 16.11μg/mL putrescine (Sigma-Aldrich), and 5.2 ng/mL selenite (Sigma-Aldrich)], 1x 
B27, minus insulin [Gibco], 1 mM N-Acetyl-L-cysteine, 1% bovine serum albumin, 10 mM 
nicotidamide, 50 ng/mL EGF, 100 ng/mL Noggin, 500 ng/mL R-Spondin-1, 10 nM gastrin, 10 
μM SB 202190, 500 nM A 83-01, and 100 ng/mL WNT3A), and incubated with 5% CO2 at 
37 °C for 1 d. A subset of crypt cultures were then incubated in insulin and IGF1-free crypt 
culture medium with 25 mM HEPES (control) or with different concentrations of insulin (Santa 
Cruz Biotechnology, Dallas, TX) (0.1, 10, 100 nM) with 5% CO2 at 37 °C for additional 1 d. 
Another subset of crypt cultures were then incubated in insulin and IGF1-free crypt culture 
medium with 1x PBS (control) or with different concentrations of IGF1 (R&D) (0.1, 10, 100 nM) 
with 5% CO2 at 37 °C for additional 1 d. These concentrations and time points were chosen 
based on previously published experiments testing insulin or IGF1-induced proliferation of 
intestinal epithelial cells (Lu et al., 2017; Mah et al., 2014; Van Landeghem et al., 2015). Cell 
proliferation was then measured using Cell Proliferation Reagent WST-1 (Roche Diagnostics, 
Indianapolis, IN) according to the manufacturer’s instructions. For determination of proliferation 
in response to PI3K/AKT pathway inhibitor Wortmannin (Cell Signaling Technology, Danvers, 
MA) or MAPK1 pathway inhibitor PD98059 (Cell Signaling Technology). After 1 d incubation 
in insulin and IGF1-free crypt culture medium, crypt cultures were pretreated with DMSO 
(control) or with different concentrations of Wortmannin (0.2, 1 μM) or PD98059 (20, 50 μM) 
for 1 h, and then incubated with 10 nM insulin or IGF1 for additional 1 d with 5% CO2 at 37 °C. 
These concentrations and time points were chosen based on previously published experiments 
testing Wortmannin or PD98059-induced changes in intracellular signaling of intestinal 
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epithelial cells and other cell types (Chan et al., 2014; Lu et al., 2017; Svegliati-Baroni et al., 
1999). Cell proliferation was then measured using Cell Proliferation Reagent WST-1.  
Data analysis 
 Data are expressed as Mean ± SEM. Differences between groups were analyzed using a 
one-way ANOVA followed by a Fisher’s LSD post-hoc test. p<0.05 was considered statistically 
significant. 
5.4 Results 
Insulin and IGF1 enhanced crypt proliferation 
 Crypt proliferation was increased in the 0.1, 10 and 100 nM insulin conditions compared 
with the control group. Specifically, proliferation was increased in the 10 and 100 nM insulin 
conditions compared with the control and 0.1 nM groups, and in the 0.1 nM insulin condition 
compared with the control group (Figure 6.1A; p<0.05). Moreover, proliferation was increased in 
the 0.1, 10 and 100 nM IGF1 conditions compared with the control group (Figure 6.1B; p<0.05). 
Inhibition of PI3K/AKT pathway attenuated insulin/IGF1-induced proliferation, but inhibition of 
MAPK1 pathway had no effect 
 Crypt proliferation was decreased in the 0.2 and 1 μM Wortmannin conditions compared 
with the control group, and in the 0.2 μM Wortmannin condition compared with the 1 μM 
Wortmannin group (Figure 6.2A; p<0.05). Moreover, proliferation was decreased in the 1μM 
Wortmannin condition compared with the control and 0.2 μM Wortmannin groups (Figure 6.2B; 
p<0.05). However, there were no differences in the insulin-induced (Figure 6.2C) and IGF1-
induced (Figure 6.2D) proliferation after PD98059 application. 
5.5 Discussion 
 The aim of this study was to investigate the effect of insulin or insulin like growth factor 
1 (IGF1) on crypt proliferation and the effect of insulin and IGF1 signaling inhibitors on insulin 
or IGF1-induced proliferation in IESCs and other crypt cells isolated from obese humans. The 
major findings were 1) insulin and IGF1 enhanced the proliferation of intestinal crypts, and 2) 
phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT), and not mitogen-activated protein 
kinase 1 (MAPK1) signaling, was involved in insulin/IGF1-induced proliferation.  
 Despite extensive research on the roles of insulin and IGF1 in coordinating systemic 
growth and development with nutrient homeostasis in normal versus obese conditions, little is 
known about their roles in controlling somatic stem cells and tissue regeneration. Non-diabetic 
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obese humans and diet-induced obese rodent models exhibit high circulating levels of insulin and 
IGF1, and local release of IGF1 from mesenchymal cells that underlie the IESCs (Frystyk et al., 
1999; Mah et al., 2014; Winesett et al., 1995). These factors have been found to impact IESC 
proliferation in rodents and is the underlying mechanism responsible for the differential IESC 
proliferation and growth potential of IESCs isolated from diet-induced obese compared with lean 
mice (Mah et al., 2014; Van Landeghem et al., 2015). Consistent with previous findings in 
rodents (Mah et al., 2014; Van Landeghem et al., 2015), our results showed that insulin and 
IGF1 enhanced the proliferation of intestinal crypts (including IESCs and other crypt cells) in 
humans. This indicates that obesity-induced high levels of insulin and IGF1 in the stem cell 
niche may impact IESC proliferation in obese humans via a similar mechanism as has been 
found in rodents and may drive abnormal proliferation as insulin resistance develops.  
 The degree of insulin and IGF1-induced increases in proliferation differed (Fig. 1A&B). 
It is likely that the varied effect reflects differences in the ligand-receptor binding affinity and 
signaling between insulin and IGF1. The three highly homologous tyrosine kinase receptors by 
which insulin and IGF1 mediate their biological effects, insulin receptor isoform A (INSRA), 
insulin receptor isoform B (INSRB) and insulin like growth factor 1 receptor (IGF1R), are 
expressed in intestinal epithelial stem cells (Mah et al., 2014). Both insulin and IGF1 are able to 
bind to each receptor, albeit at different affinities, and INSR and IGF1R can also form 
heterodimers that modulate the selectivity and affinity for insulin and IGF1 in activating 
downstream signaling molecules (Boucher et al., 2014). Moreover, IGF1, but not insulin, binds 
to insulin like growth factor binding proteins (IGFBPs) in circulation, thus, the actions of IGF1 is 
inhibited by IGFBPs, while insulin is not affected (Werner et al., 2008). In addition, a variety of 
receptor substrates and signaling molecules have been identified to be differentially activated by 
insulin or IGF1 (Dupont and LeRoith, 2001). Taken together, these differences in the ligand-
receptor binding affinity and signaling molecules between insulin and IGF1 may contribute to 
their differential effects on metabolism and proliferation. 
 Insulin and IGF1 receptor resistance is a hallmark of obesity, and insulin and IGF1 
receptor resistance in other tissues or organs (e.g. adipose tissue, liver) is driven by high levels of 
insulin and IGF1 (Catalano et al., 2014; Renstrom et al., 2007). It is traditionally thought that 
there is a balance between two downstream insulin and IGF1 receptor signaling pathways, the 
PI3K-dependent pathway regulating nutrient flow for cell survival, and the MAPK1-dependent 
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pathway regulating cell proliferation (Boucher et al., 2014) (Figure 6.3A). The balance between 
these two pathways determines the cellular response to insulin and IGF1 (Aksamitiene et al., 
2012). Contrary to this traditional thought, we found that insulin and IGF1 induced an increase in 
the proliferation of crypts isolated from obese humans through the PI3K pathway, and not the 
classical MAPK1 mitogenic pathway (Figure 6.3B). An activation of PI3K signaling prevents the 
action of cell cycle inhibitors [e.g. cyclin dependent kinase inhibitor 1A (CDKN1A) (Zhou et al., 
2001), cyclin dependent kinase inhibitor 1B (CDKN1B) (Motti et al., 2004)] and inhibits pro-
apoptotic proteins [e.g. B cell leukemia/lymphoma 2 associated agonist of cell death (BAD) 
(Datta et al., 1997), caspase-9 (Cardone et al., 1998)], and regulates the activity of a variety of 
transcription factors [e.g. Forkhead (FOXO) family of transcription factors (Cardone et al., 1998), 
mouse double minute 2 (MDM2) (Cardone et al., 1998)] that are responsible for the transcription 
of pro- and anti-apoptotic genes. An obesity-induced increase in PI3K signaling and activation of 
these mechanisms may not only increase proliferation, but lead to a greater chance of mutation or 
less DNA repair, which causes an increased cancer risk (Bielas and Heddle, 2000; Comaills et al., 





















Figure 5.1: Cell proliferation in response to insulin (A) or insulin like growth factor 1 
(IGF1) (B)  
Data are expressed as Mean ± SEM of fold change relative to the control group (n=4). Means 


















Figure 5.2: The effect of Wortmannin on insulin-induced (A) or IGF1-induced (B) 
proliferation, and the effect of PD98059 on insulin-induced (C) or IGF1-induced (D) 
proliferation 
Data are expressed as Mean ± SEM of fold change relative to the control group (n=4). Means 









Figure 5.3: Proposed mechanisms of insulin receptor (INSR) and insulin like growth factor 
1 receptor (IGF1R)-mediated proliferation of IESCs under normal and resistant states 
(A) A balance between the phosphatidylinositol 3-kinase (PI3K)-dependent pathway regulating 
nutrient flow for cell survival and the mitogen-activated protein kinase 1 (MAPK1)-dependent 
pathway regulating cell proliferation determines the cellular response to insulin and IGF1 under 
normal conditions. (B) An imbalance in signaling between the two pathways may result in an 
uncoupling of the control mechanism between survival and proliferation in IESCs and lead to 
abnormal tissue renewal and function. (C) Inactivation of PI3K and/or MAPK1 signaling 
molecules may induce insulin and IGF1 resistance in IESCs and result in abnormal tissue 
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CHAPTER 6: SUMMARY 
 
6.1 Overview 
 The intestinal epithelium plays important roles in nutrient absorption, hormone release 
and immune barrier function. Proper tissue function is maintained by continuous cell renewal of 
intestinal epithelial stem cells (IESCs) localized near the base of the intestinal crypts (Barker et 
al., 2010). In addition to maintaining tissue homeostasis through cell renewal, IESCs are also 
responsible for tissue growth under high nutrient availability through increases in the rate of 
proliferation and changes in the mode of division (Blackmore et al., 2017). Although there have 
been great advances in the IESC field, some basic questions are still left unanswered. These 
include questions about how IESCs function in response to varying levels of nutrients and 
whether there are sex differences in these responses. I have contributed to answering aspects of 
these questions through my research and found that: 1) glucose-induced crypt proliferation is 
driven, in part, by increases in glycolysis and that this effect is modulated by protein kinase 
B/hypoxia inducible factor 1 subunit alpha (AKT/HIF1A) pathway, 2) short- and long-term 
increases in nutrient availability induce an increase in proliferation, but the long-term increase 
results in lasting consequences in how the cells are proliferating, 3) high-fat diet (HFD) alone is 
not the driving factor in increasing proliferation, but requires either an increased intake of a HFD 
or factors secondary to the development of obesity [i.e. insulin, insulin-like growth factor 1 
(IGF1)], and 4) although there are no sex differences in obesity-induced increases in IESC 
proliferation, IESCs isolated from female mice show an initial nutrient-induced increase in 
proliferation compared with those from males when transferred into new nutrient environments. 
These findings have expanded the knowledge for understanding 1) what the nutrient source is for 
the induction of IESC or crypt proliferation, 2) what is the contribution of nutrients directly or 
indirectly driving proliferation, and 3) the differential effect of short- versus long-term changes 
in nutrient availability on proliferation. 
6.2 Nutrient source for the IESCs and other crypt cells to promote proliferation and 
growth 
 Intestinal epithelial stem cells (IESCs) are continuously dividing to regenerate cells 
normally lost due to apoptosis under homeostatic conditions and are responsible for growing the 
tissue under high nutrient availability (O'Brien et al., 2011). For example, whenever there is an 
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increase in the level of food intake, there is an increase in IESC proliferation and tissue growth 
(Cripps and Williams, 1975; Kaushik and Kaur, 2005; Mah et al., 2014). This likely reflects 
greater exposure of the IESCs to a higher level of digested nutrients either directly or indirectly. 
The crypt cells are likely affected by the levels of nutrients and growth factors in the local blood 
vessels and interstitial space around the crypts that would include ingested nutrients, systemic 
nutrients and growth factors supplied to the crypts by the superior mesenteric artery, and local 
growth factors secreted by mesenchymal cells within the lamina propria (i.e. myofibroblasts, 
fibroblasts). In addition, data support the role of luminal nutrients, and not just the systemic 
nutrients, in driving growth of the tissue because parenteral nutrition leads to a decrease in 
epithelial size and atrophy of the villi (Buchman et al., 1995). It is unlikely, though, that luminal 
nutrients directly interact with the apical surface of the crypt cells because goblet cells in the 
crypts secret mucus to form a diffusion barrier which is impenetrable to luminal factors 
(Birchenough et al., 2016). It is likely that luminal nutrients absorbed from enterocytes enter into 
the local blood vessels and mix with systemic nutrients and growth factors to affect crypt cells 
through the basal surface receptors (e.g. fatty acid receptors) or transporters (e.g. glucose 
transporters, fatty acid transporters, amino acid transporters; Figure 6.1). This idea of 
proliferation being driven by basal surface receptors is supported by organoid in vitro research 
where factors supplied to the media affect the basal surface of the cells and are not injected into 
the lumen of the organoids to affect the apical surface (Figure 6.2). Much of the organoid in vitro 
data mimics that found in in vivo conditions, thus, further supporting a role for basal surface 
receptors. Thus, local and systemic nutrients and growth factors may be the nutrient source that 
promotes proliferation and growth through an interaction with the basal surface of the IESCs and 
other crypt cells. 
6.3 Direct versus indirect nutrient-sensing mechanisms 
 Sensing the level of macronutrients may involve 1) a direct interaction of the nutrients 
with membrane transporters or receptors, 2) an indirect mechanism by detecting local surrogate 
molecules (e.g. growth factors) secreted by niche cells (e.g. Paneth cells, mesenchymal cells), or 
3) an indirect mechanism by detecting systemic circulating surrogate molecules [e.g. insulin, 
insulin like growth factor 1 (IGF1)] whose levels correctly reflect circulating nutrient abundance.  
 The results in Chapter 2 and our previous data (see Appendix B; Blackmore et al., 2017) 
show that glucose transporter 1 (GLUT1) and glucose transporter 2 (GLUT2) are highly 
128 
 
expressed in intestinal crypt cells, and glucose induces an increase in proliferation and changes 
the mode of division of crypt cells in vitro. Although our in vitro preparation excludes input from 
systemic circulating factors or surrounding mesenchymal cells, it does include IESCs, progenitor 
cells and Paneth cells. Thus, we cannot confirm using our in vitro preparation whether glucose 
directly acts through GLUTs on the IESCs or progenitor cells to increase proliferation because 
Paneth cells, the differentiated cell type surrounding the IESCs, are known to secrete growth 
factors [e.g. epidermal growth factor (Poulsen et al., 1986; Sato et al., 2011)] to increase crypt 
cell proliferation. Thus, glucose-induced crypt proliferation may involve a direct mechanism on 
proliferating crypt cells (i.e. IESCs, progenitor cells) and/or an indirect mechanism by detecting 
local growth factors secreted by Paneth cells. Moreover, although it is unknown if the 
transporters or receptors of amino acids and fatty acids are expressed in IESCs and other crypt 
cells, administration of amino acids [i.e. glutamine (Moore et al., 2015), methionine (Saito et al., 
2017)] and a long-chain fatty acid [i.e. palmitic acid (Beyaz et al., 2016)] in vitro have been 
found to increase the proliferation of organoids that include IESCs, progenitor cells and 
differentiated epithelial cells. Thus, as with our findings in glucose-induced crypt proliferation, 
amino acid- and fatty acid-induced organoid cell proliferation may involve a direct mechanism 
on proliferating crypt cells and/or an indirect mechanism by detecting local growth factors 
secreted by other epithelial cells. Using organoids, it is possible not only to have a contribution 
of growth factors secreted by Paneth cells, but there are also growth factors secreted by the 
enteroendocrine cells (e.g. glucagon like peptide 2) located in the villi of the organoids (Drucker 
et al., 1996).  
 In contrast to a direct sensing mechanism or an indirect mechanism by detecting growth 
factors secreted by non-proliferating epithelial cells, an indirect nutrient sensing mechanism by 
detecting local or circulating surrogate molecules may underlie a nutrient-induced increase in 
proliferation and growth of the tissue. It is well known that in response to high circulating 
nutrient availability, high levels of circulating insulin and IGF1 are released from the pancreas 
and liver, respectively (Rafalski and Brunet, 2011), and high levels of local intestinal IGF1 are 
released from the pericryptal mesenchymal cells [i.e. myofibroblasts, fibroblasts; (Winesett et al., 
1995)]. Insulin and IGF1 receptors are expressed in IESCs and have been shown to modulate 
nutrient-induced expansion of the crypt cells in mice in vitro (Mah et al., 2014). In addition, the 
results in Chapter 5 show that administration of insulin and IGF1 in vitro increases crypt 
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proliferation in humans. Thus, high nutrient availability-induced increases in circulating insulin 
and IGF1 may increase crypt proliferation by directly affecting proliferating crypt cells or 
indirectly by inducing the release of growth factors by Paneth cells (a crypt culture preparation 
was used for these experiments with no villus cells included). Taken together, nutrient-induced 
proliferation may involve a combination of direct and indirect mechanisms involving both 
intestinal epithelial-derived, local mesenchymal-derived and systemically-derived indirect 
factors to guide crypt proliferation and grow the tissue (Figure 6.1). Delineating whether there is 
a direct or indirect mechanism for nutrient-induced proliferation within the epithelial tissue is 
difficult to examine given that isolated IESCs will quickly proliferate and differentiate into the 
other cells and the other cells types are difficult to culture in isolation. In addition, inhibiting the 
differentiation of IESCs induces changes in nutrient utilization that may not represent normal 
IESC proliferation conditions. Thus, additional studies that compare the nutrient-induced 
proliferation on isolated IESCs, crypts and organoids may help to develop a more dynamic 
picture for the underlying mechanisms of nutrient-induced proliferation involved within the 
epithelial tissue. 
6.4 Short-term nutrient-induced crypt cell proliferation 
 Although it is not clear how the level of nutrients is sensed at the cell membrane of 
intestinal epithelial proliferating cells, short-term increases in nutrient availability promote crypt 
cell proliferation. Our previous data show that varying the level of food intake for 18 hours in 
mice by food deprivation, allowing only the consumption of 50% of their normal intake or 
allowing them to freely feed, we find that the ad libitum fed mice show a greater change in the 
mode of the division from asymmetric to a symmetric mode of division, leading to an increase in 
the number of proliferating cells (see Appendix B; Blackmore et al., 2017). In addition, mice that 
were food deprived for 12 hours followed by 6 hours of free feeding, show a similar greater 
symmetric division pattern to the ad libitum fed mice. This same short-term nutrient availability 
effect on proliferation was also found in vitro. Increasing the level of glucose application to 
crypts or organoids induces a greater proliferation (see Appendix A; Figure A.1) and a greater 
symmetric mode of division (see Appendix B; Blackmore et al., 2017). This short-term in vitro 
effect on proliferation can also be seen after applications of amino acids (Moore et al., 2015; 
Saito et al., 2017) and long-chain fatty acids (Beyaz et al., 2016; Mao et al., 2013). Thus, these 
130 
 
data support a role for IESC and progenitor cells in responding to changes in nutrient availability 
within hours, and not just across multiple days, to alter proliferation of the tissue. 
 Short-term changes in nutrient availability alter proliferation through protein-kinase and 
metabolic signaling involved with nutrient sensing. As found in Chapter 2, glucose activates the 
phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway, a signaling pathway well-
known for its role in controlling cell metabolism, proliferation and survival involved with 
nutrient sensing (Hassan et al., 2013). Glucose increases the phosphorylation of AKT in crypt 
cultures (Chapter 2; Zhou et al., 2018), which results in the phosphorylation and inactivation of 
glycogen synthase kinase 3 beta (GSK3B). The inactivated GSK3B causes β-catenin to 
accumulate and translocate to the nucleus, activating the transcription of target gene cyclin D1, a 
gene promoting cell cycle progression, which eventually leads to increases in crypt cell 
proliferation [(Mao et al., 2013); Figure 6.3]. In addition to the PI3K/AKT connection with the 
wingless-type mouse mammary tumor virus integration site/β-catenin (WNT/β-catenin) pathway 
to induce proliferation, glucose-induced activation of PI3K/AKT also mediates changes in the 
hypoxia inducible factor 1 subunit alpha (HIF1A) pathway. Glucose-induced stimulation of 
PI3K/AKT can activate mechanistic target of rapamycin kinase (MTOR) to upregulate the 
synthesis of HIF1A (Masoud and Li, 2015; Semenza, 2003). HIF1A is a transcription factor that 
directly induces the expression of genes involved in cell proliferation [e.g. transforming growth 
factor alpha (TGFA), insulin like growth factor 2 (IGF2)], increasing cell proliferation 
[(Semenza, 2003); Figure 6.3]. Moreover, we found that high glucose availability in vitro 
inhibits the serine/threonine kinase 11/adenosine monophosphate-activated protein kinase 
(LKB1/AMPK) pathway, a pathway well known for its role in regulating metabolism and growth 
involved with energy sensing (see Appendix B; Blackmore et al., 2017). Under low nutrient 
conditions, the energy sensor AMPK is activated in an adenosine monophosphate (AMP)-
dependent manner by the upstream kinase LKB1 (Mihaylova et al., 2014). Therefore, glucose 
increases the adenosine triphosphate: adenosine monophosphate (ATP:AMP) ratio, and the 
decrease of AMP inhibits LKB1/AMPK pathway (see Appendix B; Blackmore et al., 2017). The 
inhibition of AMPK can cause the activation of MTOR (Shaw, 2009), which can then intersect 
with HIF-1a-induced expression of proliferation genes mentioned above [(Semenza, 2003); 
Figure 6.3]. Thus, glucose may coordinate increases in crypt cell proliferation through multiple 
protein-kinase pathways, including PI3K/AKT/GSK3B/WNT/β-catenin, 
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PI3K/AKT/MTOR/HIF1A, or LKB1/AMPK/MTOR/HIF1A pathways. In addition to nutrient 
sensing pathways, in Chapter 2, we found that glucose induces a metabolic switch from using 
oxidative phosphorylation to glycolysis (Zhou et al., 2018). The glucose-induced increase in 
glycolysis may generate glycolytic intermediates [e.g. glucose-6-phosphate, dihydroxyacetone 
phosphate, 3-phosphoglycerate, acetyl coenzyme A (acetyl-CoA)] to synthesize macromolecules 
(e.g. nucleotides, lipids, amino acids), duplicating all components needed for proliferation (Shyh-
Chang and Ng, 2017). Taken together, these data indicate that glucose enhances crypt 
proliferation by modulating nutrient-sensing (LKB1/AMPK, PI3K/AKT) and the downstream 
proliferation-related (WNT/β-catenin, HIF1A) pathways, and increasing glycolysis to produce 
the additional biomass that is necessary (Figure 6.3).  
 Fatty acids may also induce proliferation through driving changes in nutrient-sensing 
signaling and energy metabolism. Just as with glucose, fatty acids induce changes in WNT 
signaling to alter proliferation through activating peroxisome proliferator activated receptor delta 
(PPARD). In vitro administration of dietary fatty acid (i.e. palmitic acid) to crypt cultures 
activates PPARD, a nuclear receptor sensing fatty acids. The activation of PPARD activates the 
downstream WNT/β-catenin pathway by upregulation of β-catenin and its target genes related to 
proliferation (e.g. jagged 1, jagged 2), leading to increased proliferation [(Beyaz et al., 2016); 
Figure 6.3]. In contrast to the promoting effect of dietary fatty acids on IESC proliferation, 
multiple studies show that omega-3 polyunsaturated fatty acid inhibits the number of tumor-
initiating IESCs during the progression of colon cancer by enhancing tumor protein p53 
signaling to induce apoptosis (Kim et al., 2016), and inhibiting WNT/β-catenin signaling to 
decrease proliferation (Kim et al., 2016; Vasudevan et al., 2014). These data suggest that there is 
a differential effect of specific fatty acids on the proliferation of crypt cells. Just as glucose is 
used for the production of biomass for the new cells formed, high levels of fatty acids increase β-
oxidation to produce acetyl-CoA (Mihaylova et al., 2018), which is used to generate 
tricarboxylic acid (TCA) cycle intermediates (e.g. oxaloacetate, citrate, α-ketoglutarate, succinyl 
CoA). Thus, dietary fatty acids increase crypt cell proliferation by activating nutrient-sensing 
(PPARD) and the downstream proliferation-related WNT/β-catenin pathways, and increasing 
fatty acid oxidation (Figure 6.3). 
 Amino acids may induce proliferation through similar glucose and fatty acid-induced 
proliferation mechanisms. As with glucose, glutamine activates the amino acid-sensing MTOR 
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pathway to upregulate protein synthesis needed for crypt cell proliferation (Moore et al., 2015). 
The activation of MTOR may also increase the synthesis of HIF1A to activate the transcription 
of proliferation-related genes as with glucose (Figure 6.3). Just as with fatty acids, amino acids 
may also be used to produce biomass needed for cell proliferation by generating the TCA cycle 
intermediates (e.g. oxaloacetate, citrate, α-ketoglutarate, succinyl CoA). Thus, amino acids may 
increase crypt cell proliferation by activating nutrient-sensing pathway MTOR and increase 
biosynthesis needed for proliferation (Figure 6.3). One limitation of the current study is that 
energy metabolism was investigated in intestinal crypts, including stem cells, progenitors and 
Paneth cells, without delineating individual cell types. A recent study (Rodriguez-Colman et al., 
2017) shows that glucose differentially drives changes in energy metabolism between IESCs and 
Paneth cells, such that glucose enhances glycolysis in Paneth cells, generating lactate to increase 
oxidative phosphorylation in IESCs, which eventually promotes IESC differentiation. Thus, 
future research will be needed to investigate how nutrients directly impact stem cells alone or 
indirectly impact stem cells by modulating the function of the niche cells by in situ hybridization 
or immunohistochemistry in vivo. 
6.5 Long-term overnutrition/obesity-induced crypt cell proliferation 
 Long-term overnutrition, as seen in obesity, leads to increases in crypt cell proliferation, 
the size of the tissue and a change in the composition of the type of epithelial cells. In particular, 
we and others (Mah et al., 2014; Mao et al., 2013; Wolnerhanssen et al., 2017) find that HFD-
induced obesity increases crypt depth and villus height, and this increase in tissue size is 
reflected by an increase in the number of IESCs and goblet cells. In Chapter 3, we also found 
that these obesity-induced changes are independent of HFD alone and require either an increase 
in the level of food intake of the diet or an increase in secondary factors related to obesity. These 
obesity-induced changes are not different between the sexes as we found in Chapter 4. In 
particular, HFD induced similar in vivo changes in females as has previously been found in 
males, and HFD increased the early growth of IESCs in vitro in females as has previously been 
found in males. Thus, these data support a role for IESC and progenitor cells in responding to 
changes in long-term overnutrition or diet-induced obesity to alter proliferation and size of the 
tissue. 
 The high level of nutrient availability seen in obesity is due to increases in food intake in 
the obese mice compared with the lean. Similar to nutrient availability driving changes in short-
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term proliferation, I believe that long-term increases in nutrient availability would increase 
proliferation through similar protein-kinase and metabolic mechanisms. As with the effect of 
short-term in vitro glucose application on crypt proliferation, HFD-induced obesity increases 
crypt proliferation through activating GSK3B/WNT/β-catenin signaling (Mao et al., 2013). In 
addition, as with previous short-term nutrient availability findings, HFD-induced obesity 
increases crypt proliferation through activating PPARD/WNT/β-catenin signaling (Beyaz et al., 
2016). Thus, long-term overnutrition or diet-induced obesity may increase crypt proliferation 
through similar mechanisms as with short-term nutrient-induced proliferation (Figure 6.4). 
 In addition to varying the level of available nutrients, obesity is associated with 
secondary increases in the circulating levels of insulin and insulin like growth factor 1 (IGF1), 
and local release of IGF1. The results in Chapter 5 show that insulin and IGF1 increase crypt cell 
proliferation through the activation of PI3K/AKT pathway in obese humans. As with glucose, an 
activation of PI3K/AKT signaling may activate the downstream proliferation-related pathways 
(WNT/β-catenin, HIF1A), leading to the transcriptional activation of proliferation-related genes. 
Thus, an obesity-induced increase in PI3K/AKT signaling and activation of these mechanisms 
may increase proliferation (Figure 6.4). In addition to the direct effect, the changes in 
insulin/IGF1 signaling in crypt cells may induce lasting effects on IESC proliferation, a 
phenomenon that we do not find in short-term nutrient-induced proliferation. In particular, in 
Chapters 3 and 4, we and others (Beyaz et al., 2016) find that diet-induced obesity results in 
lasting effects on IESC proliferation in vitro, such that isolated IESCs from obese versus lean 
mice grow at different rates in vitro. It is striking that the obesity-induced effect on IESC 
proliferation remains across multiple days of growth in vitro. Thus, there must be some intrinsic 
differences in how the “obese” versus “lean” stem cells adapt to a new environment. The 
retention of mechanisms of IESC proliferation after isolation and culture may be driven by in 
vivo high levels of insulin and IGF1, as suggested previously (Andres et al., 2015; Mah et al., 
2014; Van Landeghem et al., 2015). The long-term changes in insulin/IGF1 receptor signaling in 
the IESCs may promote metabolite-mediated epigenetic modifications in the proliferation 
process, which might be retained in IESCs across generations of new cells in vitro, mechanisms 
that have yet to be studied. Metabolites of glycolysis and the TCA cycle function as co-factors or 
substrates for enzymes involved with epigenetic modifications, which may lead to alterations in 
the expression of genes regulating stem cell proliferation (Lisowski et al., 2018; Shyh-Chang and 
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Ng, 2017). Glycolysis-derived pyruvate may be converted into acetyl-CoA by pyruvate 
dehydrogenase in the nucleus (Moussaieff et al., 2015). Acetyl-CoA is then used as the acetyl-
group donor for histone acetylation, inducing the expression of proliferation-related genes (Cai et 
al., 2011). Thus, glycolysis-derived acetyl-CoA-mediated histone acetylation may be the link 
between glucose-induced glycolysis and crypt proliferation. In addition to glycolysis metabolites, 
TCA cycle metabolites, citrate and α-ketoglutarate, are associated with epigenetic modulations. 
Mitochondrial citrate is exported to the cytosol, and converted into cytosolic acetyl-CoA which 
enters the nucleus to be used as the acetyl-group donor for histone acetylation. Mitochondrial α-
ketoglutarate is transported to the cytosol, and entering the nucleus to be used as a co-factor by 
epigenetic modification enzymes, ten-eleven translocation (TET) methylcytosine dioxygenases 
and Jumonji C domain-containing histone demethylases (JHDMs), demethylating DNA and 
histone methylation, respectively (Shyh-Chang and Ng, 2017), which eventually activates the 
expression of the stemness genes (Zhu et al., 2017). Thus, obesity-associated secondary factors 
(i.e. insulin, IGF1) may induce lasting effects on IESC proliferation through the mechanisms of 
metabolite-mediated epigenetic modifications (Figure 6.4). The mechanisms of obesity-induced 
lasting effects on IESC proliferation have not been studied, thus, future studies will be needed to 
determine if the metabolite-mediated epigenetic mechanism found in other types of stem cells 
also occur in IESCs. Regardless of the mechanism, it is not known whether this obesity-induced 
effect on IESC proliferation would also be maintained in vivo after weight loss or if animals 
were switched to a new diet. Thus, additional in vivo studies may help to understand how the 















Figure 6.1: Nutrient source for proliferating crypt cells 
Luminal nutrients [e.g. glucose, amino acids, short-chain fatty acids (SCFAs), medium-chain 
fatty acids (MCFAs)] absorbed from enterocytes enter into the local blood vessels, and luminal 
long-chain fatty acids (LCFAs) absorbed from enterocytes are packaged into chylomicrons, 
travel in the lymph vessels, and finally enter systemic circulation. The proliferating crypt cells 
[i.e. intestinal epithelial stem cells (IESCs), progenitors] are likely affected by the levels of 
nutrients and growth factors (GFs) in the local blood vessels and interstitial space around the 
crypts that would include ingested nutrients [e.g. glucose, amino acids, SCFAs, MCFAs],  
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Figure 6.1 (continued) 
systemic nutrients [e.g. long-chain fatty acids LCFAs, glucose, amino acids, SCFAs, MCFAs] 
and growth factors supplied to proliferating crypt cells by the superior mesenteric artery, and 
local growth factors secreted by Paneth cells and mesenchymal cells within the lamina propria 

























Figure 6.2: Schematic of a mature intestinal organoid in culture 
The central lumen is surrounded by an epithelial monolayer with budding crypt-like domains. 
Factors supplied to the media affect the basal surface of the cells [e.g. intestinal epithelial stem 
cells (IESCs), Paneth cells, progenitors, villus cells] and are not injected into the lumen of the 















Figure 6.3: Short-term nutrient-induced crypt cell proliferation 
Glucose increases the expression of proliferation genes through phosphatidylinositol 3-
kinase/protein kinase B/glycogen synthase kinase 3 beta/wingless-type mouse mammary tumor 
virus integration site/β-catenin (PI3K/AKT/GSK-3β/WNT/β-catenin), phosphatidylinositol 3-
kinase/protein kinase B/mechanistic target of rapamycin kinase/hypoxia inducible factor 1 
subunit alpha (PI3K/AKT/MTOR/HIF1A), or serine/threonine kinase 11/adenosine 
monophosphate-activated protein kinase/mechanistic target of rapamycin kinase/hypoxia 
inducible factor 1 subunit alpha (LKB1/AMPK/MTOR/HIF1A) pathways. Glucose also 
increases glycolysis to generate glycolytic intermediates which are used for the production of 
biomass needed for proliferation. Amino acids (e.g. glutamine) increase the expression of 
proliferation genes through MTOR/HIF1A pathway. Amino acids are also used to produce 
biomass needed for cell proliferation by generating tricarboxylic acid cycle (TCA) cycle 
intermediates. Fatty acids (e.g. palmitic acid) increase the expression of proliferation genes 
through peroxisome proliferator activated receptor delta/wingless-type mouse mammary tumor 
virus integration site/β-catenin (PPARD/WNT/β-catenin) pathway. Fatty acids are also used to 







Figure 6.4: Long-term overnutrition/obesity-induced crypt cell proliferation 
As with short-term nutrient-induced crypt proliferation, glucose increases the expression of 
proliferation genes through PI3K/AKT/GSK3B/WNT/β-catenin, PI3K/AKT/MTOR/HIF1A, or 
LKB1/AMPK/MTOR/HIF1A pathways. Glucose also increases glycolysis to generate glycolytic 
intermediates which are used for the production of biomass needed for proliferation. Amino 
acids (e.g. glutamin) increase the expression of proliferation genes through MTOR/HIF1A 
pathway. Amino acids are also used to produce biomass needed for cell proliferation by 
generating TCA cycle intermediates. Fatty acids (i.e. palmitic acid) increase the expression of 
proliferation genes through PPARD/WNT/β-catenin pathway. Fatty acids are also used to 
produce biomass needed for cell proliferation by generating TCA cycle intermediates. In 
addition to the mechanisms underlying short-term nutrient-induced crypt proliferation, obesity-
associated high levels of insulin and IGF1 increase the expression of proliferation genes through 
PI3K/AKT/GSK3B/WNT/β-catenin or PI3K/AKT/MTOR/HIF1A signaling. In addition, 
Metabolites of glycolysis (i.e. pyruvate) and TCA cycle [i.e. citrate, α-ketoglutarate (α-KG)] may 
function as co-factors or substrates for epigenetic modification enzymes, increasing the 
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APPENDIX A: GLUCOSE INCREASES CRYPT PROLIFERATION 
 
 This appendix contains additional data. Unlike our previous studies that showed no 
concentration-dependent effects of glucose (only a glucose dependent effect) using 5 mM and 
17.5 mM glucose conditions, a concentration-dependent effect of glucose on proliferation can be 
found using lower glucose concentrations that we had previously used. In particular, crypt 
proliferation was increased in the 17.5 mM glucose condition compared with the 0 mM at 4 h 
(Figure A.1; p<0.05). At 24 h after glucose application, proliferation was increased in the 17.5 
mM glucose condition compared with the 0 mM, 0.5 mM and 1 mM, and in the 5.5 mM glucose 
condition compared with 0 mM and 0.5 mM (Figure A.1; p<0.05). In addition, proliferation was 
increased in the 1 mM compared with 0 mM (Figure A.1; p<0.05). 
Figure A.1: Glucose increases crypt proliferation  
Isolated crypts were treated with different levels of glucose (0, 0.5, 1, 5.5, 17.5 mM) across time 
(4, 24 h). Cell proliferation was then measured using Cell Proliferation Reagent WST-1 (Roche 
Diagnostics, Indianapolis IN). Data are expressed as Mean ± SEM (n=5). Means with different 





APPENDIX B: LKB1-AMPK MODULATES NUTRIENT-INDUCED CHANGES IN THE 
MODE OF DIVISION OF INTESTINAL EPITHELIAL CRYPT CELLS IN MICE 
 
 This appendix contains collaborative publication. This chapter was published in 
Experimental Biology and Medicine. The citation for this article is as follows: Blackmore K, 
Zhou W, Dailey MJ. LKB1-AMPK modulates nutrient-induced changes in the mode of division 
of intestinal epithelial crypt cells in mice. Exp Biol Med. 2017 Sep;242(15):1490-1498. 
 
B.1 Abstract 
 Nutrient availability influences intestinal epithelial stem cell (IESC) proliferation and 
tissue growth. Increases in food results in a greater number of epithelial cells, villi height and 
crypt depth. We investigated whether this nutrient-driven expansion of the tissue is the result of a 
change in the mode of IESC division and if serine/threonine kinase 11-adenosine 
monophosphate-activated protein kinase (LKB1-AMPK) signaling plays a role. We utilized in 
vivo and in vitro experiments to test this hypothesis. C57/B6 mice were separated into 4 groups 
and fed varying amounts of chow for 18 h: 1) Ad libitum, 2) 50% of their average daily intake, 3) 
Fasted or 4) Fasted for 12 h and refed. Mice were sacrificed, intestinal sections excised and 
immunohistochemically processed to determine the mitotic spindle orientation. Epithelial 
organoids in vitro were treated with no (0mM), low (5mM) or high (20mM) amounts of glucose 
with or without an activator (Metformin) or inhibitor (Compound C) of LKB1-AMPK signaling. 
Cells were then processed to determine the mode of stem cell division. Fasted mice show a 
greater % of asymmetrically dividing cells compared with the other feeding groups. Organoids 
incubated with 0mM glucose resulted in a greater % of asymmetrically dividing cells compared 
with the low or high glucose conditions. In addition, LKB1-AMPK activation attenuated the % 
of symmetric division normally seen in high glucose conditions. In contrast, LKB1-AMPK 
inhibition attenuated the % of asymmetric division normally seen in no glucose conditions. 
These data suggest that nutrient availability dictates the mode of division and that LKB1-AMPK 
mediates this nutrient-driven effect on IESC proliferation.   
B.2 Introduction 
 The availability of nutrients can dictate the size of many tissues. Somatic stem cells sense 
the level of nutrients and increase or decrease the rate of proliferation to grow or retract tissue 
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size, respectively (Ochocki and Simon, 2013; Puig and Tjian, 2006). Stem cells have also been 
found to change their mode of division, from asymmetric to symmetric, in order to increase the 
number of cells during development, after injury or in abnormal tissue growth (Morrison and 
Kimble, 2006; Quyn et al., 2010). Whether changing the mode of stem cell division is utilized as 
a means of normal nutrient-induced mammalian tissue growth is unknown. The ability to switch 
cell division modes would allow stem cells to respond to the environment and change tissue size, 
but an “on” and “off” switch mechanism would be needed in order to maintain a balance in 
proliferation and prevent aberrant growth. Thus, identifying the mechanisms underlying nutrient-
induced stem cell proliferation would provide new targets for pharmacological manipulation to 
control tissue growth.   
 Changes in the mode of cell division require alignment of the mitotic spindle in an 
orientation parallel to the apical-basal axis and polarized localization of cell fate determinants to 
the apical or basal poles of the cell. This allows for two molecularly distinct cells to be produced 
and for the two cells to develop in different environments (one towards the apical border and the 
other towards the basal; see Fig. 2). The trigger for apical-basal protein localization and spindle 
orientation is unknown, but likely involves a metabolic cue. The best characterized of these is 
initiated by the activity of adenylate kinases that buffer declining adenosine triphosphate (ATP) 
production by converting two adenosine diphosphates (ADPs) to one ATP and one adenosine 
monophosphate (AMP). The accumulation of AMP activates adenosine monophosphate-
activated protein kinase (AMPK). This activation is dependent on the tumor suppressor protein 
LKB1 and leads to phosphorylation of several targets to improve the energy status in cells (Kahn 
et al., 2005). The role of the serine/threonine kinase 11-adenosine monophosphate-activated 
protein kinase (LKB1-AMPK) pathway is well known in metabolism and growth (Shackelford 
and Shaw, 2009) and mutations of the LKB1 gene lead to Peutz-Jeghers syndrome in humans, 
characterized by the development of benign polyps and an increased risk of developing cancer 
(Mehenni et al., 1998). In non-mammalian species, LKB1, or the homologous prostate apoptosis 
response 4 (Par-4), is known more widely as a PAR protein involved in directing the partitioning 
of molecules during asymmetric division (Benkemoun et al., 2014; Bonaccorsi et al., 2007). 
Therefore, LKB1 is a likely candidate for linking metabolism with changes in polarity during 
cell division. Moreover, AMPK has been shown to directly interact with the microtubule-based 
spindle (Thaiparambil et al., 2012). Thus, we propose that activation of the LKB1-AMPK 
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pathway that occurs under low nutrient availability results in asymmetric division and the 
maintenance of tissue size. Inhibition of this pathway under high nutrient availability would 
result in greater symmetric division and an expansion of the stem cell pool, resulting in growth 
of the tissue once asymmetric division resumes. 
 A unique model of nutrient-induced stem cell proliferation and tissue growth is provided 
by the intestinal epithelium. Maintenance of this tissue is driven by continuous proliferation of 
intestinal epithelial stem cells (IESCs) localized near the base of the crypts and nutrient 
availability is known to affect tissue size (Leblond and Stevens, 1948; van der Flier and Clevers, 
2009). In vivo, an increase in food intake or luminal nutrients results in a greater number of 
epithelial cells, villi height and crypt depth [methods include: intestinal transposition (Altmann 
and Leblond, 1970), hyperphagic animal models (diet-induced obesity (Mah et al., 2014), 
lactation (Crean and Rumsey, 1971), cold exposure (Kaushik and Kaur, 2005; Toloza et al., 
1991)], whereas, decreases in food intake or luminal nutrients does the opposite [methods 
include: fasts (Ross and Mayhew, 1985), surgical bypass (Gleeson et al., 1972; Robinson et al., 
1980), hibernation (Carey, 1990; Carey and Cooke, 1991)]. In vitro, varying the levels of 
specific nutrients or growth factors known to be indirectly related to nutrient abundance (i.e. 
insulin and insulin-like growth factor 1), correlates with the level of proliferation and intestinal 
epithelial organoid growth (Beyaz et al., 2016; Mah et al., 2014). Thus, we used an in vivo and in 
vitro approach to test whether the level of nutrients dictates the mode of division in intestinal 
epithelial tissue. Mice were fed varying amounts of a rodent chow diet and were separated into 
four groups; 1) Ad libitum fed (Ad lib) 2) Fed 50% of the average daily intake (50% fed) 3) 
Fasted or 4) Fasted for 12 h and then refed (Fast-Refed). All mice were terminated and small 
intestinal tissue samples were collected and processed to visualize the orientation of division. In 
vitro analyses were performed on epithelial organoids treated with varying amounts of glucose 
and immunohistochemically processed to visualize the mitotic spindle orientation. We further 
tested whether LKB1-AMPK signaling mediates the nutrient-induced switch in vitro by 
activating or inhibiting this pathway using Metformin or Compound C, respectively, in no or 






B.3 Materials and Methods 
In vivo Methods 
Animals 
 Male C57BL/6 mice (Jackson Laboratories, n=32 at 2.5 months of age) were housed 
individually in modified single shoe box cages with a raised platform and lined with brown kraft 
paper for collection of food spillage and feces, which allows for a more accurate measurement of 
food intake. Mice acclimated for 1 wk with ad libitum access to standard rodent chow diet 
(Teklad 22/5 Rodent Diet, Teklad Diets, Madison, WI) and tap water and maintained on a 12:12 
light:dark cycle (lights on at 1000 h). Mice were weighed daily at 0900 h under a red safelight 
(Adorama, New York, NY). Room temperature was maintained at 21ºC±1 with 60% relative 
humidity. All procedures were approved by the Institutional Animal Care and Use Committee at 
the University of Illinois Urbana-Champaign. 
 Following the 1 wk acclimation, food intake was measured each day for 4 d and an 
average food intake for each animal was calculated. The average food intake (13.6±0.5 kcal) and 
body weight (26.3±0.3 g) were used to equally divide the animals into four feeding conditions; 1) 
Ad libitum fed (Ad lib) 2) Fed 50% of the average daily intake (50% fed) 3) Fasted or 4) Fasted 
for 12 h and then refed for 6 h (Fast-Refed). Even though mice fed Ad lib have the highest 
available nutrients, these mice might be in a homeostatic state of proliferation because they have 
maintained this level of intake for multiple days (during acclimation and the 4 d of daily intake 
measurements). Thus, we have included the Fast-Refed group in order to ensure that we capture 
“growth” of the epithelium. At 1600 h, food was taken away from the Fasted and Fast-Refed 
group while the Ad lib group was given fresh food in excess of what the mice would normally 
eat. The 50% fed group was also given fresh food but only 50% of their average daily 
consumption. After 18 h in each feeding condition (at 1000 h), the mice were killed by 
decapitation under isoflurane anesthesia (Henry Schein Animal Health, Dublin, OH). An 
abdominal incision was then made and the intestine was exposed. We collected tissue from the 
duodenum, jejunum and ileum. To ensure that we are collecting similar segments of the intestine 
for analysis between animals, we measure from the pyloric sphincter, throw away the first cm 
and then collect a 2 cm sample to be processed for the mitotic spindle orientation and two 
additional 5 mm segments to be processed for other measurements. We then measure from the 
cecum, throw away the first 1cm and then collect a 2 cm sample to be processed for the mitotic 
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spindle orientation and two additional 5 mm segments of the ileum. From the remaining jejunal 
segment, we measure from the middle and collect a 2 cm sample and additional 5mm segments 
to be processed similarly to the duodenal and ileal segments.  
Tissue fixation and sectioning 
 Each of the 2 cm intestinal segments were flushed with cold 1X phosphate buffered 
saline (PBS) and then filled with 15 μM Taxol (S1150, Selleckchem, Boston, MA) diluted in 4% 
EM grade paraformaldehyde (PFA; Ted Pella, Redding, CA). Taxol was diluted from 10 mM to 
a working concentration of 15 μM in 1X PBS. The filled intestine was then placed into 3 mL of 
Taxol/PFA solution. Following a 6 h fixation in Taxol/PFA at RT, the tissue was immersed in 
30% sucrose diluted in 1X PBS overnight at 4°C. Tissue was then embedded using Tissue-Tek 
O.C.T medium (25608-930, 22 VWR, Radnor PA) and sections were cut on a cryostat at 8 um 
thickness and mounted onto charged glass microscope slides. Slides were left to dry overnight 
and then stored in slide boxes at RT before immunohistochemical processing. 
Immunohistochemical processing for mitotic spindle orientation 
 Sections were washed with 1X PBS and then incubated in 0.5% Triton X-100 (Triton-X, 
Sigma-Aldrich) diluted in 1X PBS (Lonza, Walkersville, MD) for 5 min at RT. The slides were 
then marked along the edges with a hydrophobic marker (ImmEdge; Vector Laboratories, 
Burlingame, CA) to allow for on-slide processing. All solutions applied directly to slides used a 
volume of 400 uL per slide. Slides were incubated in blocking solution (0.3% Triton-X, Sigma-
Aldrich, St. Louis, MO and 1% Bovine Serum Albumin, diluted in 1x PBS) for 20 min at RT 
followed by an overnight incubation at 4°C in rabbit monoclonal anti-α tubulin (DM1A) Alexa 
Fluor 488 conjugated antibody (Ab195887, Abcam, San Francisco, CA) at a 1:100 concentration 
diluted in the blocking solution. After rinsing in 1x PBS, sections were incubated in phalloidin 
AlexaFluor568 (A12380,ThermoFisher Scientific, Waltham MA ) at 165nM and 1 μg/ml DAPI 
(D1306, ThermoFisher Scientific, Waltham MA) diluted in 1x PBS for 15 min at RT. Slides 
were coverslipped with Permount mounting media (Fisher Scientific, Fair Lawn, NJ). Slides 
were stored short-term at RT and long-term at 4°C in light-proof boxes. Images of the sections 
were captured by digital camera attached to a Zeiss LSM700 Confocal Imager (Carl Zeiss 





Calculation of spindle orientation 
 Several cell inclusion criteria were set prior to analysis. 1) Dividing cells had be clearly 
adjacent to, and not overlapping with, other cells. 2) Dividing cells must be localized below the 
+4 position to exclude transit amplifying cells as described previously (Barker et al., 2012; 
Potten et al., 2009). 3) The crypt had to have a clear basal border, apical border and intercrypt 
lumen. 4) Tissue sections had to have clearly defined crypts adjacent to villi. 5) Cells had to have 
two defined spindle poles and spindle poles had to be in the same image plane. To determine the 
mode of division, the angle between the spindle poles and apical border was calculated using the 
ImageJ angle tool. As described previously described (Fleming et al., 2007; Quyn et al., 2010), 
an angle less than thirty degrees was considered a symmetric division and an angle over 30° 
indicated asymmetric division when in a single image plane. All dividing cells per 8 um section 
with a total of 48 um total per duodenum, jejunum and ileum were analyzed per mouse. Results 
from the duodenum, jejunum and ileum are presented separately and pooled and presented as the 
whole organ.  
Immunohistochemical processing for Ki67 
 Mounted tissue sections were heated for 30 min at 67°C. Sections were then washed in 
1X PB and antigen retrieval was performed by immersing slides in Sodium Citrate Buffer 
(Sodium Citrate Hydrochloride, Fisher Scientific and Tween 20, Sigma-Aldrich, Germany, pH 
6.0) for 20 min in a water bath at 95°C. Slides were allowed to cool for 30 min at RT and washed 
in PB. Tissue was then incubated in a blocking solution containing 0.3% Triton-X (Sigma-
Aldrich, St. Louis, MO) and 3% Normal Donkey Serum (Jackson Immuno Research, West 
Grove, PA) diluted in 1X PB for 20 min at RT. After blocking, tissue was incubated overnight at 
4°C in sheep monoclonal anti-Ki67 antibody (Santa Cruz Biotech, Dallas TX) at a 1:100 
concentration diluted in the blocking solution. Tissue was then rinsed in 1X PB prior to 
incubation in a donkey anti-sheep biotinylated secondary antibody (Ab6899, Abcam, San 
Francisco, CA) at a 1:500 concentration diluted in 1X PB for 2 h at RT. After washing in 1X PB, 
the tissue sections were then incubated in an avidin–biotin complex (Vectastain Elite reagents, 
Vector Labs, Burlingame, CA) for 1 h at RT. Tissue was washed in 1X PB and then incubated in 
diaminobenzidine (SK-4100, Vector Laboratories, Burlingame, CA) for 10 min at RT for 
visualization. Sections were washed in 1X PB, left to dry overnight, then dehydrated in a series 
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of graded ethanols and cleared in xylenes. Slides were coverslipped with Permount mounting 
media (Fisher Scientific, Fair Lawn, NJ) and stored at RT. 
Quantification of proliferating intestinal stem cells 
 Intestinal tissue sections were visualized and quantified using the NanoZoomer Digital 
Pathology System (Hamamatsu, Hamamatsu City, Japan) and NDP View 2 software using a 40x 
objective. 5-10 crypts per 8 um intestinal cross section was analyzed with a total of 48 um from 
each segment of the intestine (duodenum, jejunum, ileum) per mouse. Inclusion criteria included 
that crypt morphology had to have distinct apical and basal borders and labeled cells must be 
localized below the +4 position to exclude transit amplifying cells, as previously described 
(Barker et al., 2012; Potten et al., 2009). Quantification of proliferation was performed in two 
different ways; 1) number of positive Ki67 cells and 2) ratio of positive Ki67 to total number of 
cells in the proliferative zone. Furthermore, these data were analyzed both as whole organ 
(duodenal, jejunal and ileum data combined) as well as by individual segments to detect 
differences from the proximal to distal axis. 
In vitro Methods 
Isolation of Small Intestinal Crypts and Small Intestinal Crypt Culture 
 Male C57BL/6 mice (Jackson Laboratories) at 2.5 months of age were sacrificed under 
isoflurane anesthesia and the intestine was exposed. Approximately 2 cm of each intestinal 
segment was excised, opened longitudinally and flushed with ice-cold PBS. Crypts were isolated 
as previously described (Sato and Clevers, 2013). Villi were scraped off using a coverslip and 
the tissue was washed with ice-cold PBS in a 50 mL conical tube. In a sterile cell culture hood, 
intestinal fragments were cut into 1 mm x 1 mm squares and washed by gentle trituration in 30 
mL of ice-cold 1X PBS. Supernatant was discarded and the procedure was repeated 5 to 8 times. 
Fragments were incubated in 2 mM Ethylenediaminetetraacetic acid (Sigma Aldrich, Germany) 
diluted in 1X PBS at 4°C for 30 min with gentle rocking. The supernatant was removed and 
fragments were washed with 20 mL of ice cold 1X PBS. This was considered fraction 1. Fraction 
1 was discarded and fragments were resuspended in 10 mL of 1X PBS. After gentle trituration 
fragments were allowed to settle and the supernatant (fraction 2) was removed and put in a 50 
mL conical tube. This was repeated two more times, each time adding the supernatant to the tube 
containing fraction 2. These are considered fractions 3 and 4. Crypt fractions were passed 
through a 70 μm cell strainer and spun down at 300 x g for 5 min. The pellet was resuspended in 
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10 mL of ice cold advanced DMEM/F12 (11320082, Gibco, Elmhurst, IL) supplemented with 2 
mM GlutaMax (35050061, Gibco, Elmhurst, IL), 10 mM HEPES (15630080, Gibco, Elmhurst 
IL), and 100 U/mL penicillin/100 ug/mL streptomycin (15140148, Gibco, Elmhurst, IL). Crypt 
fractions were spun at 200 x g for 2 min to separate single cells. Crypts were counted using 
tryphan blue exclusion and an inverted light microscope. Crypts were then spun down and 
resuspended in Corning® Matrigel® Growth Factor Reduced (GFR) Basement Membrane 
Matrix (356231, Corning, Corning, NY) at 1000 crypts/50 μl. Fifty microliters of resuspended 
MatrigelTM was added to the center of a pre-warmed Millicell ® EZ slide (1.7 cm2 growing 
area per well) (EMD Millipore, Kankakee, IL). The plate was incubated in a CO2 incubator (5% 
CO2, 37°C) for 10 min to allow the MatrigelTM to solidify and 500 μl of complete culture media 
(Basal culture medium with N2 supplement (1×), B27 supplement (1×), and 1 mM N-
acetylcysteine, 50 ng/mL EGF, 100 ng/mL Noggin, 1 mg/mL R-spondin.). Primary crypt 
cultures were kept at 5% CO2, 37°C. 
In vitro experimental design 
 Following primary culture, crypts were allowed to grow for 4 d into epithelial organoids. 
At 0800 h on d 5, cultures were changed to glucose-free media (Basal culture medium with N2 
supplement (1×), B27 supplement (1X), and 1 mM N-acetylcysteine, 50 ng/mL EGF, 100 ng/mL 
Noggin, 1 mg/mL R-spondin) and incubated at 37°C at 5% CO2 for 4 h. Organoid cultures were 
then supplied with glucose at one of three concentrations, 0mM, 5mM or 20mM and incubated 
for 5 h. The glucose concentrations were chosen based on hepatic portal vein or systemic levels 
of glucose after or between meals in mice (Ayala et al., 2010; Han et al., 2008). After glucose 
incubation, the organoid cultures were fixed, immunohistochemically processed and visualized 
as described for the in vivo mitotic spindle orientation experiments. 
Activation or inhibition of LKB1-AMPK 
 Isolated crypts were allowed to grow for 4 d into epithelial organoids. At 0800 h on d 5, 
crypts were changed to glucose-free media and incubated at 37°C at 5% CO2 for 4 h. Organoids 
were then supplied with 0 mM or 20 mM glucose and either 1 mM Metformin HCL (Ab120847, 
Abcam, San Francisco, CA), 1 mM Compound C (Ab120843, Abcam, San Francisco, CA) or a 
vehicle control (ddH2O for Metformin and 10% DMSO in PBS for Compound C). Following a 5 
h incubation, organoids were fixed and immunohistochemically processed for visualization of 




 Values are expressed as the mean ± SEM. Mode of division data were analyzed based on 
the % of asymmetrically dividing cells in each group. Data from the in vivo and in vitro glucose 
concentration experiments were analyzed using a one-way ANOVA (feeding conditions or 
glucose concentration as independent measures). A two-way ANOVA was used to analyze the 
effect of LKB1-AMPK signaling on the mode of division (2 x 2; glucose concentration x drug 
treatment). Tukey-Kramer post hoc analysis was utilized, when appropriate, and differences 
among groups were considered statistically significant if P<0.05. 
B.4 Results 
Number of proliferating cells 
 There was no significant difference in Ki67-positive cell number in the crypt zone across 
the feeding conditions when the individual intestinal segments were analyzed (Figure B.1A-C) or 
when the segments were pooled and analyzed as a whole organ (Figure B.1D). There was also no 
difference in the ratio of Ki67-positive cells to total number of cells in the proliferative zone 
(data not shown). 
In vivo mode of division 
 In the duodenum, the Ad lib and Fasted-Refed groups had a significantly lower % of 
asymmetrically dividing cells compared with the 50% fed and the Fasted groups (Figure B.3A; 
P<0.05). In the jejunum, the % of asymmetrically dividing cells was significantly higher in the 
Fasted group compared with all other groups (Figure B.3B; P<0.05). Whereas, the Fasted-Refed 
group had a significantly lower % of asymmetric division compared with all other groups in the 
jejunum (Figure B.3B; P<0.05). There was not a difference between the Ad lib and 50% fed 
groups in the jejunum (Figure B.3B). In the ileum, the % of asymmetrically dividing cells was 
the highest in the Fasted-Refed group compared with all other groups (Figure B.3C; P<0.05). 
The Fasted group had a significantly higher % of asymmetric division compared with the Ad lib 
and 50% fed, but a significantly lower % than the Fasted-Refed group (Figure B.3C; P<0.05). 
There was no difference between the Ad lib and 50% fed groups in the ileum. When analyzed as 
a whole organ, there was a greater % of asymmetric division in the Fasted group compared with 
the other groups (Figure B.3D; P<0.05). No significant difference in the % of asymmetric 




In vitro mode of division 
 There was a greater % of asymmetric division in the 0mM glucose condition compared 
with the 5mM and 20mM glucose conditions (Figure B.4; P<0.05). No significant difference in 
the % asymmetric division was found between the 5mM and 20mM glucose conditions (Figure 
B.4). 
Activation and inhibition of LKB1-AMPK 
 There was a significant decrease in the % of asymmetrically dividing cells in the high 
(20mM) glucose condition compared with the no glucose condition (Figure B.5A; P<0.05). 
Metformin, or the activation of AMPK signaling, induces greater asymmetric division even in 
high (20mM) glucose conditions (Figure B.5A; P<0.05). There was a greater % of 
asymmetrically diving cells in the 0 Mm glucose without Compound C compared with the other 
groups (Figure B.5B; P<0.05). Compound C, or the inhibition of LKB1-AMPK, increased the % 
of symmetrically dividing cells even under a no glucose condition (Figure B.5B; P<0.05). There 
was no effect of Compound C under the high (20mM) glucose condition (Figure B.5).  
B.5 Discussion 
 The aim of these experiments was to investigate if nutrient availability alters the mode of 
division in IESCs and whether LKB1-AMPK plays a role in this nutrient-driven response in 
proliferation. The lead findings were: 1) the amount of food intake did not affect the number of 
proliferating cells in the crypt base, 2) the amount of food intake changes the mode of 
proliferation in vivo, 3) glucose availability changes the mode of proliferation in vitro, 4) LKB1-
AMPK activation attenuated the % of symmetric division normally seen in high glucose 
conditions and 5) LKB1-AMPK inhibition attenuated the % of asymmetric division normally 
seen in no glucose conditions. 
 It is not clear if there is an actual switch in the mode of division in a single stem cell, or if 
the nutrient-induced division pattern is represented by a population of stem cells where a subset 
divides asymmetrically and the other symmetrically. Although AMPK has been shown to 
directly modify the microtubules and spindle orientation in a single cell (Thaiparambil et al., 
2012), it is possible that a subset of stem cells may always divide asymmetrically while another 
divides symmetrically. Nutrient availability may then differentially affect each population. Even 
if this is the case, LKB1-AMPK appears to still be a mechanism by which high or low nutrient 
levels induces proliferation in only the symmetric or asymmetric population, respectively.  
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 Symmetric division can result in duplication of the IESC (self-renewal) or loss of the 
IESC due to production of two daughter cells that differentiate (non-stem cell fate). Although 
data support the notion that high nutrient availability induces symmetric self-renewal in order to 
increase the number of stem cells and grow the tissue once asymmetric division begins again 
(O'Brien et al., 2011), it is possible that there is also a switch between the two types of 
symmetric division patterns under nutritional variability. Lineage-tracing experiments can reveal 
whether the stem cells duplicate themselves or extinguish themselves by producing two daughter 
cells (Barker et al., 2007). When lineage-tracing was performed in Drosophila, the two types of 
symmetric division patterns are followed at equal rates and, thus, maintained the epithelium at a 
constant size (O'Brien et al., 2011). When high nutrient intake is maintained in mice over several 
months using a diet-induced obese model, an increase in the stem cell pool is seen suggesting 
that the IESCs did indeed divide utilizing a symmetric self-renewal pattern (Beyaz et al., 2016; 
Mah et al., 2014). Thus, we believe that the greater % of symmetric division that we see may 
also be represented by the IESC self-renewal pattern under acute changes in nutrients.  
 The glucose-dependent change in the mode of proliferation that we found in vitro mimics 
the many studies that find a correlation between the amount of luminal nutrients and crypt cell 
proliferation or growth of the epithelium in vivo (Altmann and Leblond, 1970; Beyaz et al., 2016; 
Cripps and Williams, 1975; Kaushik and Kaur, 2005; Mah et al., 2014). That said, it is not clear 
if the glucose levels that we chose to use are representative of the levels of glucose in the crypt 
microenvironment. Systemic levels of glucose in C57BL/6J mice, the strain utilized in the 
present study, vary greatly, but generally fall ~5 mM during acute fasts and as high as ~20 mM 
after meals (Berglund et al., 2008; Han et al., 2008; Klueh et al., 2006; Savontaus et al., 2008). 
These systemic values, though, may not be the same within the crypt microenvironment. The 
IESCs within the crypt are likely affected by the concentration of nutrients in the venules that 
would include ingested nutrients, systemic levels of nutrients supplied to the crypts by the 
superior mesenteric artery and cells underlying the crypt epithelium within the lamina propria. 
Thus, we do not know if the exact levels of glucose utilized reflect the in vivo crypt environment. 
We can only conclude that the crypt cells are able to respond to varying glucose levels by 






 The ability of stem cells to divide asymmetrically or symmetrically allows for flexibility 
of a tissue to expand or retract in size based on cues in the stem cell niche. We show that nutrient 
availability is such a cue and that a metabolic protein-kinase network is able to mediate this 
effect. How the stem cells sense the level of nutrients to induce these changes, though, is still 
unknown. This may involve a direct effect of nutrients on membrane transporters or receptors 
(e.g. the differential affinity of glucose transporters for glucose) or, as has been suggested by 
others, an indirect mechanism that involves growth hormones whose levels correctly reflect 
nutrient abundance. Understanding the normal mechanisms underlying changes in the mode of 
stem cell proliferation may elucidate signaling that lead to abnormal tissue growth and provide a 

























Figure B.1: Food intake does not dictate the number of proliferating cells in the crypt base 
Average number of Ki67-positive cell number in the crypt base of mice fed ad libitum (Ad lib), 
fed 50% of their normal daily intake (50% fed), fasted (Fasted), and fasted for 12 h and then 
refed (Fast-Refed) in the duodenum (A), jejunum (B), ileum (C) and combined as the whole 
intestine (D). n=8 mice per group, 5-10 crypts per 5um intestinal cross section was analyzed with 
a total of 30um from each segment of the intestine (duodenum, jejunum, ileum) per mouse. 









Figure B.2: Representative photomicrograph of symmetric (left) and asymmetric (right) 
divisions 
The mitotic spindle is in an orientation perpendicular to the apical border in symmetric division 
and parallel in asymmetric. Green=microtubules (α-tubulin); Blue=nucleus (Dapi); Red=apical 
border. Note that the chromosome alignment is in an orientation perpendicular to the apical 















Figure B.3: Food intake dictates the mode of division of proliferating cells in the crypt base 
% of dividing cells that were asymmetrically or symmetrically dividing in mice fed ad libitum 
(Ad lib), fed 50% of their normal daily intake (50% fed), fasted (Fasted), and fasted for 12 h and 
then refed (Fast-Refed) in the duodenum (A), jejunum (B), ileum (C) and combined as the whole 
intestine (D). n=8 mice per group, all dividing cells per 5um section was analyzed with a total of 
30um from each segment of the intestine (duodenum, jejunum, ileum) per mouse. Values are 
mean ± SEM. % of asymmetric division data were analyzed using a one-way ANOVA. Tukey-
Kramer post hoc analysis was performed. Means with different letters are significantly different. 







Figure B.4: Glucose availability in vitro dictates the mode of division of proliferating crypt 
cells 
Intestinal epithelial ids from mice were glucose deprived for 4 h and then incubated with 0mM, 
5mM or 20mM glucose for 5 h. Organoids were then immunohistochemically processed in order 
to determine the mitotic spindle orientation. All dividing crypt base cells per well (run in 
triplicate for each mouse) were analyzed. Values are mean ± SEM. % of asymmetric division 
data were analyzed using a one-way ANOVA. Tukey-Kramer post hoc analysis was performed. 
Means with different letters are significantly different. Means with different letters indicate 







Figure B.5: Adenosine monophosphate-activated protein kinase (AMPK) modulates the 
glucose-driven effect on the mode of proliferation in vitro 
(A) Activation of adenosine monophosphate-activated protein kinase (AMPK) using Metformin 
(M) induces greater asymmetric division in a high glucose (20mM) condition. (B) Inhibition of 
AMPK using Compound C (C) blocks the switch to asymmetric division normally seen in no 
glucose conditions. Epithelial organoids from mice were glucose deprived for 4 h and then 
incubated with 0mM or 20mM in the presence or absence of M or C. All dividing crypt base 
cells per well (run in triplicate for each mouse) were analyzed. Values are mean ± SEM. % of 
asymmetric division data were analyzed using a one-way ANOVA. Tukey-Kramer post hoc 












Figure B.6: Graphical representation summarizing the nutrient-induced effect on the mode 
of proliferation 
(A) Fed mice in vivo or high glucose in vitro inhibits the phosphorylation of AMPK (pAMPK) 
and results in vertical cleavage and symmetric division. (B) Metformin, an activator of AMPK, 
blocks the high glucose-induced effect in vitro and results in horizontal cleavage and asymmetric 
division. (C) Fasted mice in vivo or no glucose in vitro stimulates the phosphorylation of AMPK 
and results in horizontal cleavage and asymmetric division. (D) Compound C, an inhibitor of 
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C.1 Abstract 
 The sympathetic (SNS) and parasympathetic (PNS) branches of the autonomic nervous 
system have been implicated in the modulation of the renewal of many tissues, including the 
intestinal epithelium. However, it is not known whether these mechanisms are direct, requiring 
an interaction between autonomic neurotransmitters and receptors on proliferating epithelial cells. 
To evaluate the existence of a molecular framework for a direct effect of the SNS or PNS on 
intestinal epithelial renewal, we measured gene expression for the main autonomic 
neurotransmitter receptors in this tissue. We separately evaluated intestinal epithelial regions 
comprised of the stem, progenitor, and mature cells, which allowed us to investigate the distinct 
contributions of each cell population to this proposed autonomic effect. Notably, we found that 
the stem cells expressed the receptors for the SNS-associated alpha2A adrenoreceptor and the 
PNS-associated muscarinic acetylcholine receptors (M1 and M3). In a separate experiment, we 
found that the application of norepinephrine or acetylcholine decreases the expression of cyclin 
D1, a gene necessary for cell cycle progression, in intestinal epithelial organoids compared with 
controls (p < 0.05). Together, these results provide evidence of a direct mechanism for the 
autonomic nervous system influence on intestinal epithelial stem cell proliferation. 
C.2 Introduction 
 The intestinal epithelium is critical for nutrient absorption, hormone release, and immune 
barrier function. In order to maintain proper tissue function, intestinal epithelial cells undergo 
rapid turnover, a process that is driven by proliferating intestinal epithelial stem cells in the crypt 
(Barker et al., 2007). The stem cells divide to produce transit amplifying (TA) progenitor cells, 
which proliferate and differentiate as they migrate up the crypt. Once they reach the base of the 
villus, these cells are fully differentiated, and will serve their mature functions until eventually 
undergoing apoptosis at the villus tip (Figure C.1). Both branches of the autonomic nervous 
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system (ANS) have been implicated in the control of this turnover process, as denervation 
(surgical or chemical) of either sympathetic (SNS) or parasympathetic (PNS) nerves to the 
intestine alters intestinal epithelial cell proliferation (Callaghan, 1991; Kennedy et al., 1983; 
Lachat and Goncalves, 1978; Musso et al., 1975; Tsibulevskii and Orlova, 1976; Tutton and 
Helme, 1974). However, it is not known if these changes occur via direct or indirect mechanisms. 
Previous studies may have detected indirect effects on proliferation due to post denervation-
induced changes in food intake, inflammation, or other factors that can alter intestinal epithelial 
cell proliferation (Dailey, 2014; Slater et al., 2017). In contrast, a direct effect could potentially 
be driven by autonomic neurotransmitters binding to receptors localized on proliferating cells of 
the intestinal epithelium. SNS and PNS neurotransmitter receptors are expressed by cells of the 
intestinal epithelium (Greig and Cowles, 2017; Valet et al., 1993) and mediate various epithelial 
functions (e.g. fluid transport and hormone release) (Greenwood et al., 1987; Rocca and 
Brubaker, 1999), but whether the stem cells or TA cells express these receptors and mediate 
changes in the cell cycle has not been investigated. Because a direct effect of the SNS and PNS 
has been shown to alter the regeneration of other tissues [e.g. liver (Cruise et al., 1985; Oben et 
al., 2003a)], we postulate that the SNS and PNS could modulate intestinal epithelial regeneration 
through direct control of the cell cycle downstream of neurotransmitter receptors.  
 To determine if the main neurotransmitters for the SNS and PNS, norepinephrine (NE) 
and acetylcholine (ACh), can mediate a direct action on the proliferating cells of the intestinal 
epithelium, we evaluated gene expression for the alpha2A adrenoreceptor (Adra2a) and the 
muscarinic acetylcholine receptors M1-M5 (Chrm1-5, also known as cholinergic receptor 
muscarinic 1-5), which were selected due to previous studies localizing them within the intestine 
and implicating them in control of proliferation (Greig and Cowles, 2017; Schaak et al., 2000; 
Valet et al., 1993). We analyzed the expression of these receptors in the two major regions of the 
intestinal epithelium, the crypts (where the proliferating cells reside) and the villi (where the 
mature cells reside) in mice. Then, we further analyzed whether crypt cell receptor expression 
occurred in the stem cells or the other non-stem crypt cells (the vast majority of which are the 
TA cells). In addition to investigating the presence of the molecular framework for the 
autonomic nervous system to influence intestinal epithelial turnover, we also investigated 
whether NE or ACh could induce changes in the cell cycle. We used intestinal epithelial 
organoids grown in vitro to measure the response of NE or ACh on the expression of cyclin D1 
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(Ccnd1), which is critical for the progression of the cell cycle from G1 to the S phase and 
remains at high levels until the end of mitosis. Both alpha2A adrenoreceptor and muscarinic 
acetylcholine receptor signaling have been linked to changes in cyclin D1 in other tissues, 
resulting in changes in the cell cycle and/or proliferation (Arredondo et al., 2003; Braga et al., 
2013; Karkoulias and Flordellis, 2007; Peng et al., 2013). Thus, these experiments begin to 
describe the molecular components and physiology through which a direct ANS control of stem 
cell proliferation and tissue regeneration may occur.  
C.3 Materials and Methods 
Ethical Approval 
 All procedures were approved by the Institutional Animal Care and Use Committee at the 
University of Illinois at Urbana-Champaign, which operates under the Association for 
Assessment and Accreditation of Laboratory Animal Care International guidelines.  
Animals  
 Adult male G protein-coupled receptor 5-enhanced green fluorescent protein-internal 
ribosome entry site-cyclization recombinase-estrogen receptor T2 (LGR5-EGFP-IRES-
CreERT2); n = 3 for receptor expression experiment) and wild type (C57BL/6J; n = 3 for the 
receptor expression experiment and n = 3 for the proliferation-related gene expression 
experiment) mice were used (Jackson Laboratory, Bar Harbor, ME).  These transgenic animals 
were selected for their global and constitutive expression of a green fluorescent protein tag on 
the intestinal epithelial stem cell marker Lgr5 (Barker et al., 2007). A power analysis (G*Power 
3.1.9.2) based on previously published and our preliminary data investigating mRNA expression 
differences between IESCs and other crypt cells show that to achieve a power = 0.8 and a type I 
error of 0.05, an n = 3 mice per group are needed (Akcora et al., 2013; Kechele et al., 2017; 
Mustata et al., 2011; Tsai et al., 2014; Zhou et al., 2018). Animals were single housed in shoebox 
cages and maintained with ad libitum access to tap water and laboratory chow (Teklad 22/5, 
Envigo, Madison, WI) on a 12:12 light:dark cycle (lights on 0700) in a climate-controlled room 
(temperature = 21±2°C and humidity = 50±10%).  
Isolation of small intestinal crypts and villi 
 Small intestinal crypts were isolated as previously described (Sato and Clevers, 2013; 
Zhou et al., 2018). Briefly, the animals were anesthetized under 3% isoflurane at 1.5L/min in an 
anesthesia induction chamber and then decapitated. The entire small intestine was harvested, 
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opened longitudinally and washed with cold 1x PBS to remove luminal contents. The villi were 
scraped off with a coverslip. Villi from the wild type mice (biological replicates, n = 3) were 
collected into a falcon tube, and centrifuged at 300 g at 4°C for 5 min. The supernatant was 
removed and the pellet containing the villus cells was immediately stored at -80°C to await 
processing. The remaining intestinal tissue was cut into 2-4 mm pieces with scissors and washed 
5-10 times with cold 1x PBS until the supernatant was almost clear. Tissue fragments were 
incubated with 2 mM EDTA (Fisher Scientific, Pittsburgh, PA) and gently rocked at 4°C for 30 
min. After removal of EDTA, tissue fragments were washed with 1x PBS 3 times. The 
supernatant was then collected and passed through a 70-um cell strainer (Corning, Corning, NY) 
and centrifuged at 300 g at 4°C for 5 min. The cell pellet was resuspended with basal culture 
medium [Advanced DMEM/F-12 Medium (Gibco, Grand Island, NY) containing 2 mM 
GlutaMax (Gibco, Grand Island, NY), 10 mM HEPES (Gibco, Grand Island, NY) and 100 U/mL 
Penicillin-Streptomycin (Gibco, Grand Island, NY)] and centrifuged at 300 g 4°C for 5 min. The 
supernatant was removed. The isolated crypts from the wild type mice (biological replicates, n = 
3) were immediately stored at -80°C to await processing. The isolated crypts from the Lgr5-GFP 
mice (biological replicates, n = 3) were used for intestinal epithelial stem cell isolation (see 
Isolation of IESCs). Both sets of samples were then processed to evaluate gene expression (see 
Quantitative real time polymerase chain reaction). Isolated crypts from the second set of wild 
type mice were grown into organoids (see Organoid growth).  
Isolation of IESCs 
 Isolated crypts from Lgr5-GFP mice were resuspended with single cell dissociation 
medium [basal culture medium containing 1x N2 (Gibco, Grand Island, NY), 1x B27 (Gibco, 
Grand Island, NY) and 10 uM Y-27632 (Sigma-Aldrich, St. Louis, MO)] at 37 °C for 40 min. 
During incubation, the cell suspension was resuspended every 10 min. Dissociated cells were 
passed through a 40-um cell strainer (pluriSelect, Leipzig, Germany), followed by a 20-um cell 
strainer (pluriSelect, Leipzig, Germany) and centrifuged at 300 g at 4 °C for 5 min. Single, live 
IESCs were sorted as GFPhigh (stem cells) or GFPlow (other crypt cells) by fluorescence-
activated cell sorting (FACS) with a BD FACS ARIA II sorter into single cell dissociation 
medium as previously defined cell populations (Sato and Clevers, 2013). Dead cells were 
excluded from the FACS with the viability dye propidium iodide (Invitrogen, Carlsbad, CA). 
Sorted cells were centrifuged at 300 g 4°C for 5 min, supernatants were removed, and the pellet 
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was immediately stored at -80°C to await processing for qPCR (see Quantitative real-time 
polymerase chain reaction).  
Organoid growth  
 After the final centrifugation in the crypt isolation process, the supernatant was removed 
and crypts were re-suspended in Matrigel (Corning Inc., Corning, NY) and plated in triplicate 
(three technical replicates (i.e. wells) per treatment from each biological replicate) onto a pre-
warmed 24-well plate. Matrigel-crypt mix was applied to the center of each well and then 
allowed to solidify for 10 minutes in a 37°C incubator. Once the Matrigel solidified, 500 μL of 
IntestiCult Organoid Growth Medium (StemCell Technologies, Cambridge, MA) was added per 
well. Media were changed after 4 days of growth. After 5 days of growth, organoids received 
one of 3 treatments: 1 μM norepinephrine (A0937, Sigma Aldrich, St. Louis, MO), 1 μM 
acetylcholine (A2261, Sigma Aldrich, St. Louis, MO), or a vehicle control. The physiological 
neurotransmitters of the ANS were used instead of pharmacological agents targeting specific 
autonomic neurotransmitter receptors in order to most closely mimic the in vivo physiology of 
this system. Doses were chosen based on other studies demonstrating NE- or ACh-induced 
proliferation in other cell types in vitro (Cruise et al., 1985; Liu et al., 2017; Liu et al., 2014; 
Oben et al., 2003a; Oben et al., 2003b). 24h after treatment administration, Matrigel was 
dissolved using 1 mL QIAzol (QIAGEN; Germantown, MD), the cells vortexed, and stored at -
80°C to await processing (see Quantitative real-time polymerase chain reaction).  
Quantitative real-time polymerase chain reaction (qPCR)  
 Total RNA was extracted from samples using RNeasy Plus Universal Mini Kit (Qiagen, 
Hilden, Germany). RNA was reverse transcribed to cDNA using iScript cDNA Synthesis Kit 
(Bio-Rad, Hercules, CA). qPCR was performed with TaqMan Universal PCR Master Mix 
(Applied Biosystems, Foster City, CA) and TaqMan probes (Applied Biosystems, Foster City, 
CA) using Applied Biosystems 7900HT Real-Time PCR System. Negative reverse-transcribed 
samples were generated and all reactions were carried out in triplicate.  Technical triplicates 
were generated from each biological sample in the autonomic neurotransmitter gene expression 
experiment, and from each cell culture well in the experiment using organoids.  The following 
TaqMan probes were used: alpha2A adrenoreceptor (Adra2a): Mm00845383_s1, cholinergic 
receptor muscarinic 1 (Chrm1): Mm00432509_s1, Chrm2: Mm01701855_s1, Chrm3: 
Mm00446300_s1, Chrm4: Mm00432514_s1 , Chrm5: Mm01701883_s1, cyclin D1 (Ccnd1): 
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Mm00432359_m1, glyceraldehyde-3-phosphate dehydrogenase (Gapdh): Mm99999915_g1. To 
determine relative expression values, the 2-ΔΔCt method was used, where triplicate Ct values for 
each sample were averaged and subtracted from those derived from GAPDH. 
Confirmation of compliance  
 The investigators understand the ethical principles under which Experimental Physiology 
operates. This work complies with the animal ethics checklist outlined in ‘Principles and 
Standards for Reporting Animal Experiments in Experimental Physiology.  
Data analysis  
 All variables were analyzed using Number Crunching Statistical Software (NCSS LLC, 
Kaysville, UT). Data were expressed as fold change compared to control, and are expressed as 
mean fold change ± SD. Two-tailed independent two-sample student’s t-tests were used to 
determine differences between: 1) Adra2a expression in villi versus crypts, 2) Chrm1 expression 
in villi versus crypts, 3) Chrm2 expression in villi versus crypts, 4) Chrm3 expression in villi 
versus crypts, 5) Chrm4 expression in villi versus crypts, 6) Chrm5 expression in villi versus 
crypts, 7) Adra2a expression in stem cells versus other crypt cells, 8) Chrm1 expression in stem 
cells versus other crypt cells, 9) Chrm3 expression in stem cells versus other crypt cells, 10) 
Ccnd1 expression between NE treatment and control, and 11) Ccnd1 expression between ACh 
treatment and control. Assumptions of normality, homogeneity of variance, and independence 
were met. No inclusion or exclusion criteria were applied to the datasets. Differences were 
considered to be statistically significant at p < 0.05. 
C.4 Results 
Autonomic neurotransmitter receptor expression in the intestinal epithelial crypts and villi 
 We found that the crypts expressed Adra2a (122.3-fold ± 45.8), Chrm1 (26.4-fold ± 0.8), 
Chrm3 (17.2-fold ± 8.4), and Chrm4 (2.4-fold ± 0.7), but there was no detectable expression of 
Chrm2 nor Chrm5 (Figure C.2). We found that the villi expressed Adra2a (2.4-fold ± 0.7), 
Chrm1 (6.2-fold ± 0.2), Chrm2 (1.0-fold ± 0.7), Chrm3 (5.1-fold ± 0.4), and Chrm4 (3.6-fold ± 
0.7), but there was no detectable expression of Chrm5 (Figure C.2). Adra2a was expressed at 
higher levels in the crypt compared with the villi (p = 0.015; crypt: 122.3-fold ± 45.8 versus 
villi: 2.4-fold±0.7, estimated difference: 119.9-fold, 95% confidence limits of difference: 78.4 
≤d≤ 161.5; Figure C.2). Similarly, Chrm1 was also expressed at higher levels in the crypt 
compared with the villi (p = 2.0x10-6; crypt: 26.4-fold ± 0.8-fold versus villi: 6.2-fold ± 0.2 
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estimated difference: 20.2-fold, 95% confidence limits of the difference: 18.9 ≤d≤ 21.6, Figure 
C.2).  
Autonomic neurotransmitter receptor expression in intestinal epithelial stem cells and other 
crypt cells 
 We found that the stem cells expressed Adra2a (13.5-fold ± 2.8), Chrm1 (5.9-fold ± 0.9), 
and Chrm3 (3.0-fold ± 2.0) (Figure C.3). We found that the other crypt cells also expressed 
Adra2a (6.4-fold ± 2.0), Chrm1 (4.9-fold ± 0.6), and Chrm3 (1.0-fold ± 0.03) (Figure C.3). 
Adra2a was expressed in the stem cells to a higher level than the other crypt cells (p = 0.022; 
stem cells: 13.5-fold ± 2.8 versus other crypt cells: 6.4-fold ± 2.0, estimated difference: 7.1-
fold, 95 % confidence limits of the difference: 1.6 ≤d≤12.5, Figure C.3).  
Effect of autonomic neurotransmitters on expression of a proliferation-related gene in intestinal 
epithelial organoids 
 Norepinephrine (NE) decreased relative mRNA expression of Ccnd1 in intestinal 
epithelial organoids compared with control (p = 0.037; NE: 0.78-fold ± 0.06 versus control: 1.0-
fold ± 0.10, estimated difference: 0.21-fold, 95% confidence limits of the difference: 0.02 ≤d
≤0.41, Figure C.4A). Acetylcholine (Ach) decreased expression of Ccnd1 intestinal epithelial 
organoids compared with control (p = 0.047; ACh: 0.77-fold ± 0.10 versus control: 1.0-fold ± 
0.10, estimated difference: 0.23-fold, 95% confidence limits of the difference: 0.003 ≤d≤ 0.36, 
Figure C.4B).  
C.5 Discussion  
 The present study determined that the SNS and PNS autonomic neurotransmitter 
receptors are expressed in the villus, crypt and stem cells of the intestinal epithelium. Notably, 
Adra2a, Chrm1, and Chrm3 were expressed in both populations of proliferating cells, the stem 
cells and the TA cells. In addition, we found that application of NE or ACh decreased the 
expression of cyclin D1 in intestinal epithelial organoids. Together, these findings suggest that 
both the SNS and PNS may be capable of directly influencing intestinal epithelial cell 
proliferation by a direct modulation of the stem cells.  
 Sympathetic (SNS) and parasympathetic (PNS) nerves come in close contact with the 
intestinal epithelium, which supports the idea of a direct autonomic effect on intestinal epithelial 
cell proliferation and tissue renewal (Bohorquez et al., 2015; Gabella and Costa, 1968). 
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Norepinephrine (NE) and ACh released from these terminals may bind to receptors on the stem 
cells and/or the TA cells to affect proliferation. Both NE and ACh have been shown to directly 
alter proliferation in other cell types, mediated through a variety of adrenoreceptor and 
muscarinic receptor subtypes (Bronnikov et al., 1992; Cruise et al., 1985; Geloen et al., 1988; 
Liu et al., 2017; Liu et al., 2014; Morgan et al., 2016; Oben et al., 2003a; Oben et al., 2003b; 
Sloniecka et al., 2015). However, in contrast to other organ systems, the gastrointestinal (GI) 
tract is innervated by the enteric nervous system (ENS). The ENS makes synaptic contacts with 
both the SNS and PNS, but also provides intrinsic neural control of gastrointestinal functions 
independent of extrinsic innervation. Due to input from multiple neural systems, the source of 
neurotransmitters effecting changes in intestinal epithelial cells must be considered. All 
noradrenergic innervation of the GI tract is sympathetic, as the ENS does not utilize NE as a 
neurotransmitter (McConalogue and Furness, 1994). Thus, our results demonstrating that NE 
alters expression of cyclin D1 can be attributed exclusively to the SNS, without participation of 
enteric neurotransmission. In contrast, since ACh is both a PNS and ENS neurotransmitter, it is 
not possible to elucidate the effect of PNS versus ENS sources of ACh in the present experiment 
alone. However, considering PNS denervation alters intestinal epithelial cell proliferation despite 
enteric circuitry remaining intact (Callaghan, 1991; Lachat and Goncalves, 1978; Musso et al., 
1975; Tsibulevskii and Orlova, 1976), it is plausible that the PNS participates in mediating 
intestinal epithelial cell proliferation via ACh signaling.  Thus, our results support the narrative 
that the intestinal epithelium is among the tissues in which regeneration is under direct SNS and 
PNS control.  
 We found that both NE and ACh both decrease expression of cyclin D1 in intestinal 
epithelial cells in vitro. As the effects of the SNS and PNS are usually thought of as antagonistic, 
opposing effects of NE and ACh on cyclin D1 might be expected. However, a more nuanced 
description of the ANS includes cooperative function of the SNS and PNS on certain organs (e.g., 
iris muscles in the eye and sexual organs (Wehrwein et al., 2016)). This SNS and PNS 
cooperation is also seen in regard to control of cell proliferation, as NE and ACh both increase 
proliferation of hepatic myofibroblastic stellate cells, reflecting the dual participation of the SNS 
and PNS in liver regeneration after injury (Oben et al., 2003a; Oben et al., 2003b). Similarly, the 
SNS and PNS may differentially coordinate suppression of intestinal epithelial cell proliferation 
in vivo. This may be a strategy for the ANS to inhibit proliferation during specific body states. 
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When sympathetic tone is high, the SNS coordinates an overall decrease in energy and resources 
to the intestine (Browning and Travagli, 2014; Wehrwein et al., 2016), which may subsequently 
limit the energy available for cell proliferation. In contrast, PNS tone is increased during 
digestion, which is accompanied by increased cellular metabolism and subsequent reactive 
oxygen species (ROS) byproducts (Granger et al., 2015). Because ROS induces DNA damage 
that can cause DNA synthesis errors, this may not be an ideal environment for cell proliferation 
(Cadet and Wagner, 2013; Oberreuther-Moschner et al., 2005). Thus, by decreasing cyclin D1 
expression under conditions of exceptionally high SNS or PNS tone, the ANS may be restricting 
progression of the cell cycle during physiological states that are unfavorable for proliferation. 
 The present study also revealed which autonomic neurotransmitter receptors are 
expressed in proliferating cell populations of the intestinal epithelium, thus identifying 
candidates for mediation of this proposed direct effect of the ANS on proliferation. Previous 
research has shown that the disruption of these receptors can modulate proliferation. Intestinal 
epithelial cell proliferation is increased in transgenic mice with global knockouts of M1 (Chrm1) 
or M3 (Chrm3) compared with wild type controls (Greig and Cowles, 2017). In addition, 
proliferation is altered in a CaCo2 cell line model of intestinal epithelial cells transfected to 
express the alpha2A adrenoreceptor (Adra2a) (Schaak et al., 2000). Therefore, under 
homeostatic conditions, it is likely that the specific receptors we have identified on the stem cells 
and the TA cells are directly modulating proliferation via autonomic neurotransmitter signaling.  
 We can now use the results from this study as a framework to definitively demonstrate 
which specific proliferating cell subpopulation is driving these changes in proliferation-related 
events: the stem cells, the TA cells, or a combination of both cell types. Stem cell isolation 
techniques used in this paper can be further employed to answer these research questions, which 
will add to the understanding of the interactions between somatic stem cells and the autonomic 
nervous system. In addition, we can also reveal the exact intracellular signaling mechanisms that 
are causing changes in cyclin D1 downstream of the autonomic neurotransmitter receptors. Our 
current results provide a foundation for in-depth exploration of neural control of stem cells in the 
intestinal epithelium, and can be expanded to investigate stem cells from other tissues throughout 
the body. Further research on this topic is necessary to elucidate the mechanistic details and 






Figure C.1: Intestinal epithelial morphology 
Stem cells (black) reside at the base of the crypt. Other crypt cells (white) are primarily 
comprised of transit amplifying (TA) progenitor cells. The stem cells and TA cells proliferate to 
produce mature intestinal epithelial cells (gray), which reside in the villus and serve the major 













Figure C.2: Expression of autonomic neurotransmitter receptor genes in villus and crypt 
cells 
Relative mRNA expression of alpha2A adrenoreceptor (Adra2a), cholinergic receptor muscarinic 
1 (Chrm1), Chrm2, Chrm3, Chrm4, and Chrm5 in the intestinal epithelial villi and crypts (n = 3, 















Figure C.3: Expression of autonomic neurotransmitter receptor genes in stem cells and 
other crypt cells 
Relative mRNA expression of Adra2a, Chrm1, and Chrm3 in the intestinal epithelial stem cells 















Figure C.4: Effect of autonomic neurotransmitters on expression of a proliferation-related 
gene in intestinal epithelial organoids 
(A) Effect of norepinephrine (NE) on relative cyclin D1 (Ccnd1) mRNA expression in intestinal 
epithelial organoids compared with control (n = 3; * p < 0.05). (B) Effect of ACh on relative 
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